var title_f25_62_26592="Diffuse optic atrophy";
var content_f25_62_26592=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76278&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76278&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diffuse optic atrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 428px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGsASADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwwJ3GMe1PGcYcd6eOrZ6DjGKnVRnkZU1xykdEUmiKMrxyanQhUYjrT0iDKMgehPrUflKWbr6cVm2mapWHgblz79+1O2BSdwHvSRwFBkO2P5U5kJPL8d+OlTc0VmiIAcHnHTNWEyeOcjvUSwycFSre2KsRo4XBQcjtUyZdODbHDAYEgk0YIcuTkDtSGUr1TAx0NNMp6BCcn2rKzNVGSZOMtwpxn3psj4I+bJ61EJepCnkUxmZgMr06Uco5ydtC2SCAGx0z1qFs56jAqNJW3cpkgY+lTh8KSyc4/OhKxlK8kR7Tgc4GamUttG05wO9QrMA44IHT6VPDIuM8j2olcmzQhXeMZOR3B5q9EMRjeeOoxVVVBf5foTirkSg4z1rOT0Oii9SCdRLFIDgccVJYRhoffOMYqQphjwcH0703TzsV8jgH8Km94s2jHR3LOwgE/L71zesoRdB+dr8eldCx3EglQOoxWVq6B7bdtHyGroNqWpMp9h2lyFrTsSPlqR1YDkksPX61U0TBEyHjHatERA8k4A5FOfuyZzzVx8CDAJ6DtUV1t8xPXv6VM2BHkHPt61Ukw0oLDkDtURV3cUmoqwgzI3BGM96l+ZQOOfao41O3jBB6YqRdwYAnNUY30Fj4yScH1qcD1b3qJWJU9OBRuBOAcHFS2yoRTGzLljgZNQMvPofWrTFR3qGWRGyAP1qothOKRRuCGwAODzzTdpEeSOfrVggMcHk9jinSeUsQJ4b0NbXsZxp3uzJuULLk5wOpNUiMt/se1assRlQl8hfSqM67Vrpps5a8VAlkyeAKkj+RfmzuHIpUOzduAPrTmAwDnPPWpfY3iupKMBVxx65p8Y3nGMd8mmrlQOhB7/hSocjGPTFZM3ikSMu3Iz19+Ki5LZ5AJ5FSg5Iy3T0PWlK7Tt7ZOfUUhtIjjIzgEBverMUmzqA3pmmBFOCc4HoKUk8+nWolqXTQu/c5B4z1FSKxOQR7ZqvtO4bueOCKkJGfl+lQ0acy6jscA5HUjPrTmLKGGOR3pVbBwATjjPSnugK9R361LZMo3V0UgXwQTz35qdM4w2cd6idCC3AOe47U8Kec5I7mrMdh6R/Oeh/lTCgYjoO3Hen4xGvp1HvS7eOQam40rCRh1UYwe/rVmCQZwetRggAjHXrmnHa3Iz7EUnqWpalkyAKQcY9aisjkMAehpm1h97B5xxUlimzeCDuz2qbWRr7R8rHOcDAH1NQywtLBJHgjIPWrsiF2+UYFOWMJw4/GhSsjLmuzntG+W82t0cHOT3rdlATGMEfSsa3Ag1Jf981v8MCTzV1nqmVJalZ+AMBQMc1WdBnOeMZyatHAYkkfhTVAIIOTz9KiOiIepWLKvHIPt1o+8RzU8kQXOOB7VGijPPWqRm1fQft+QknJxUAOWx05qaRsKR19MGoiQMHPekhyVhjnOe3P41BJHgcngjk087SSxY5BzUDN8u4k1rFGMpXG+YFyS3XoKI0Mh3uec5x3qSCAyEvJkegqQgjAPIz6Vd0thNuKshpxtB/lWZfKADnpWrIwHykY9OOlZ+ocpxwPTNaU9zOo+aGoMxCsACD60sKkod4PfHtTlGDkDmpJzuUbRgdDim30NlEaclFAxxx19qcgIIOewyaUxBQM8568dKUKCpJJFQzaOwfQ5IqSI7lO4kEe3Wo8HGG5xQAep4HX60hbCjHmEZwP6VMq/JlSf8KhX7y4wcnHHangsA3GB3qZXKg+40na2chjTkLMD2J9aTncAFHXPFPRPnOQRx1xUsb3HRrtAA5welTKd689u5oXaYgSfxxim4HAyPas3qVG60EZTvGeAO1GMHaPX86UHcMMNwz1x0qTaoJI6npxT9ROGtxm1gQcnn2o645IxT8g9SB7daVEwemaT7it0GxrucE8kmnYySBTlBJXCjrzzU6RAthjjHak2OwyFRJ2J+tW7WIRuCeN3rSIqR/IfvdeKnhUyArkkHuaiTBWW5JKoUYUjNVmUseuFHINaaWzugBQ7hx06VIdPdlyY3468VmpWJd0chdJ/ppYE53CtkjK8HniquoWzRXhBUgZGKvmMDKtW05XSKlpYqKm9snH0p/lNsPIHfpzTzCSCFzuPOKaVIGTxgdRUp3M3JIhb7uBnjrUYI2nIGfWpZGLKOBk1VckPyCaqKuDklqOlC9PWoXjwQMlqlMR69vr0pMhU+bqOc1S0FfmZTlARctnHpTLeIswkkPHZasGPzTucHZ2FSsqhcjJFac1kL2dmQsBuHoe1Ndg2B3zU+xArF8g44GOpqEjjjrQmZNEUgDEckgc5qjdDdyAxIzkf1q9vIBzjI60Mqsc4B/Ctoys7kuPNG1yEINpx0OOaYwwAMjb71KnRs800AnoBz60Pc6CxmJoyAuATxnrTBtCrjB9cmoMMDhs4PpT41JPQ4649ajlLUyRV/dhgAc5/CkihLqfzqZVz049s01GwwxxijUHa5GIirgep9O1OkXGPyz607OX5PX06U9QcYY5HfJzUsEiKFSWIJxxxipwCFyoxjjJqQAZOBx7VGuWyN2QPSs27jSsLKWCcc/jSxk4yVwBzmlOBgKPqP600Bgfvfge9Jlkx2nDKOScmg4JGW5HOKcAMc5DfpSIm5ueDSQNjo0BOMdP1qRz5YP93scU9EAQ5OMDrUDuSpXHU0t2SmhVO5sJxV+CwmlK7STu54FXNE0zzpEKgtIe57CvSPDugJHGsk2Nx5xWNSryicr7HM6P4Ra5hV5iUGe4611lh4VtLfazxhzjrXUQWy4AAGB2q9FDgAYGDXHKvJvQmy6nKz6Vb21wlwsQ8sja4x+tXWsYinCL+VbU9orxupHykYIrOtyYnNtN94fcb1FZuTaNlaS06Hmvi/TYv7YQKoG7HSoNU8NzQQiVAHTGfpXSeK4ANdtcjhiP511LW6tEAQCMDqK29o4pGlaK5I2PFJI9i47iqQXafQE/lXoHivREiDT264z95R2rh5o/KcluBXTTndHBNNMpvEAxLHjHFReWG68Z6VNIQx4PJp5AXHpj8DWt2CKUqAAcgEdeKiCeYSxHA9amlUu5AB2j9aRztHpVptI0SsRHg9OtDHHAAoBpc5ztxn3phEickKcj6ZqLIJ54PbNSSbmJB6etVmGflCk4rSJlPcQuOmR/SmebuyFPHpUchIXBAyPSlXGQD36HPWtUjBvURH2kqc59aeMnI7HrQgDNyOnFTKqkEg4OeAaGzshG5CyktVmFGhk/fIWA5K5xmmpGGYZzkU92LPmUlj2z1FRJ30NFTtqEhABI7jIqFSeCvJHTNWRGojDE8nt6UwQkISOT6daSkhODuNKkjJGO1LtYfTtUqrwARg9808Y9j2qHIrlI0ZuhU4HB96lRQAT3NHTkYoV8Zzx6+1RcLWFAH3sGlOOBnOKeo3DGeaXZ8u5gO4+tJuwAoGME1KIxjKHI4Jpgj+TOCBmngFVPIxjFFyWwc5O04Ax1zVqxtBJKuV3E9KzTua4VMjmut8NW7vexL0OcCs6kuVaCudr4V0oRRLIyrt7ZGDXX28Q44AHpUNrCoUKBwPQVfjiG4KvevOnLmY9iaJQeFq7HGdvUGnW1sFwMVfEO0fKMmmoGMplEp2I/Gs7VLETw/KcSLyrehro/JXGM5+lQS2+c4GKfLYIVLO6PMPEccs3lSSIRcQHJ966TTZkurGORe6jI960tX02O5iII+bsRXO6aTYXLW0o2hjwexpSs46dDv5lVp6bom1CAMJPlB4xivNPE+jfZT5kSHyHPb+FvT6V61PHknHORWBq1jHcwSxS/cYYOO1OnU5Wc0o3PF5YmjJzyfam78Lg/jntW3qGnG1maOQ7ipxuHesmaMAjYMAfrXfCaZi1bcaoJTI6VXlU4OCOlThm6HrULjjH49apbgrlZxgj6+tPCELnP9cU90Bwcc/lT9u/7v3ulXc0joimxG7rio3QcH0q28Xy4OAc5+tMeP86tSREo3KLx5B44NMMfPqOtW2HI/LrUbYC8DjvWqkYOJWV9v8OQe+OlSo2CCAOe9RHKAgjBB705Rx+n1oaTOynIlOQwK4yOoHpSou4gnpSLnBzg1IpO3PGcVDNxIWIcdxT/ADC3zDgDikjGAMqM4pQhxjBye/ak7MV7AXbcAc4HWhCNxA49qYwYYHb+VPVP4+TzjjvUtInmHjk9fz7UoCsCc0+FVZsMDx7kUwjqT1+vWswuPDBVwP8A61ITlCDnPtSKoK55z+hpVCgjfkZ7ijQVyxGxMW3jHSrSoCnzAn3qvHuLnapPPU1YBkcbQqkfXpUNa6EvURLVJJFZRXceGbKaO5tTJGdjnIb09q5jTo9kqEIC2fXrXpfh9jcXQDDYY0yAOa56sgSOmhG3A7+lben2vIduvpWbZRAuozn3Nb1quMDsK5oLqZVX0LUaBB60/IyQO9HbmgRqBuY4HpWpgh68Lxio5DknNRXGoQRD7w47VlTeIIFJABqXJGsKM5bIuToSeOK5TxJGizx7h9449wfWtaTW0cfICT6VTeE30izT4CjoKlPU6qUJU3zSMtb6SErbyIXkxhT2NR3VtPMAZGCqeqirmsRJGYJV4ZWwKtTDMCnuRmpdlqjWbSSklueb+MbVYoUZQMCuGlGHzkntivUfF0XmaZNkAlcEZrzSfgEED8a66D0OOruUmjBYVGFO4j+VT58xgBwfpSPCQM/Lx6V0XIRA4JBOetMHyn1FWAuVK5AJ59xTJYyFxkjPUVSfQtMruMnj+dK2QuWOTTxEqjksWNSPCu3O0GnfUroUGA9cGo3PTq2fSrki4H+AqFscZJ5OBW0Wc0ombI26Q4+7nipoCCwyD25qqRkjJPWrcKr8rA5OM4x0rSRsn2J2IyAFwfcUAYHP04pY8EOXJBxhcDrUsKtKAqAbs9Kyeh1Q1REc/h3oXd25xUqqOSSFIHQ96Tv0H1oE9BqjJBPQcipVDN0HAx+NIMA8gVKjqOG71EiRqggAgHB70kuWOVB4NSB8rtA6Gl3qyjPXntUW1AjAJABGMc5oQZYsV9hUwjBjBfj0H9aTIXHHFIGSxYwGGQP6VZj6eg9aigAJ4UkVcVAFII61EjNskjmKSDpkdDXo3gG5a5t7h5OWVsBvUV5m8agj5fl4Neg/DmbFvLE2Pnbcv+Fc9WK5bjTueh2h/eLW7atnHrXPQth1x61uWpwoOa54GVRGig3VU1KUrH8vSpBKccUsqh0w61puZx0d2Y/lLIuWGTVOa1RjyABWv9jkQnyzlT0qnf2FyEZ1+7Q0+h2U5q9rmQ9ttf5Gq5HZvJGAHINOTRJpIvNWQ561LYyNHvifllqJabm0p3XuvYwdUt5FuoI2cnnpV+Y7YgD6VBdTCfVucfIKbdzqqkswAqG7jqXaimZOuRia0lUg8jFeR3gKzsCMgHHOa9O1fVrdYJFG5zj+EV5TqF6onYlG/KurDxkzCrTdtho3FmKgH3pxYbsHoeoqgdQjQgqG9+KUaihbKxlsc9K63Tl2MFCTLiD5uhzijPykN165qk15PKf3NuQaje3vZRudwgz3NHs++hp7O25akJGGGNp461C9woUBpF496ryac2AZZmOfTmgadbqf425/OtFGPcLxQS3cCnIfd9Kr/aZXP7qMge/NXWtYkC4QZ96UdAAAOK0jyrYibXQxo0zgk8Zq4ME5XPIHbgVHbMqtvkUEHOM09XA6d60k22FNJassFVAA796VWwBgcnuO1RKVw2SRjpQBgjBOfrWTOjm00JQrMSTjH8qVBhhkZ7c0gZlUrk4br708jIOSeKGyLihWbPAx0xTT6DH409Tn0xSuhGfrUtjsMA2r1x245qWJVGDyTilRPlDEcDvUsQ44AqHIHccp3KF4/wAKQp8/zdv1o4DZGKOCQc9e1R6CZYiwMY6VbjYN3496pRNgAjoexqeLAbJ6YxUszZZnw6rtxXR+EJxFdKgkIyd2PeuX3fNgVYtbmS1uVlQZx1NZyV1YcdD2y1mWaJZEOc8jFbdrL+4zmvPPCutI9vHFNlGJOwn+KuxtJtjYz8jfoa5GuV2HKNzfgblSTV44LD6VlW0oISrvnL5uCevSqTOdxdycKytj1pl4SsDc84qeJ8qd2OOlZWtXIGxAeWNEmrFUouUki1agpaDmuS8QzGyvDMrEbh0Heuiku1ggwW6CuF1S7F5qI3n93uwPepvzOx3YWDcnJ7FNr14roMvzzP8AeHYVYa2eaTfdSbj2RelTzWcHlv5Qw7DrmqUN5iN1m4kj6g96LreJ0znzK8Sp4haKz02VlUDPAwK8zuWDklgPxro/FGrm7cpCwMYPGOhrl5jk811UYvdnnVZXdiHyUMmRGpHpirO2OPDBFGelRoOP69qc7Dbt6VrJt6GcRVfcflwKbMMeuB/OhHAC8dOxpJJCFOCAOlCVmU2V5MfLjoffpSAL0A5oZxnlf/10wnJGD7mtREkgTjqT7VCRg4xhSKf90DJ5x+NHOATzxVR0BmKx+Xpx2NSomVLZA6DjvUWcDGAO/WpFXoSSBmuhkokwdoIweKkjIJO704NMGM9ML60/btBUYJFZs1TZKcE4C44xTsEZ/CmRnD5HXGKaWI4Az60rDuSBjvJHr6cVMnIz/MVChGOvFOzjG4YFRIcS3ArMzRnJJHFMQ7Nu4cdOaajsCWUke+elG47Rv5Hfms7DY53BAwOvqaYCTyD17Z6UMBgBj05Ap67d3Q46U9ibj1yMccYqyjbsY9cVBgbgATg1aRRgYziobJbGglevHPerMBB5Oc1XKkPg8j0qaNxz6etZiNq3mZoCu7aDg5/ukdxXoHh3U1vLZEZh5qpk/wC0OmRXlhkz8m7Ga3vC1+bOdRKCVDYVh29vpWE4e6ap3PWracqR3rRjukI+euahvEdUKMDkZqwbtFQlyABXPdoHTudE98qpy3FYM9+rX7STHbGnTJqjLcNN+8ZjHCvIHrVKZGv287OxBwo9apK+5tSpKO5pTTSX75LFIP1aua8Sx/ZlYxEjYd6n0rRs72QXUttMQdgBVhWP4nkDpcBunl5qoLldjppvllboaGlX32ywjlH3ujfWsnxXdQxQgZxcN0K9awNM14WdpLBH8zZyPasvUbmW+mEjknPetY0/e8jnrzUJOxUmcsxPUd8VVZWL8Dj1q2RtwKTA4PVT2rqjoee3ciUAAhiQcZqORRtBzn8OtWW5HGD9KgkxnHNJMENTDEZyMc4zUTckrnA96nBJH3QP61FL19D601uUMaPcOcVEcgnPOf0qYnB+YnpURZc/MTirQCZGPl5FCLz7VJtU4x3pSwVSCOTxVJmiRz5LEkk8t1qVR8oyeBTARgH+LJqTdyBjgf5zXSxJIlV8gA8dhTdw5C5A+tAXKMdxBBG0DvSxp8gJbnoSKhjvcUMxPQEd6kTPBP8AOo2O3qOPapBkqG425xQ0KI8nnNKoz07c8UhX5iCenBPY09RggZHHHHes2WmO5JIH4mnMNwTB+tIw8o4yMmmxjGMdB2qNxslCbmJLHIFSRKMj5jUWScc8euetSLySRwc1LuSWCAM89D1xUsW7G7IIz+dRI3A46daejKRgdulRYROATlsjnik28cH14piyNuxU0ecnjjFRqiWIvCjPWrEE3lkZyaiXbmo5ZVjjOT09aGrii2mbUOvTWI8xXJB/h65py+Ibq7lRpJtuOg6Y+tc1bSmeXdIPkH3R6+9WTKi5JwB/Oj2KXqbOo1ojupNc8yNITMHV8bjjGBWlca7aW0OBICwHyr615sHMcDSsccZ5ptnI7r5khO49Pas3RuaKqkrM7WHWo7dJXbm4c5znj6VzOq6rNdXJZ35wRgcDFQyuCeetVZcBwxHHSqjTV7sylXcmY+9obz5zwDyfat1DhKyNZh2lJFOOcHFT6dI0tvG2Onykk9a6ZrmipImp7yUi6w39fwo8v8u9KhIYiQfl0NSkE9AQfSsGzJIqTZi5B4781Gm18lSOefcVbYBsgDmqbwmKUSR9O49apO5dkxWySFHAxUUw+YHBI71OHEhwo2sO1BYrGR69aadg9SmVAHJOaRlVlGMZFSNyxx0A4NNCnaScYFaJiFjwpweRT5WG7r2qqzDPHamM5IPP61Shd3KvoY6sCcDmnoSzcnioYz3HNStwc44PFdbMot2LCsoGeo4pytjG3A9qrRHOc5z71Iq8jr0/Ws2ilJkxI2kY5+lSKoPHaoR14APPOT+dTxYJ+nr2pM0grksUfBBP50u3jAoPBB7HmnLIpcjGMdD71i2zdRSREQctnP41KgyQcA1JFGHOeue1TeUFbGBxUOa2H7O5XZDkAKc/TrSqTwMHI61KQSA2RnkUxeFyeMelLmuQ4WHICT35NODsOPemjk4BwO1IP7vrTM7Ey5U8gjJqyknBbf8AQVSLng56DmkEjcrENzdc+lK1ybF0yYG4n8O5qpdn7ROiYIXqwNTKFhHmMckcljRaAktNIADIcj6Ul7uoLTUfGpiz0xj8qiizPKWbIjH60+9l4ES4LNx05qzbQCOEAjp19qL6XY17qv1K+oksIYBwXIyR6VYkUxgBD8vSqkLGbU2bHyxLirrAsvp7UPRJEz0SSI+Vx1NR3JIjzz1qdVIPQYxx9fSo7r/UNx0/SlfUiG6K+rRlrNyOSuGqHR2HkyBum+r10ofT3AHVDWbocnMqkHHDVSd6bRsvgZtqgZefu96RyQNv4g+tIHz+VN8xSmMZrDUlC8qD3PvUeARk4/OjLLjBHToahMu1uRjNUkDC6iPDx53deKjSRZcK+Qw4we9TebuOPT9aq3QR23RnDe1aR10Y1roxJFxkkg1GzsCVB46Uz7QSuJMBh3pQMr1zxWiVtyXFrQrtgnIOM881GTz7Yp8nHGB+NQE5J44xXRFGEpWMrYEAKEjPbNSCbBCuoHv2poOByetLuwMEcVuxqRajUZX9TU6hD3IwPwqgvIOGZetTwLK5Chx83B4rKUTZNWJ03ZbIxmp0GPmYgVALchzvZj+mamiVFb7uSB1NRI6KUV1H+YvIBJbsAKYzEvxGxPvTi7A5Xg0yQlm45GKzsatpEsckwwQVVffmrgaSVc+aB64Ws4Mfut19qnSUjgcetTKN2SqrROI5QSFkyCMZI6UrLNgEyISf9ntSJNz6n1qRWGBurN3BzuKEl2kHYAOlN8uZyM+XjPap2ZWBBPFERAycfMeOtJMlsj+yl8GR89cKBjFSwxbU2qAopfMGAPSmTzFFCoMyE4GKV5PQjfQQgzziBSPLX5mI/lU1yCkWegHAFLYxiGPB+93PqaY6/arkIv8Aq15J7Gjr5Byp7bIdp0G5jNNnd/Din3lwIY3fPToPerDsqJjtisgZvrzIBEEZ59zRH3nd7ENX1Ze0xPLhy/LOd5NWmPPNQxthW2rx+lOd8/Lg/Wk9XczeobsN7d6S52m0lz2FMGMncevvSvgxlRyuCKVhLRkUT7rQdQNpFZOiOPtTjrlcfrV6wkHlOh5OTWdozBb9geDtI5PvW8Y2UkbJaSRvvtUBuTTU4xnjI601jkEA/TNAJ+7nv3rDlM0DcH5sk47GmuSwwfTv0qU4IzkZNVlLK77uV604q4MZgZIIAPenggLzwaSRgx5496iEgGV5x0FXa40LcQeamDwQOoqiJNmVlAPoa0AcjJ49agmRGGwjJ9fSrg+jLKrrkZVvl6461XyckYqSSN4X3Idy9SDTgUkBxgMOxrqjoc1WJhOxBHXp0FSwlScv+VbH/CFeLCMHwtr3Ttp8v/xNPTwT4sU4HhbXcdv+JfN/8TXRKDOeMtTHXGMhc+1W4GI9C3BGK1B4K8VgceGdc/8AACb/AOJqVPB3ioAf8UzroPT/AI8Jf/iaylBvodEJpbmdDMwfn6896VmzKSO+f/1VrR+DvFIJ/wCKb1vPvYS//E1MPB3ijDE+HNa/8AZf/iaycHfY6KdRdWYTEjIIpFfjkAjpWyfB/indgeGtbx3/ANAl/wDiad/wh3igj/kW9az/ANeEv/xNJwfYbrLuYgckcgccU/OOGz7k1rR+DvFPU+G9bz/14S8f+O1L/wAId4nIyPDetA/9eMv/AMTS5H2Jc13MiNhkk08ScgckjnmtT/hEPFCgbfDetfT7BL/8TT18IeKCcnw5rWen/HjL/wDE1Lg+wlJdzPQ7h83UU+MfMGHSteLwj4lP3vDuscetlJz/AOO0/wD4RPxGvJ8Payc/9OMp/wDZaj2cuxXMu5jOwjidjyO+agttxczy8egz0FbEvhPxPNIi/wDCO60E6kmxl/D+Gra+D/EIGToGsM3/AF5Sf/E0ckorYTkktzn57oswii+83WtK2QQwbR17mltfB/idrx5ZPDutKOxNjKP/AGWrt14Z8TJCxj8Pa0z9gLKU/wDsvSlOlLSKRfMvhTMS+uWlk+yw/fbqc9BVi1WOGMRqMAcfX3rRs/BviKCPc3h/V2lflibKTj9Ksp4T8RcsdB1bPp9jk/wqZU2lZIic47IyIjyf7uKd1Hf8K1/+EV8Rk/8AIA1YZ6/6HJ/8TSP4T8RDJGhat/4BSf4VPs5djNyRisAWxnpzTxwnTHetJfCniTfz4f1fp/z5S/4VL/winiJsZ0HV8j/pzk/wodOXYLruc5ZELPMpHfOe1ZNsfK1Uggj52FdZB4Q8SpfSbvD+sbG7/Ypcf+g1nz+DvFP9s+YvhvWinmA7hYy4x/3zXTCErteRspRTevQXchXnvTPMXBUnv3rcPhTxFgA+H9XPv9ik/wDiaik8JeI2Qf8AFP6xnr/x5S//ABNZKnLsY8yMlpM9SMUwtgZOAPbtWv8A8Ij4kJx/wj+rjnP/AB5S/wDxNPPhLxFt2jw9rGP+vKX/AOJo5JdhuS7mGzAg4Ge1QM3HzDpW8fCHiXLf8SDWCO3+hS//ABNRN4Q8TM2T4e1nP/XlL/8AE1pGEuwuZIyVkz0xnpTHPOe/1rbHhHxMOP8AhHtZwOf+PGX/AOJpreEPExP/ACL2sD/txl/+Jpqm+xftEYZfg5J96qSQZy6naRyMV0z+D/EpAC+HdY/Gxl/+JpJPBviU5I8O6xn/AK8pf/ia1jFroYzlc3v+Em8QnrrurD6Xkn/xVQyeK/ECnH9var/4GSf/ABVZbyKDgEH3qrJyfampS6s45W2RsnxZ4iUf8h7Vj/2+Sf8AxVNk8X+Igo/4nurfX7bJ/jWPu+UZH41HIu7oOfTNHO+4OJsL4v8AEhzjX9XI/wCv2T/4qhvFviPHy6/q/wD4GSf/ABVYq/KRuBowRnH3j60nN9wtqXNW8XeJ44I2j8R60pzg4vZf/iqm0fxj4kktAX8QawzAkEtey5/nWFrasbBicYyDxUHh9g0LqTyG6CnzPkvc6VFOmdhH4s8SPKwGvatt97yT/wCKq1H4o8Qt8p13Vv8Ae+2Scf8Aj1c9DGCz49cAVOsbFlbPfnHrWDqO24OFmbw8Ta+SFXXtW47/AGyT/wCKrm/EPjnxCLwQ2/iPWEVBlil7KP8A2anahdfY7J5TgDB+pNcIFku7hEHMkrZOfSqott8zeiO2hTT1aO98M+K/E8okurnxFrUi5witfykfluraPinxE2ca9q2B/wBPkn+Nczbxi1jSFMhF4PfmtBDlQB1Nc9SrJybTLlyzexvxeKNdFv8A8h7VXOOWF5J/8VVCXxd4iiR5ZNe1VVUd72T/ABqisjF+o5PFZWtsGYQL8yJyfc+lTGpJvVi9jGSSReh8W+Kbu7ATxHrKqeeL2Xgdv4q1x4n8RDA/4SDWNijr9sk5P/fVc7p1uLeFR/y0flj6VZknBaIY6f0pyqyvoxOMb2sa3/CV+Jd/y67q5HbN5IP/AGakfxb4jDf8h7V//A2T/wCKrMyDhjuyeTVZwxdsgAE8c1HtZPqXKjFLRGsPF/iTcMa/q59vtsmP/QqsS+LPERVdmv6vn/r8kGf/AB6sWKAlsvgMfyNMlOW4PTvR7WTe5DpKEbtbmr/wlviQPzr+sH/t9kx/6FVi18XeInOw65qx9/tkn/xVc27ADOCfwxU8EgU89WGacpytuKjGPMjoZ/FXiHaWGv6uM+l5J/jVA+LvEhx/xUOsAf8AX7L/APFVQYq33SOfWq8qkA5/KpjVl3NMRBN3ijYPjDxGowfEGr49ftsmf/QqcnjDxFtyNf1c/W9l/wDiqwZFYKOn0pAML15x2queTW5lp2N9fF3iIkn/AISDWPfN7L/8VSt4v8RKeNf1jA/6fZP/AIqudU44BX60mVD+pp88u4012Rty+MfESMoPiPWF39B9ulBP0+aqDeM/FUTlP+Eh1pw3Kn7dLkf+PVnXIUsCyqzKcgkAkH1qtOfl38ZBFbQnLuZzs3axuDxn4pOCPEWsDPGPt0v/AMVSjxj4qA+bxHrGP+v6X/4qsUAEfypj8NjHP1queXcy5V2Nr/hMvFDg/wDFR62pz0+3S/8AxVQS+M/FSgBfE2tnvn7fL/8AFVjlh35b1qBnGM9frWsZy7kOKOjt5c5Rh8y1L5uSAD7Cq1yM7XUdOpqaNVwpBqpNHLGOtySTcT/hUZPPGfpU0uAB3qEMBj1PFZ3NGrMACe/NO2le/Pc0obA5BNIxLEkfrU3CxHdJ5tpJGxGccc1iaK+y8Kj+MY/EVssuQSxJ/lWBKfsd+ADjDBx7A1UNU0dVFJpxOqtSSGPYN196sMd0ZzkbeozUNhIjW+TgnORUquN5xgnofeuZspx1MDxXOzC2tt2R95sdhVbwvama4uLo8bRhSaqeIrrzdRldGG1Rt/Gug8PqLbSkVhgsMk1rK8aXqdekKdu5ct8CQZxnPBzU5UAOFIZe+O5pVQRkMqg4Hf8AnTQQm52PQbmPb6VyNmKjZ2Kt7N9mRBx5zc49PrVEK8jhzyM5HqT605f9IumeTJHUj+QrQeVY1x6HkintsdSahHl6lUxyqTubbnoM9KZtkYcH8cdasPIJAxAPHIHUmo4mYsCoOSM88YpJ6GD0kMFwxLBsA/lVmAiVeTg+veq7JuG0ryKfbjaxGWx0OaUkraG0G76ltpQmVxggYFVZCHJJIGKbLG2/KuDjsaZJv2rkDnrzSSIqtsjkbBGMbR2Pep1K7drHlqiDM+MbBjjPWm4C9HJH+zVtXMIu2pLlUYkkAZ9ac8ilNxP0AFMRRnJI9cnmngjIIzsNSzZXaGyH93gD35pkmQAcjHp2FPkbLYVTxTJBuQdQKEKSK7PuYZ+WnqitnHbkfWmuAAD/ADoRgDx6d60e2hlHR6kcuc4OCaicAkg9MY47VYcdCOtRKgHWrT0IadyOE/uhzkjI5ocnPHT0psoWKQk5CNz+NIzA4OVx+dWt7kyVhkg54aq7D+9yOxNWm5XGATUEzYBAxmtYsyZ0ZXjBqO2fy3Mbj5T0JFOV8gE9DTZ/miGMkjkYq2zCKWxbwcHuO1QFeMH731ot5C8SnNOl46cnpms9jRq4i/d6A1IsZK/LwMcmmJjqAOfalRwoIzgVDY4RXURkUdOfbNYHiCPEkcq/7prcklyD2FVtQhWe1ZQMtjINEJ8rTZvTXLK4mlzb7RQM+9XpZmjhJJzxwRWNosoWNkcdDnFXdUuEFu5QZwtRUXvWNnD3jkj++lCHq8hNdvaBljVCCTnFcfYoWurcjBx831rsrSXJDNGD71eJeyNq8dUi8XxtUgkHqKqao7FVC4CHnHtVk+XIQASo96pshnucN/q8Z/4CK4luVTinq+hXijKCPcMM53n+lST72cZ59akuZllkLwRs2BtyBgCqv2poz88bBj3xVp3MpU5c1yx5e3kKB/KmedhflHuMjrTXukYA55Ix0wBVSR1LZR9zD8BTim9x1NNi20xOcjjvTfMy2MkD09KqSTDGQQMfpQkoYfeGBVcpm5tlsyHIYc59+tMe5jDDzG2k9s1ny3ZZikRDv0yO1TQQLGCThm6lmGSaOS2402i9GYiAVbn9M1IYAMnOSetZ0kWG/dHYw9uD+FAvGDKsu5GHAA5BpcrexalDsaKBCMMce1SqFVMn16Cs/fubIzipm4TBPzdce1RKJvCslsidnQgcAjrTi67Dj+VUSSVHaliwrctzU8gliLvYWePABxmqpBzyDWmrFkw3I68VUkhxyp461cJdGY1qf2ojA5xyB6UhXJyDmkZcZzz2560+JRwCOfbvVvTUxi77kboAnPNUnQpIxjA2kfcx1rSkQHhf/wBVV9mFx1z0qoSsE4tFPzFOexGM+1QSEt2qeePD7uAKim9M/wCfauiNuhi1Y2kfDFRxUitz83SmsisOmG9aZuKfeUt7jmtGzlSHxsY5yo+63Iq2XzhG4z6VnyyjapUNuB9KsearpuT8RWTRtq0PY7X4JFBdW6Y/CqsjMSeRUkCnk9Mccn9ah6FQjd6jwm5uTkdjStt8sqDTd5JCxjJ9qvWmnT3TfdZsVlJ21Z00oOT0MLT08vUfLwSD6Vf1m0dLI7gVVyAK0xppstbtd6gbsHrV/wAajEVtCBzknGaiVW842Pao4FSnFy6mH4N0NLueVpM7Y16+9d7D4etlC9jUHgKwKaV5hH335PsK6t1jhh3ysEUc5JrgxOIk6jSZrXox9o0kcjrul29paZjxub5Rn1qgPDsv2WLY2Z5xnH91a31gfVr0zyZWyg52929vqa6Wxs2O6WVP3jjATH3V7ColXdNWvqFShCEOVrXqeaaloz2NsI2iYEclxWJOkgzzuXGMEfyr2+WxBQqUyMd65jVvDUUod4lw/UYFXSxafxHmzotu8WeWlxjayDA6e1SLDA0fQFnOAPT8a27zR3hkIKDcO1ZUlq0RZgMbTyPSuxVE9jnipKVmYtzbx7yFBHPrxTPs0Kjc43f8Cq86hgeaiKhj1GT710KbtuRqQYVASihR7cVPFJlAVwV+tGwDII9qbu2nAB/woepL01ZKTkEDA/U014xIxDL8p7GmozFs+nepXJChieoyMmlsydxEjaPJhb7oyQ3NTEgpwSXbuKFYMqnjOOaj2FX3Rtyf4exNTe+5aelhHGJOM05eAOR16GlWVWcqw8tvQ09lABOcj60mw5Wh0ZwRk4Hep5ACgNVAxLdcgVZQfIeDzWclbU6KcuZcpUcDzAOfXFIpKnIpzpyzjOc1EWRSdzAfjWi1RzuLix7vjJJqLeD078U13VmG0OfoKhEoyQyuOfSqUSW3clkGQc4qjLGADkZ+h6VcaaPBxuP0FVnJdSAhJ9TxWsG0KUbm3yDwTSYO47f1qLzZMYZcU0zSc/KePatmcqgWZI/3R3Ht1qNFVoD2I/iFQl5GGGwM9ic0zy3BJDfhUG0Y9Byko+ZPz9aDI8jYT7vqKjaUlSCR+NW9Ni3Srjco9hmok0tWbU6MqmiNfRdKedwFVgvUkV3mnWcdtDtQYbHNYum3sNqixl1VvV0KZ/Gt6OSUwNLF5BQdW8zOPyrzMROUnrsexSwrpqzRheJ7B1jt7yJG/dk7uO1c/r96t5eQspyBGAR6GuqvdRlu43gOfJxg44H1Jrh/s5+3NEh8wBuCORWtBae90PcwtOyXPuj0rS9QtLHSreOFPOlCdMYAPuau2Vh/aMgudVm+T+CFOp+g7Vr6Bopk06DEVvESgyRHubp6muhsvDtqjbgib+7EnJrzJzV3y7nmVcVSp3tuZNrpgmMQMYt7aM7lhHVj/tVrfZAvQ9q000W0C/cG4e1MbSlUDyNyH0ViK52mebLFRm9zHntRuB5B74PX2qq8Sg84Psa1pYLmDhh5qjr/AAt/9eqbiKUEx4yOoIwR9aSKvc5fxDoouoTLb480clfX6V5/qNo8DSs8Zyw6N3r19l2ggg4rlvF+km5t/OhRS6DOcV1UK1nyvYmUeb1PILtPmyoHqSKpEgkY6gmti/RkiZihXqCpHINY527vv8jtivZg7o4ne9ibZv5TORjr3qEyeXcBXUkNxkVMkxhUMqM3eqV3PNJIjJb8Bv4TyaqKbY5w5VvqTzgpNlfXp0qcAFASCciq8k5Vf3sUob1xmhLqPYd24HHUqaLNgkWArY4P1qaONsZ3c461BDPEwwsoYeh7GrKONg5PP41ErouCj1GbVOQ6lv61H5Z/hkIx261ZC5HTOD6UzZ8xABBz0pJhJ/cQgGPlxuHqP8Ke86gZVsn0FTIm0ZdvxNQzQiVvMx8oPykfzoum9TRRvG6HBA6jeWLHqOwqMxBPujA9qaowxJZz75p5d9u0ruz37iizWwXVRa7kLg7sgmoyF9ccYq0qhhxjPpULpt78ZqoswnScdSLoPemmMsQc+tSNwx5H0qCaYBcEnj0rRJvYhWRokEt81SbdoBPApm0gZIpyDdwxyK1kzlSIZuX+Ucdye1RMx7dasyou3jr71WByDnipuaRH2UJll6CvR/DmnJDbpKyhmxwMVw+i2+64XHJzXqdhEFt0XoQPSuLF1LaI9DC0/tAtpHOMSxo4PZlBrE120jsbqIQDyw4yUHT8q7GzgBYA1zPiHD6wR1CgDrXFSk3M9rCSfPboYk6z6heJZWibhxlR3J7mvQPDHgO1tmjmvEZ5xyR2FRfD3T4t094eXZuDXo1qrgDawFFaq2+SOiMsdjZQ/d09AtLSKNcLG2B0FXYo1H8G3HTNPj81jzIPyqdcgYfn3rFQPnalRt6jACeQoNRyxykZGB9Kt7fl+UCmsmehKtVOmYqepmTBmHI596w9QtQW3rlJB/EtdRMj9GAI9RVOaHeuCMj3rnnA7KNXl1OOneWNsSxFh/eTn8cVUmuomQjEjuBjYEOa6C8gwx4rKeNQSMfrUHdGUZK9jw/xo0ttq09uUMQmAba3JasmPTxHG7sOT931zXVfEPTribxbC7KTbiP5GAz06g+9YV7diBSBhkUAknj9a92lK9OPKczSU5Slt0MPY7By5JGcDtUMrtCgAHI5rRDLJskjCOjDKkc0otlYbtuMdcniuhStuck7X3G20vmwbickDgmlhBAHRiw5qOFhGSFwAasKowDz8vcHrUSHB22IXjRs/ulPPpQtgmM5deP73FWEUMcBeQOaklZU6Y/Gk5NbG8L2uyosRixsmk6855p8gmCF0mBx6rShgxJK/pT2BYFQwIA7daTfcpSYwIuczbnJ9alYbf8AVH5RztNCgKi8dsZNRu218ADPap3L52o2Yq7XyVHTqKYzc5FNdeQy5D+tB3IMunHqOgqjK3YdIFwMjj1HWoWGTjeaHIZAUOTUZJ+9mmkV7V2sxHjHJPX36VTniVc4HXHSrbNlTnrUEgzycflW0G0YT8jVLgr16ds0gkA4NMwSMkYFNdTgkZ4rRnMkOkJHI+771XZ/mwOlHLdSaWMKTjHPWlsaJHReE1L3qAqGGepPTmvTosDaOM+ledeDV33yBQdtejqfnAz04NeVjHeZ6+FjaBrWaHaT04rkYbSS+1W62LkrnHFdjZt+6Kg847VzNrLJba1J9mYlmJziuel1PRw1/etuUdP1TVNBkeNIyFz0KcVt2njjVxIMwRuM9CuKnulvrtsKjPn/AGajbRZY133k6Qg+p5q3OL3SubyVCetWKub9h41upMFrSEH0DVow+Nf3oSeydeeWB4rm9Lsbcv8A6Lvkb+8RgVb1DR9Rl2iHeV9hUKaucFXC4Rys1b8D0LTdQhvIwYjye1XWGa5Lwzo11ZhHnYg+ma67tXRC0lZnz2JhCnUtTd0ROSvXkVSuNpB461fkOB0qpN90nHGOlc9VEU2YeopgA5FYV22wlthc9ML1+tb2p428AdawJmOSSMAVxvc9Wiro4vx3E0sSGJ9rq2cjpjHNeZamY7ZDJOARJ8px3OeB9K9R1nUYp4JkVlKglB6k9zXneuQpIdpQtjnLc5NephNFaROIbSTRiyyEkbF2AcbfSphKojAbow5xTJVyACenTNUdSGy3jYOI28xRnrgZrvUeayOBu+pYmKYyMgDip4CHjClucZFZ0SyuWaVwwZiVGP4e1X4QBg9qJxsVB2JRhMnGSRg4pjyBgpbsMUryjIxyRyT0FQE/KBznrxUJGjlceoVh1qaJgGBP3uxqsp47VKgdiO/sKUjamuwryEs644BzjNM4bnH60pRg2454/lTwu0lsnGOoFK6WwnGT3GRrzkjjsTTpX7A4Bphbk4HNISCvHWi3Ud9LFZ1B5U7T7VHmTcQQD3BFSuCOQTUcgdk+U85rZGN9dSMmTJPy4z1pj72IJJAIxiniRSCTkEfzpkhO0Y6nk56Vcbg9S1ZXYlUBj83dSKsZLcelUJ7DPzw4U9cZxikjuJoTiWPcPWtpJS1iZKN9UaDD5eF5HamIDu5GPpUaXsbD5m249anR0Y5VlOfTFZO6KV76m94auPs9yMA4zXpkTKYkdTnI7V5RpU3lTq2V698V6Tpcwmtl3EDjtXm4uPU9XCvSxv2TkEAnrVHRNsXiSQSgEMcj3qW2bBGSaoai5tNRhuR04FcUHrY9GlG/NHujq/EWtC0jEFoirIwxnHT3qp4b0OfVZxNdFnHUsxzWPqMizTx3B5DY5r0rwi8Z0yMxY6CnFaHNiZPCYe9NavqXrHRra1A2KCR3rRWNVHApQc0jHA5OBW8VGCukfMzqTqO8mDEd6VSMVAeTwaWNiOpFSqmtw5dB8+dvB5qhJJwck1cdznuFAzmsu5cLuY8VjVlqa0Y3MvUZMsR6VzWrysLWRI+ZHBAUGta9lyxOeDmvPdW1Vbq/uQkjFYPk+X5cf/XrKnBzkerBcqSOZeSeLzLad1LRMckdMn0Pesu+dmOFHH061a1e5j3bY3Z8jq38PtXOy300TkA7lHBFexShfU5sTK3uolvIWKrgZJ7VUdQ0qtOoPl/dXHGadPdeaoJTLdMgk1XUuX3PnH8q6oqyONprYnZvNmLkBSew7VNyVPOfpUMBAcbwCWPerRChuGIFZTZpCNyuzEDkDOMdaaq7mz1A4qw8S+VuDc/hVZAnTeOvrSTutDT2bjqyZUBGBkD2py4TGBkioWbauCOB39aar8fL0PUGk02XGdnoXAC34DuKiYtHwufdaWA5U44/DmlZCR0/Go2Z1Nc6uivzywOM0KB3PNOkyjcYweDmkzj0qzBaMjdSv061CTnPrUzNuUjIz2qFxxlR1qosVSC3RTcsjEgAKeeaZ5nI579qszDoWyQPSo5IVLjqPcd63jLuZcvU1gAevX1oZQUIIwPeqSC6kIz8gNWFtjgeZJuP505K3UxjG3Ua0cHOB+ANNWOEfdRsD3q2tsg6jOKl8v5SQOPSo5y722II1DY+TB9zXQaZLdQIGhuiqjkpu61zzyLB8znHfmomu3nwqbgpPQdWqJwcjvwtZpnef8JDboi4kvHk7gEACoZfFnmQ+VNEzr2Ynmq/h7S7dED3qCViPu7sBa6qKztV5S2hx/uCuGbpwe1z3qdalva5k6d4kt5I/s1zu2ds9RXo3gbUngcR7xJbvypBHH1rjrjS9PuUKvbRg9iowRXO3E114fu1SGZzbE5Bz0qLQq6R0ZdWlTxUHBaXPpq3uFZR8wP41KxB6tgeleI6Fr2r3EYexvknX+7uBP5Gus0zxsY5RDq0Rik/v9q52mvdZ85WyirDWDT9Nz0BuBURfAJrH/t+zdQVnjfPTDjmmT6qT90AD1J4rOU7HHHDVOqNS5uBHFljge9c/qF55hOPlA6A1Wu70ucs+T0FUJJDISWICjv61hKbZ20cOoaspa5clLZhu2s52ivMdRmhihlCsTKWJkc966bxreiW3MKuuzrya87u5C+UDDZ3969HC0ny3ZVSfK7DJmMzblc47ZrOmiKt8w+uash9r8AAA9qhvJVZcQ/PL046fjXowTTscc7S23Ird1RmfaGHTHoaMFyXbJPXFRxxu6hHlKkdQgxzUjQEr/rpivQmtHa5lbSw9Ocg+lJLMsZwWBPp1qP7OVGDNKWB6bqlRIkT5QVPcmpdhx0GESScyMSo6Iv+eal6hRwce1Coo4BIFTNHnDAgkj0qGzZXexCIxu+UcjnrxSMnPBxVkR4ByQeM4FNkTBBHIJ/Kp5i+TTVDIuoIx6datKwK4OKqEhSOuR6d6VpsHkGk1c0pTUCV492SV4qF0IHfI/SpopyD/tdc5okYsxySW681KbWjNXGM1dFEccbsfypAoywbB9D7VLJkDvj0NQMQWXIPpmtlqc9uXRjHXOR1z2qKckqMDGOMZqdc856jpVeQBiCQc+taR3IfY1QuRnv61MnUAcfhVVM45Y4qZCq8jqKuSOSJcQgLgnH1rN1C/W2O0fPL12+nuao6nq/l7orcgyDq392qul2Et4/mykiLOSx6tThSsuaex0RgrXlsSIkt9JubJx1Y9BWvp8CwEHBLf3j1qxDEiqFRAo7AU4qxIBAA/nUzqcyt0J9q9lsbFhd4wBkEd89a6G0vmwFfGPrXHIBgFe3ar1vcS9JOg7jrXJOmpHTTrThqjuRLGVBDbWbgCsi9tRqN29sACAvzMegrBk1Qo+yBsk9welW7TU1WH7PCf3snLyHtXN7CUNUeth8Wmrt2ZmaFey6LrWC3yq5R/QivVrkwX1rtkCyBlyrY5H0rzXXrKBbeK4t85Xh/f3rX8NeJIlsViuXAaLjcfSliIe1SnHdHViKsJRVWL1RteGmQNfW06h3Tpnk1qWt/JakK7OYM856of8K4S58QRWuutc2pLxMRu4xmtO48RWdxGTiQsRgBeD+dZToTk723OWtiqTd29Gd4H3pvDhlPTn+tY+vatHa27KGViBxg9TXFy6nd2sAVJ3MbchWbIFYt3e3FyWZgwPfP3aKeE1u2cVWaXw6kmp6izkl2yT7k49qwpp3kbCR5x7VO0Zbqct6Yprts2k9MYOB3r0YJLY86pO7Kk8byf6x8f7Kf40kaAJtRQBnPHX8amZy44ALHjmleMgqcdRzWl+hEbkXGQQBn+VTqMqDxn271EASoHOPXvTw2wYBznrgUpAt9SQQZyQpx6Ux1CkKy8jjOf50+JyDnIHPftSTcNuGTmoV76mlk43RGCgxuXBz1xUhZgQcZHqKh3Y4TJPXkcClHUgkVTRKdiZWDHk8dj60MBg4yQahD/KMACkD4TI5+tRym0Z9wkYBc9QOMdxTG+5lgD71Gz8jJ/wDrUxnPv1rRRIdQlR9pOec+1SpLk5OT2qqeAeDiiM84J/OhxuVTqNMnkJZTyRVS64Td1AIJNWnc7elVZFBBA9OlENzWp3Qpcg8Yx61HLtVQwJx0yBnmofMZGMeAcdCcdKdLN5cWQeegAXvWqi76Gd76Gl1wVArN1bUNgMMJG/o7elGpX32cFUOZCMAegrP0u2+0z75ATGpyfc11QppLnlsc9OKtzSLOj6d57CWYERZ4B6t711MRAHKg9gAOBVONuOBjj8qsCQMMLXPVk5u7JlUcmWkCkcEAe9D7T0wT79KijQgA5yR6mnq6pln+73zWDQJk5C7AehHUmq8tzlvLi5yOTmq8ty11IEjGF9P61Zgh2AcBievrRa250QfIVyGjDY6mo7KZ13IQNwPNaEyDyzgEe2KzLNVOpuvI4/OmtUwU3qafnvJEVcDGKykmexvRkA7TnB7itKTGMKD9aoapGCgkUcjr34qIb2ZtTq20LurzI0iTIqqHXdgCrELsVyoCA81zq3PmIkZbG3IGe9bEEzNboYwSQOtOUHFWJrPRMvT3G5NrdOmapCQlDGTg9vcU4/MMnPvUVwmckH5scY61CSRkpXVmPKsyLn6e9RMqkdSR3qu13LBxKpKjjcKkW4STlWA9ieavldiJR6ieWQCyc8cDFMVypyCcj1qUNj3APXNQOdzlc5HUtQtdwsSbx958c+lMww/5Z8dQTxSKAMZwT696kLgIQWJAHrQOyY+JSozhc98moZS4JJIAPoKsRScH+92Oaa+0Nn26ZqU7M1cU43RCoUKMfUmjbjHPFK6rkdetNfp1P1PpVLUztZCEjkKAR6UDDqc9fpTD97ANB3jJPQehosEdSIbeS3XPamswAwOlKgGB1OfzzTZDsPc57itEjKWjGseACeDSo+48DPtjpTSyhcjoexFKmOuflptaBFsnBx349KgfknJ+vtThLngdB70yY5yRxgVCWp1N3RTu5NitICPl6c8EelVLfzZCszsAf4VPSoriUT3AgVvkB+YjnmrKsFGCQCOhFdijyxsRexDawPf3ZLE9csf6V09tbrFEAi4UdBVPTIEghVFPJ6t6mtHLKBkkj2orzcnZbHNKfNohwUnnB+nrU8EZ5JB+tRrgAZHPepg/4ZrlZCFYiMM0hxGOprMaWS6m2p9wjpngfWn3rm5mESt8i8k1aRUijCxLz3PrR8KNlaOotsqwpsGdx5Y+tW4D82eQaqKSwHY1YTJz6Acms35jhqWbh8IVAySeh4wKx7Q7r+ZyoXjBA6VPqEhVQA3zHim20JhUk5LNyTQtEapaXZbT5VOeCfzqtMhdWULwBU68sS2celOAzuU+neo2Mk9Tk2Zo7obieDzXQ6UwNuMjpVHVrIoPPUZyRnijSLpVBifjLHvXRN88bo6JJygmbaIrDPr0BNNaNsnccHse1TJblo8l/cYHSkfcUKjJA6HHeua5gU2jZsjkD86rvaRFMAEf7Qq4S3TBIH3qaxA6rj2p8zWxcNzMeyY42TMmOhxTBBcwqQsquO+4YJrRcqTz0qF+pbsf0q1UfUppopG6eJ83EThRxlRkVMkkcmTE6MfTPNWD9zgAg9c1TktIXJJXY3YrxVXT3JdiyGIOGPNSthx1BNZrWjh18q4cn0PIqaSW7iXBjSTb6HFS4pvRmkdFoXCpzgDJHoajIO7GeM5FVU1CZTg2rZ7FWzTLi+LDPkShvTHFChK5bhzRuWHIzzwfakdwLdtuQccVmtd3LkFLQ47ZNSPPeiAkRImOpJq+RmUU0WI5N6L06daim4YZ559arxSX0cY/cxupHY4NL9qkAJmtXXHdeatRs9DOUW9h8hXaQQPqOtIr/KMd+1QrewM/zuV/3lxUkEsUiYDh8HgVTTS1QRg1uhQwBbIyPUCqLu9/K6xExwg889TU99IsEJ54bj8aisgY4ACn1qoqy5jWDsrkRgSE4Cn6+tNY/KepB7VPcOOAoI9qqhsf4VrG73Ie+p0SYQAgj2GKnEoxtYEAcfWqwOew+lSR5J4H/wBapkjjvoXY9pXI5H0qK6m8uMBBl271C0zQxbiM8cD1qO1WWVvNfA7gVly9WXFdS1bRCOMFuXb9KkkLZIViue4HIpjSMcDB+tO3ADBOOcVm7jvclj5Cgnjjk9TU6LszjAJ9OlQphemM96cGx27dfSs9zoirIqxZl1Fg5ZlXjk960wBuHpWNpxH2qde+eK1HYKV5xgc05oJStoWXRGcEKBnjFQn93yeecfhSxSITlun14FOmAKjaenasXe41FSWhDdtu0+ZXGOOuK5S5b7O+4jCkj7tdqqh0YEAgjBFcrqFvv8yD+JuB9R0rahJJtM78PFKNpHUaPOLu1Vhzx2FWLqIrJlQSp64rifDOqfZrn7PKSqscfQ12QnLRnPOODmprU3TlYxq04xdmMdAYxt5x+eKqtGCfX69RUrSKGxkqe3pStyNxIJz9KyuFOESoY8ZCfcHbpUbxckAE+pxipXfCkoRj0NRiUcd8+9UrglHZkWNjbcNnGTx/WmMVxhSCe/erLKWPAAPc5qqw4I/GqTMqtOwRYaTb2AqSQqOoyKqo2GJx+NK0nXJGfSm46kqSSsxwxv5H1FOILgnjkVBuNTxMNp+Y8DkU2ioST0KzD5uDkVFd4KqvUFh+VWZFA6cVTnYfaI/xzWkdWZtWHiQj92TkjualVi2QwxjnHaqhwT1H1p/mbFJ5B757U3EyRJKkbFiyKT67elZOpPboSoiIn7BOPzp91eO7GK35k6E44ApttAkJLSMWcjJY85rWEeXVm8fd1ZUWyu2CTSsHweIyasrdoMK4MZx0PSrAl2qfT0qGcrKp3gEn2q+Zy+IrmUtxJGWVQVO4e1V9uMkkmmfZY8jbuX6d6Q2r9Y5m9cHmtEkuonBNXudIrDOe/v2qbzAo4HHrVGOYmBpNq5CFu/WniVjaCTgMVB/SpktTzVqNEy3V5sHEae3NagbA7YFY2lMdjtnk85rSt5Gcc9jjFRVVtDWW9ifeQDk5PoKU4K+lR5JY9u3FIW+VsAVgy4qxMsuGHTIGMmpfMYqc96pIf54p8srEqOgqbalXKlnMRqNwQTgdq0mm46cGsfTzm6uScE5q9u3DB7Vc1qOotS9BhuByvpVtWUHYOo7etVYDiNCOpqWIZyT1rlnubUY2LaygLjIU55FYutRqT50Rx64Pf1q/O29wjAYqvewo1uRjGR2NFPSSOrns0cnqa/vVliAAkOT7MK6XSNQSezUs5LAYYHsa5q5YuHQnjbv47Ed6TTRmaM5Pz9RnivQnTU4WfQVVXXodRPfQBgrSDHr6GrEM6TBgrhvcGqttbRyNtYEjpWPqAOn34a1ZkJ5I7HmuaNKM/dW5hBc2iOglYqcHBHbHWo1ByHHPtQD5kaFuNwycUgkZeR1PBrNLTQqGu5MrgBc9T3qK4UY3AZGM8UpbZIMAd+tIzbl56HtU7HRG01ZlLBCkE845phcliOCOxB5P4VbmUANjj6VV7njtWsXc5KkOV2ERlJwW5pysM4UnIqHuo7dMUZIlbHvV2MkTKzcA9Ov0qvKv78gn5QOfepix6g4qIEtvLHJLYNC01NV70SNphGmWxjsazi7ahOwUlYVP50t+S1ysJP7vGcVOFEe1UGB1raNoq/USioq/UeIUhQiLjJx7/WolyH5GO/Ip3mNuK56cg96ickuB0FNX6kvcVj6HH9agkJxzn8KcWOGbuKhkJBJFaRRTHbyBzgfjTVk7E8YqJmIG3t0pqHBX8atR6kqT2P/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Top: diffuse optic atrophy. Bottom: fellow eye with normal disc color.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl C Golnik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26592=[""].join("\n");
var outline_f25_62_26592=null;
var title_f25_62_26593="C difficile sonogram";
var content_f25_62_26593=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Abnormal ultrasound in a child with",
"    <em>",
"     Clostridium difficile",
"    </em>",
"    colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right lower quadrant intestinal ultrasound, 13-year-old girl with Down syndrome and acute lymphoblastic leukemia. This was her third episode of frequent voluminous watery diarrhea without blood or mucus following initiation of intravenous antimicrobial treatment for fever and neutropenia.",
"    <em>",
"     C. difficile",
"    </em>",
"    toxin A/B enzyme immunoassay was positive for both of the previous episodes. It was negative on the first two days of the present admission, then positive on day three when diarrhea worsened. Plain films showed marked paucity of intestinal gas; ultrasound showed up to 4 mm of bowel wall thickening in both right (above) and left lower quadrants.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dana Mazuru, MD, Department of Radiology, University of Missouri Health Care.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26593=[""].join("\n");
var outline_f25_62_26593=null;
var title_f25_62_26594="Gastrocolic ligament and the lesser sac";
var content_f25_62_26594=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F75897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F75897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Gastrocolic ligament and the lesser sac",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 427px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGrAeEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooyKACijNJuFAC0ZqNmAqNpQO9K47E+aTeKqPOB3qB7oDvRcaizS3ik8wVkNegd6gfUAP4qXMi1TbN7zF9aTzV9a5t9UA/iqJtWH96lzofsWdSZV9aY1wvrXJvqx/vVA+rH+9S9oilQZ2BugPQ06O5RzgnafeuGk1gj+KmLrZB+9S9qivq7PRKK4i08SmIj5sr3B6Vv2Gv2V2wQyCKQ9AxGD9KpTTMpUZx6GxRRRVmQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFGaaTQA7NNLAVGzVE70rjsTNJTDLVOSYA9arSXQHelctRNMzD1qKS5A71hz6gF71QuNT9DUOdjRUmzoJr4DvVSTUAP4q5efUic/NVGXUGPeodQ3jhzqptSA71Rm1Mc4NcxLfk96rSXp9azdQ2jQOjl1InvVaTUc96517s+tQtdH1qOc1VE33v/eo2vj61gm6PrTTOfWlzlqkjba+96ha996xmn96jaelzFezRsNd571BJdEdDWW01RPOPWlzFKmav24jvUUmouOQ1ZD3A9ahecY60ucr2aO10Dxzd6ZIEmPn25PKMen0PavUtC1+w1qEPaS/PjLRtwwr5tlm9Kl0vW7rS7tJ7SUo6EH2rSFdx0Zz1sDGorx0Z9S0VxfgXxxa+I4hBORDqCjlOgf3H+FdpXbGSkro8epTlTlyyWoUUUVRAUUUUAFISACScAdzUF5dQ2cBluHCIOPUk+gHc1zlxPcas2JFMdtniHP3h6v8A4dPrWc6qh6lRg5GjPraFmWyiM+P+WhO1D9Dg5+oGPeq/9p6lnOy1I9MNn88/0qa3tQoGRVgwrisb1Ja3L91dCCPW0QgXkEkWerJ86j8uf0xWtDLHPEJIXV0bkMpyDWVLahh0rOe1ktZjLaO8Lk5JTo3+8Oh/nTVSUfi1DlT2Ororn7XXZIyF1CHA/wCesQJH4r1H61tW9xFcxCSCVJEPRkORW0akZ7EOLW5NRRRVkhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRSE0ALmkJqneX9taYFxMqseQvVj9B1NUjrlpn/l4x6+Q/+FQ5xW7KUW9jWLVGzCqcV9BcKWglRwODg8g+hHb8ahnuwvejmVrlKLLcswAPNUbi7VQeazLzUQAeaw7zUuvNRKZvCi2bN1qAycGsq41Drlqw7jUck81nzXxOeaxlUOuFA2J78nvVGW9J71lNclu9RGU+tZuTN40ki+90T3qB7g1UMlQvNU8xooFp5j61C03vmqzSZphapuWok7TGozKahLUwuKVykix5h9aQyGqxk96jaUUXK5S00h9aYZPeqjTCo2mpXDlLEs+B1qs9wc9ahkfPeoCwpXLSLDTE1E8x9ageQAdarSS0rlJFh5qrPNz1qJnJpoGaQ7F6xvZra4SaCR0kQ5VlOCDX0Z8NvFH/AAkWjfvyPttuQso9R2b6V82RJg16j8ERKviO4dMiAW5WQ9s5G0fXg1tQqOMkuhxY+lGdJye6PdKKAQelZd9q8NtIYY1aecdVTAC/7x7fTk+1ejKSirs+fSb2NSse91mKPMdmPtE2Svyn5FPuf6DJrNuXvNRJE77Ij/yxjJAI9z1b9B7VYtrJIlAIAA6AcACsJVnLSJooJfEVo4J7yfzruQyP27Ko9FHb+fqa1IoliHApN4QYUVG0hNQko+pTuyz5gpPMFVC3cmhXB6Gnzk2LoekKhxyKrq1ToapSuBXmtVPaqElk0bl4GaKTrvQkE/X1/Gto4NNKg0pU0xqTRQg1S+t8LcxC4QfxLhX/AC6H9K1rXULe5A2OVY/wuCp/I1UeEHtT7aEK3Sqg5rTcmSizUopE+6KWugzCiiigAooooAKKKKACiiigAooooAKKKKACiikJABJOAO5oAWisq61m1jBEBa5fpiLBH4t0/Wsua6v704Z/IiP8ER5P1br+WKylWjHzLUGzZvtUtrI7JZN0pGRGnLn8Ow9zgVkS399ekqn+jRHoE5cj3bt+H50W2nonRcZOSe5PqT3NaMUKxjpWTlOfki7RiZ9tYJHk7cseWJySx9Se/wCNWvsgI6VbyB0o3ChU4oOZmNd2A3h0JSQcB04IHp7j2PFYl/d3FsdtwMg8B1GAfY+hrtGCsOaz76xSZGBUMCMEEZBqHFx+EuFSz1OAu9QJB5rBvNQO4jNdFrvh+eEs9mC6dTH3H09a4e8ykhVwVYHBB4IrGU2epR5ZLQna6LdTTDLk9aosx9aQS471Fzp5S/5hoMlUhJnvTt/FNMLE7SGo2aomaoXmA70XGok7SYqNpveqjze9QPN70irF5phULTj1qhJOfWqsk59aANVrkDvUD3Q9azVM0zhIkd3Y4AQEkn6Vq2nhXxBeNiLS7pc9DIvlj82xUuUY7sTkluVJLsetQteH1rrrH4X61cc3U9tbD+7uLsPrgY/Wrcnwlu/+grCPYwn/ABrF4mkt5Ee2j3OBa996ha9PrXdyfCXU8ny9Rs2HYsGH58Gs9/hdr4JAksW9xK3/AMTTWIov7SH7aPc5A3RPek84muof4Z+I1bAgt3Hqs64/XFTw/DPxCxwyWqf70o/oDTdel/Mh+1j3OQDE1NGCSMV39l8K70gG81C2jHcRq0h/pXZ6N8P9KsUR3V55V5LSHOT9O1ZyxVJbO5MsRFeZ5l4f8O3epurFTFb93YHJHsO9eu+G9PGiWKx2cRWMnczMeXPqTWtb2MUcSlVAXpgCrUqHYAeATwK5J4ubd4qxx1arqaPYkOsXCRCFI8TSDajddvqxHoB+vFPsrNI4+/qSeST1JJ7mmWkYMjbuSP5VbZwox2r1cNKVSmpTdzz6lk7RFJC/dFRtJWJqWrT2eoBCAbfAJGDkjuQf6VZkuRIA6HKkZBFa+0QlBlx5h61BLdiJSxBIHOByaqGQ0xiWqHNlqBcknDRCRWBRhuBHTHWm2lyTGjMMbxuA9B2/SsUTq1ncW+8FRL5YIPQNjj8yRV+3lE9wFh+ZF6sOmfSlzXHym5HyuasREiordCEGanArojoYMkyKKaKditLiHAVJGOaiBIqWNuatMTLK9KdSL0pa1RAUUUUwCiiigAooooAKKKM0AFFMd8DiqkzM4wSdvpUuVhpFmSeKPiSRVPoTzVNtTTOIYZ5PcrsH64qHywPugKPbil21k6knsUoojmvb2TIiWGEevLn+gH61UktHuP8Aj7mkn9nPy/8AfI4/StAKKeqioactyk7bFKOzVegwBVhIQvQVOQBSU1FILtgqgU1zTsVDK1NuyENZzTN5prnAzVO4uAgBz3Az79BWLmUlcveaakWUd6oxzbhzThKOxzTUx2LM0KSj3rnNf8NW2pIfOjw/aROCP8a3lk96lDgjmlJRmhxlKDujxjWvCeo6fuaBftMI5yg+YD3FcpM5Ryrgqw6g8Gvo54Ek5xg1yXjHwjbarayOkYS8CkpIoxk9gfUVhKm1qjvpY3W0zx1LkDvUi3I9ayL1JrS4eGdSkiHBB9ar/aivepPTTTN57gY61UlnHrWU14W6UI7SMAoJZuABySadguXHuKhaYmug0zwTrl+quLQ28Z/jnOz9Ov6V22g/Deytis+pXJuplIYRINqZ9D3I/KsJ4mnDdmUqsY9TzvSNB1PWHC2Vs7qf424UfjXoHh74aQQkTa1MLhxz5MeQg+p6n9K9BtoUgjWO3jREAwABgfgKmZSDlu9edUxtSekdEc068ntoU7SxtLFFisbaKBeg2IBxV+VTEvocde9NmXYsci84PIp0jLLhm+6egrmtvfcxbvqNRGZNwYKvqepqNVMkoBPyr3qZlIjDHhOw70giKpvJAHYUOL00FcSRR5gVCdvfNOlCAADn1pqgkgjhT3pXXkY7c0krp6ARyMAuSnPQcUpVkUM4HTj2p85wq9wvJplzMJIwq9utVZK4K7sNjCiA5BJ6mpAoFr5uTuANSgBbYgdcVVMp+ztGRwRxRaMbXDfYlwVt42/hzk1PKBJCCDVS0mDw+VJwy8EGiQmMbVY7TVOVtBWHW8rK5dvufdP59aluZBjAqlczRQxg7wAODuOM1WN9G3+rLuMfwKWH5gV3YKu0vZsznBN8yH3scdzHsmXdjkHoQfUGsy3uks1e2l3uY22qVHUYBGfzxVuaW5MZ+z2srseAWwAPfGaoJpV5ISXCIWJJLHJz3OK7Xe90JW2ZK2qryEhfPbeQB+maga4mum25dz3jj4H4n/64+lX7bQgSPNd39QOBWzZ6YkShVUKo7KMVUacpCc4owrXSTIczH5TjESdOOmT3rptPshEo4AA6AVahtUQdKnyFHFdMKKjuYyqOQm3ApMUM9M31poQSdKM1Hvo30rgSbjUkR5quGqeHk1UXqJl1OlPpidKfXQiGFFFFMQUUUUAFFFFACE1GzUrmoWNS2NIHbNQtTzTDWbKQ2iiikACnjAFMozQA8mmnNJuozSATNMZc080hFSxlO5BCHFYk7GRJ41OJMED2OOD+ddK6BhisLVLAl/MjJSQdGH8iO4rCpF7o1pvUpSXJlsYFjJBmxkjqFxk/4fjViJtihRwB0FYcy3NqYfMOxYwwEi8ryQcEdhgf/Xq3HqAAHnoR/tx8j8utYc2upty6aGus5HerMMwPU4ArJiuIZf8AVTRv7AjP5VFqMsqwCKDmWU7Rg4wOpOarntqS4G1a6pbz3TQREl1BIOODggHB/GtBsSJg9a5vSLUWal2IaUgLx0UegrXW5CqMnLHoB1q1VSV5mcoa+6ef/FDwgb62a/sIs3MfLqo5cdz9a8q0vwnrOq/Na2cnl5xvk+UfgT1r6RlmeRfnKIPQdahWEqP3bAKO+Oa8yvj0nakjvoVZwjaR5FonwsuTOj6vdxpCOTHACWPtkjA+vNelaR4bsNLjVdMtLeIjq5GXP1brWmzOhzuyO5IqRd4+dMOp6iuCdepVfvvQc6kpbkKs6sVdASO61Iy7fmZCAe/SnKQ371DnHBHenm63KUcdeOlZKMerM7voIIRIm6NyGHOM0eYTGUkXDjvRGrIq49KbIrNkk44pu6WgEigvAAfu9xVbdtIxyqnpUiyMse3BqPaUgZ2+8T+lO3NsNaEzTGVl7KKe6biozweopkWDFk1IMllK9B1oWurFtsPOFGAOBULth1HrU7rxUMiB1x37GtqkbR0ErCSN0X1/lTLoKsYHTJpFQ+aCzZx0qTUFGxAKyjqm2PZoiVneMDPHelkP7kEdAeaW2wIWHcmmSMY4mU9OSDUvsPqQ3rRxor87ycALyWPXAFRR28tyd0rmNT0SM8/i3+GPrUdsrTlpiemVX2Gev44z+VSOrx/MGr1sLhEoqdRXZlOfRFldOjjIYRpuHRiMn86eE2tzzVmzcy2wLfeHFRuvzV6PKlsYczLkUAaMHFSCFB1FORgIVx6VC0wHetnZGe5MqotP3AdKpm4Apj3QAo50Fi6ZPeo2kqgboUC4Bqee5XIXCxNG6qgnFPEwpXDlLG6jdUIlBp4YGgLEobmrttzVBCCa0rUVrTV2RItr0pwpvalWukyFooopgFFFFABRRRQBE4zUTCpyKjYVDGQmmGpGFRmoZSEpKCRTS1K4DqKZuFG4UrgPopm4U0tzSbHYfuFGRUe4UbhSuMmUikkjVxUQanB6E0GpQubAEHb+VYV5owBJizET2Ayufp/hXW7gaayq1ZypxkXGo0ee3Fhcxn54RIo7rg/pUVvMLWdXC7SOCpG0kdwBXfyWqselQSWKMMMgYehGaxdBrY1VVNamTayrMgeFg6Hv/T61a2jZuPHv3zUrabBGpYQxqfUKB/Sqb2oJ+VpVx02yMAPwzXHicLUqPSWhcJxJ1bC48gY9T1p9s8W4qw2P2HY1SMN1H80dwX9pFB/UY/kaBdEMBdJ5bD+Pqv544/HFedPDVaT5pK6NFJPY13YeWQecjgioLaUwOVcZQnimowbjgMORjoRRMwkgGB8wNZczvzIa7MOPNkUD5W+b8aRDnKsM470kRxw3XoDUkX+uOOmOaz1vZjB3IUDqaQMxT5hSSsd9D/6vPvzW817rEhZeItvc8VHdHEAA68CnyMrsoB4GM0XYDAAVhsUP4+ye+KfbcRjNQBDtAJ+WrIIAGOla0leSJfYnIytV2GDVhTkVG6111NrERdirKGyGTqO1QzNLKVDDA7VaLbTTCM3AHt0rg8kaISzUEOD2JFQzLmGQehOKkkRo3Ow4zyaNuEXPPOTT5ugFDR3zahT1A2n6jg/yqzPgx471UuInsLkvGpaGTk4Gdp9celNF2kjfKwfHXac17tGtGcF3OeUHe5p2bbICD+FOZsg81RNyQvTao7nioTexHjzkJ7hTk/kK1dRJakcjNYTEJtzUDzE96zhdEn93DK/oSNo/Xn9K5DW/Gt3Y3MtutgkLIxXdISfxFFOoqr5YastU2d4WJ5zTSxPevKV8XajPMHllDp3jX5R+lb2n61Y3eBI5hkP8Mh4z7GqnCcN0WoHan/eFAJ9ayIobZ1B3dehByKbPDCi5WQgDvuIrPm6kpG1uYUCRhXMxtNJMFtppQg6sWJH4CtHbfxDImRx/tKD/AIUKo3sNq25riY1Ks5rBOoXMX+sijb3BI/oa1tNjvb62E6WMhiJwpDKCw9RkjI96qMnJ2RMklqzRtpizCt6zJKisa0tJ1cCS0mT3O0j9Ca6GGMIgGK7aKfU5qjXQfSgUUV0mQUUUUAFFFFABRRRQA1qiapyM1Gy1LQ0V3qu7AVYlUiqNycAmspuxcVcVpRURlFVWc0wyGsec05S75lHmVR80+tBlPrS5w5S6ZKaZKpecfWmtMKXMNRLvnCjzh61mmY0hmPrS5yuQ0/OFIZh61l+aaDKaTmPkNVbgetSrMD3rEDmpFmYd6FUFyGz5o9acsgNY6zNnrU8c5qlUIcbGlcAGBqyUHzVakuCYSKqK2D9aU5XCOhJO/lR7jyKoFjLn5eD1HtVq8JMQHvUcKjy6iWrsUtCrbs0EqRZ/dk4jJ/gPXb9Mf4elaJAQ+tUboDCn0dT+O4VaLlkZm4GOK8XGUo06nu9Tqi20OUb0LdBT0UKFYH73WkGBakfrSpnCDtj9a4003cpgRls08DjBpiAhqlz3ronsStyKUBVxjvUcwwqn1NLMxI/GpLsDyBj7wHNcdua7Ra0aHOAIA1IhPlKahiDyRrk/Ke1T8Y2/lWtOXLO7JJYWqVulVo+DU+flrvm1YlrUrMw80D0qMuBfdeMU91DNwcMO9VpY2B3BssD1rgT3SLLF3IDIu3vxSqMNtNRxrvw57dKlQhpPpUt3lcNtBbkDy0yMgEZqjd2MEp3GNDn1ANabIGQqehqvgqSj9uh9RVzTjqJMyY9Otmcjy0Rh0woFTGwEeHA4WrLRBizLwy9PpViGYGIq/Qjp6GoTvuyn5DImRosgdq5PxnpcFxbi4kjB52P6kdjn1rpYR++dR0J4pmp2Au7KW3kJAccEdQexrXD1ZUKsanT9Bqx4J4h0y50ORLiFzJaSHCt3B64PvV7Q7qHU4Sp+WReCK7L7GH+0aVqce5WG0j+RB/WvML2C48M+IpLdydqtlW7Oh6H8v1r7OlONRCcep1cr3mnn9xcSIvYA8flVdtav94Z7l3I6BgCPyxWrtS909ZV5JXP6Vz9zFtYiqeHhLoCimereCbZPEmjme1u/JvYW2TROoYZxkMMEHB/HnNdCvhvUuhntsf7zf/E1474I8QSeHNehuQSbdyI5065Qkc/Uda+kopEmiSSJgyOAysOhB6GsJYWnfY467nTl5HPaf4WgjkEt/L9pcchANqfiOp/Hj2rpAAAABgClorSFOMFaKOaUnLcKKKKskKKKKACiiigAooooAKKKKACiiigBGUN1FZmpWz+W7xFNoUnDZB/OtSorgBoJFIzlSKmUU0NOzOKn1SKFis6OmOpAyP8AP4VCNWsXOBdRA+jHFYeuTYmcVyN8A5NcElbY9SGHUkeoR3MMn3Jo2+jA1L94ZU5+leLSq6H93I6H/ZYiqskt32upvwc/41ndmn1N9z3Bjt+8wH1IFVpLy2Q7XuIgfTcM14XcvdEfNPM31cn+tQWN9d6ddCeBzu/iDchh6Gk79B/VGup7s1/bAZDlv91Sf6VC2pD/AJZW8r++ABXHaN4x06YKt2fs0nAPmD5c+x/xroX8SaZHFu+2Wuz13j/Gs7vqYOEou1iwmrTyMypDGjDqGJJ/LFTLPfyD5TEB/un/ABri9U8Y6NHIWSWSRx0MK5/Ws+L4jxISptJWXsdwB/EULm6l+xm9keitLfoMmSL/AL4P+NVptUntlL3E1uijuykf1rzfUviJeSrtsbVI89XkO449hXQ6ZYnV4kubhnfzYwwLEnBxnilJySuiKtOdON7XZ01r4iSXZugdkc7VeMjn3wela63SYyS6Y671IA/HpWVDpH2a0jjxyo4NXtHuTcF7eUZdPl+o7GsqtSpSgp7mdNOUby3LaXIkGY3R19VIIp4m55qGfT4R87oDngHHKn61F9llVgsc7qD03HI/XNZRzCO0lYp0upeaUMME01HABHaq/wBmux8pZCfUr/8AXo+yzs4WWUoD/d4B/H/69avG0xezFOZ51RfmVW3OR69h+fNXJMMnyjB7ikihNmFGAU6ZHapQoMwx0PWvKxFV1Z8zNYqyEUHZtPQdamC4K/lUdyvlzjHQinqdxUDnHJrOKs7Be6FK4NI5whp55pMcYNdFVaEojKB7Ytnkcioo8yAKxzUjoRGyh/l54qG1YDPqK5JLRGiFtyUcp6GrBOJFz3qqzFZgw+6eDVm5KkIV6jGad7rmFbUe5AYGpAcpUUjDb709fuV1xleL8ibEY++aZEA0zKx69KXnLVCMn5x1FcfNZplWDJt5ijfdJ4NTAEqWWotpn5YUWku0sj9Qf0p6Sd+g+nmXLeQOvuODTpIw4wR9DVa3I89sdCKuCuyg1Uhyshqz0KZUxtnqO9MlUY3KatyioPKXn+Vc1SnyuxSZDAm4OV++DkGrIkDx7WHzetV0YQyfNnBpSxeTCcZo5rrQGtbnNeL4lSOC6UYeOQISP7pz/UVwfxJ04X2kW+pxLmW2+SQjqUJ4/I/zr1jULBbuzlt5ukgwG9D1B/OuGMJltLzTrgYZkeIg9jgjP517uU1v3fJ1j+Ra10OV8D3QuNOMTHLJ8uPananEFkNYHhK4Fjq7QSHCscH65rr9XiDfOvKmvoETHQ5eVea9x+DuuHUdAawnfdPYkKuTyYz938uR9MV4ncLgn2rpPhXqv9m+MrRS2IrrNu3uWxt/8e20mtCcRDngz6JooorM8oKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPFvFhMGpzx+jlf1rmZXzk11fxLi+z69L2D4ce+Rz+tcZI1edU0k0fQYf3oJkUhy1RlQaHbmm7jWJ0jJYwRiqz2ymrROajZqB2M+ezBFUJLLFbLtVeRhSuNRMg2ppBa81fkcCoTKKVyuVEfkYHAr2/wfahPCumykctGD/SvFY2aaRI41LO7BVA6k5wAK+hLGy/s7QrKyP3oYkVvrgZ/Wk9mceMdkkWVJlO0jtXO3LNYa1HIPuOQrD2zXSQkKyn1xWF4tQKyOOuaHHng4s4I6SsbvlSTRfK+cjdg+tMhO6Aqw+YcipNFlL28Tno8YJ+uOaai7rmRR90E4rwWly+dzRb2LgG9Qe+Kk2B02tzUcfSpUq4ksiKkxlW6jgH1FQDICleoq443Diqj5XGexrOcSosTc8kgL8Y6VYiwE96gkPzK3rU8f3frSpO7FLYQnmlbgZpp60TNhR710VXaIktRrZKMfamQKMYxyadISsf1FR2bfOM9q5000XbcklUH5enpTVU8bz07VJMczgD6mknPyg+hpNK7uF9BsmVYHsasR8rVaZg8Yx1zxVi3bIweDW1B+9buKS0I0YAyA9RTbZco3pTp4QZN3TPWiEgZUVlJOM+Vh0Gxv5TkHpUTKHn3AcY5qebGRkUi7d4UcVDutBoIsIT/OrSNkVUlXbJt7YqWBj901vRm4OxMldXJ2GRVWfK4I6d6t9qicDnPSunEQ5o3FF6la6YSW+4feFLEC1sGHXGaTYCeDgHtUKu0AZCMqSce1cSldaleRPE3mRHNcn4mtfIu0vE43sEk+uOv5CukhkMYYN3ORVPU4kutPvFb7pjLA+hAyD+la4Ou6VWMumzLtY+d9eBtdbuDHwVlbafxNb2k+IBdIsE4xIOPY1i+KMf2hM4/icn9a0/BFgsyy3DrnbwCa+5j0I6l69TknHWs62lktLyKeJtskbh1PoQeD+Yrcv1HT0rCuAFemzXc+rNLvE1DTLS8j4SeJZQPQEA1brh/g/em88FW6E5a2leHP8A48P0au4rJnjTjyyaCiiigkKKKKACiiigAooooAKKKKACiiigAooooA8x+M9ni3stQXjBMLfqR/WvLfMyte8/EbTv7S8IagijMkSGZPqvP8sivnO2mJypNcGIVpXPcy+XNSt2LxakzUe6gNXPc7yQmoXbGaVn4qrNLSGkEjiqsklRyze9U5ZielItIkllFQBixqJnJNbOheHdT1hg1rblYD1lk4T8D3/DNCTewNpbnSfCnR/7R8Rrcyrm3sl8056F+ij+v4V7FcuW3fWuZ8GaU/h7TGt1CSSyvukkAIz6Ae1bjNIVwU96qVKdrJHmV1KpO/Qn3ARqayPEP76EHuKutMQm1kOBzxzWVNdCa7ihA6uBg/WpjGUbuS0MHBrWx0Gmwt9gtlyVYRgHBx25BqeBQsh/WpIGCOA3AKjH171HbEM8re/FfOvXXuUTQE4/lU6mq8JAXnv0qYHmtKe5MhQdiMp7Zx9KpXBOQPWrVznyyR1FV74ACMDrim1v6BHdDAHYqpUjHU1dQYAFMLlVGRTywqaSV9Akxjj5qbcfwemeakyDTXAb5TW1XYUXqNunXygB2GM1FFGfLBBwaDFk4JJAqZCC2OgArlvzbl7ISJMHJOTTzg5pI/vkUkhCHJ6VUU2rITGhFU5A5pCxjkDdjRJkFW6Ci62lPlqJJwfaw0TOwYr71HjbNtpgf5UJ7dTQG3yb+3rTnK7uwSsTMATg1CymM7wcgdR7U+TIG70pGG+M+hFG7ER7zM4YDAHepY2BfI7daisPnTaeoJFOb93cBfWjW9xvsi8OlRS09DxTZOa9FPngZrcrI3lyfN909KjmcGUeh4qd1DKc1AYBt3A89jXmzTjoaLuSyRL5IZeo61X2rLG6MuUYFWHYjpig3DKChXnHapbUERsD1PJpNpvTQeq3PnDxjCYNUuo/+ecrrk9cAmum8BYOjuAOcnNVPidbrH4lvwo4YhvxKgn+dM+H12PKnt2OGHIHtX3mGn7SlGfdIhmleD5mFc7qAwxrpr5Ssp9DXPamvBroNT1f9n258zT9Yts/6uVJAM/3gR/7LXrleF/s+Sga3qsIY5a3DY7HDAZ/8er3Sspbnl4hWqMKKKKRiFFFFABRRRQAUUV438U9PvW+I2m3+q6DL4g8MJpckUNmYJbi3jvvMB3zRxxytgx8BvLbB7d6APZKK8M0a58b6nqHg+y0Czv/AAVo9zZz3N5bT2X20W7i4YiNpJFUqzryASMBsAcCs/RPE/xQOrXcmu22oIkaXol061092bIRjCbaX7L5WQQP9ZNIG/u5wpAPoOivlfxNN8RPF/gnxRYanY6/NbR/2feWUclh+/b94PNiz9mh3lfvYVMgqMFlzu6/XPEHxHi8VeTpM18uixravZ3F3pczfbEIBm89YbNmR85GMw7euG7AHvNFeZ/DJvGuoeI/Et94n1K4TSbfU7uysdNm01IS0QdTFOsuAWXbuUcEHrk16ZQA1lDqVYZUjBB718q+K9Ofw/4ovtPfOyOQlD6qeVP5EV9WV438ffD5ktrXXbdctFiCcAfwnJDfnx+Vc+JhzRuuh35dV5KvK+p5fHIHXOaUyYrNtJsDBqZ5O9eee9YsPLxVK4mA7015cCqUrFjSGkEkpJ606ytbnULpLezieWZzgKvX6n0HvUMUbzTJHEpd3YKqjkkk4AH417t4B8JRaNZguA95KAZZcdP9kH0/nV04ObIqVFTV2Yvg/wCHkFtsn1RUubk8hDzGn4fxH68V6baaUiIqhAFUAAAYAHoKv2VqqKAB+NacUQAruhSSR5FbFybMtdPT+7StYpjpWxhRTGCmtOVHN7eRzl9aIkLNjHFcnpsIk10MeRGCw+vT+tdlr8gSBgPSuZ0GEtNcXBH3iEU/jk/0rz8xmqdCR0wm5bm2+Ft2J5IyQKbbxsYw27aW5Ips6tgBsAEgcVbdRGqqD26V8wn7pYx8KFA9aeGGRTPvyKOwGTStBzuU4IrSjDm2YnYlYZBB6VSdczxqxyOoPtVrJA5qDbvAYH5hwKmTsCJrvGBtPakfOxT7CmKrSEZ6A1YYApiinrJyE9LEanoaaCSWPpT4l+U0yNtpJPQmrqSu1cEJAy7GJ+9zSJkksKZtUzlOQpGalVsphBwO9ZSi1uVdDo8Dc2eelJtLuGPboKWEAj6VOi114ey1RLdhNgZdpHFRfZRnlsr6VZxTJDhamtFN3ZKbKUoMZ9jTxxCDTbnPkFu/Wmq+6BVHU1yyV1c1RZZR5GfWmRMPIxnmkxKy7dvtntTDCVOAcZ6022tUSiC1ZhK5T1zipsFpQz8YpkYEdxt7HNWLldgB9qUk73Q7k0Z5pXqKFsqD3qU8iuujLSxNtRjY2molbGQalcfLVZ4ifmVsNXPW+LQcSNlLXShfQk/So5vNjmKRHO4Z57U+2lEcshk5bHBp8DBpGkbpjAzWM4pKz3LueI/EOKSPX7zz23OxDZ9sCuO068lsLrzYT83cDuK7r4myrLr05X+FAD+Wf61zPhLTRfagzSD5EGSPxr7jANyw9NvsiXudRHdi8s0kKlWI5zWJqR+9XQ3/AJcHyRjAA6Cud1IjaTXaUjtPgBx4wvcdDYvx/wBtI69/r5//AGf2B8YXw/6cX/8ARkdfQFZy3PNxPxhRRRUmAUUUUAFFFFADWYIpZiAAMkngCuJh+Kng2aC4nXWCIIbeS7817SdUlhjba7xMUAlAPHyFq7OeGO4gkhmQPHIpRlPRgRgj8q8yX4KeHTY/Yri/1i4torKbT7NJZYj9iilOXEZEYJODjLl8DigDVf4s+DEWV5NVmjWIw+a0lhcqIxKMxO2Y/lRsjDH5eRzzWmPH/hk6/wD2MNTzfG4azH+jy+UZ1GWi83b5fmAfw7s+1c9qvwc8P6nZatbT3mqqmpWdnZTFJIwVS1KmMrlDgnaM5yD2Aqe1+Evh2z8Vza/Zh4ria8N88TWtpKPNJySskkLSoCecI4wemKAF/wCFu+E7nTJbrSb2e9l+wz39tF9iuI/tSRZDbGaPDYZSDjJHJIwDTvC3xU0HWNF0i7vmn0281CykvVtZYJmwkSB5CrmMB1AP3hw3bNQaL8IPD2lW2h28dxqc0Ok2l3ZRLLKn7yO5LGTeQgJPzHBXGPeol+D+lCy0e2XWtcDaVbz2dtNvg3i2lTY0TfutpXGcHG4Z69MAF+T4t+Co4VnbWJDC1ql6ZFsbhgkDtsWRiI/lXdxlsY79a6Dw54r0fxHc6jb6RdNNPp7olzG8MkTRlxuQ4dQSGXkMMgjkGuKX4JeHU0q608Xmr+Tc6VFpDt5se4QpJ5gYHy/vZHXGMdq6zwz4OsPD2v65q9nNdPc6utss6yspVRBH5abcKCMjrknnpigDVudb0q0naC71OxgnXG6OW4VWXjPQnNZ2sal4d1XTLmxudX01oZ0KN/pSce/WtG50TSrudp7vTLGedsbpJbdWZuMdSM0z/hHNE/6A2m/+Asf+FG402ndHy3e6BeWmo3EML2s8KSFVljuYyHGeCPm9KQ6Rekfdt/8AwJj/APiq9K+OvgKyNlDr2mWFrGLZRFcxxwqBsz8rYA7E8+2PSvE4rS0PW1t/+/Y/wrzakIwlZpn0WHq1K0FNNfc/8zebR78/ww/+BMf/AMVUTaHfY+5D/wCBMf8A8VWUbGz/AOfa3/74H+FQGytS3/HtDj/cH+FZ3h5/gb2q919z/wAz0H4e6EkOti81WazhS3G6MSXMfzN0B+926/XFey2uqaVGoB1PTh6/6VH/AI1w3w38L6bD4dtHuNNs3luMzMXgUnB+726YAruE0DRuP+JTp3/gMn+FdlKMUjzsRKpJ2bRpRa/pCD/kLad/4FR/41J/wkWk/wDQW07/AMCo/wDGqI0HRsf8gjTv/AZP8Khm0XRU66Tpw/7dk/wra6OP2bZqHxFpPbVdO/8AAqP/ABpjeItKxxqunf8AgVH/AI1kNpGjdtJ07/wGT/CoJ9I0YIT/AGVp3/gMn+FLmKVCRHrusWk6sIr+xf6XUf8A8VRpF9p0FiiyajYK/Ug3Uec5/wB6ub1DSdLmnWOPTbEMzBRi3Xrn6V1Vt4c0jylUaXYHaoUZtk5wMZ6V42aVafuwkm+uhooyiiafV9NlYD+0dPCgcf6VH1/Op7a6trvd5F5b3LKORFIr7R74JxWfLoOkLcRJ/ZVhk9f9GT/Crttptlp6yNZWtvblh8xijVCw7A4HNePVdNxvFO781/kNc1y2gG5W74Iq03C1Tf5QD3yMVacnaKVKVkxvcgmPynHpmm2oBt2J60Nlt4qCAOoKDkVnKStcaLMAyWA9acyP2IxS2ygD371Z2iurDKLjaSJbsyqgcdRTB8zlQOlWZGCj3NV4GCM2Rk1lX5OZJaIa7laT5bgeuOanSQJGVx81MiQy3RbHA6VZjtJXcgRkj1rNRnO3KrjbS3GW+dvPc5q2vSlWzmH8GKka3aNcyFFHqxArspUKsV8LM5Tj3I8iobg4jJqdRD/Fcwj/AIGP8aHigl4S7iOewcf41csPVktiVOKZQlIMDfSmWqgxqwHNXJNPfaVWaIg9Bu5pbaynjjwFDdhgg1zPC1krOLNPaR6MihY7yvamT5WRW7d6mitpkdmkjI9KJYnfhVLD0xUunPls1qHMr3Kl2A+1oxhhSPI8oAK49fpVtLCQ8sNq9yxwKF+xIu2S+tww4I3ChYetNXat66BzxRAvy4x0qwvIqMzabCf3l4jg9FQEmpYtRsD8sMczn/d/xrelhpR+OSXz/wAiZTvsgYDaag2kngE1NNfQqP3VtKzej4AFRXN5cpCWMsSdwqICPzonSprWcvu1BSl0RD9lHmMW6ECobm2fbhWwnerFrq0zjZcWkbkDIKnB/KpZL6x8iQzeZCQDkMuce+aieGp1VzQmvyKU5Rdmj5/8dzZ1y9UHO1wv5ACpvA8flWk0rAjceDVaWyOra5dzs+YpJnYH1BYkfpW/K0VnaLBAAMDHFfYYaHs6UY9kinqUb+UM7E1z+oSE5HatC7kxnJrGum3E1uWel/s9wZ8R6lP/AHbTZ+bqf/Za96rx79nqzK2er3jLw7xwq30BJH/jy17DUS3PNxDvUYUUUVJgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAEF3bQ3drLb3MayQyoUdG6MpGCK+TPG2gS+GfEl5p8gJiVt0Ln+OMn5Tn17fUGvrquA+LnhKPxH4fkuoE/4mVkhkiKjl16lD69OPf61hXp88brdHdgMR7GpZ7M+aN2BQgJIA6mmlea0vD1rJe61ZQRRl2aVSQBnC5GSfbArzT6FuyufQmiQC1sraAdIo1jH4AD+lbEJyaz7fP41eg616CPInqW8gLWfesCpHerUzYSsq5kxmnJipx1MyW+eCUrIPkPQ1BeakPKOG60zUXBVg3Squh6R/asrF5CkCnBx1J64FYVaipR5pPQ6JtJEmg28t7frOEJijbcW7Z6gCuwRpIxgK9R2ss2mwxWdokLRLwu5Tnr1PPNWX1G7UEGG33D2J/rXgYmdOvPnc7fI5XKT6FZEZrrfIOnFS3JDOqopwTyada6jeyRM3lW3B5BUj+tImp3csxSO2tlVRyTk8/nUOlStZz/Am8u34gI2klVQpwpyTV3yHbopqGHUrk/KLWHcO+SB+VMn1PUIyMfZ13cAbSf61pTp4dRu5NryRLc27WJEtZV35jOTnFQx2kqFiU61Fc32prEXa6C+gVB/UVNbareog89I51x1xtNT7PCvRya+Q/wB4tSe0tZiCdhHNWxZS47Z9M1Q+2XV6SpbyIx1VDyfxpktqkUbuGcNgkncc9K3hGhGN43kl12IfO3roWLi3WN/39xEgHYsM/lVOS4tVcCCOS5buQdo/Oo7WBXgLkZPXJ5qvbsTeSAfcA6VyOcHd04eeuuxqou2rNAajIg221nHH6lzn+VMOoX7SIpuETceiIKRYmZC46Cq0IP2055wOKiOLxF0m7Ly0GqcGXy167D/TZR6gYH9KUWaFt0mZHPUuSTU0S8ZqYCu6EZ1UuZtmTstit9li252D8qpLbQtdMhUAZA6VqycCsphuunZD1wD9a58XHksi6fUjv7WGHKxoC3rSJZIIRIjOh9mIpZ8mQKT9TVuVCluDnjPSudt2bSL7Iis7/UIcEEXMJ42v1B+tLeXepSx5MkduhIAWMZP4n/Cl05j5HPqafeDfA4HUDIPvXdGrWlRbUmRyR5tio1iZYd880sp7h2JFRQQ2qzNG0Y45Ix2qeKRwm09xz6VWfKX0b/wt8p+lebzym7voaxXQfcLEZ41jjAG4dquR4QnaMZ4wKguFAkiKnvU0TgSbiN3tQpbXE1oPljITc3eqkFsZZJDIxZVPGemamv7wYHBz2UetVWmeCDLkDdyaUuXn01QK9ipd3JTUUVMltuAB6k4H9an1K0N1bFGYqki7cDqf85qC1iaS7a4KnAH5elakAeZ1kPEadAe5qlZyUY9LGlTRJHgrLPo+qT2VwCskLlD2yOxHsetW55g6bs16D8UPDJv7H+1bGPNzAuZAvV0x19yP5fhXkSXRxtJr7rD1lVgpIzhJNC302T1rNLbmqW7Ylq0vBukHXPEunafgss0oEmOoQHLH/vkGtht2V2fQ/wAKtO/s3wNpqFcSTqbhu2S5yP02119MjRYo1SNQqKAFA4AHpT6yPIk+ZthRRRQIKKKKACiiigAooqtqFqt7YXNpIzKk8bRMVOCAwIyPegDn9L8e+G9Vu0g0+/knDzm3juFtZhbyyc/Kk+zy3PB+6xrqa8c8LeC/iH4fg0TRrHXdIj0HTUkgcbQ/2qP5ihaIw7lbLAMVmwQOADnPM6L8GvE9rcazLevoqR6no50+e20u5FgjS+erh1MVoAihAw+ZZGJ4JIbgA9y1nxBpmjX2l2epXXk3Gpz/AGe0Xy2bzZMZ25AIHHc4Fa9fP8fwZ1g6Voou7TwpeS6Zqz3a2L26RRS2zIF8uSWO3UO3yISxhGcDPQVYm+CN1LpnjS4S5tIvEGsapPcW84nmMTWUk0cv2eVRgLuKYYqpPbJHFAHvFFeDH4Q6580w/sRbFtYXUP8AhFxM/wDZhjCBdhbyhyT82PK25HSpPGHwl1nXLq4ls7Xw9ax3FhDa20PnSBdEdJAzPabYQG3DnpGc98UAelab4403UNW1XT4bfURNp1+mnSstq0qmVl3Bsx7tqY6u+0Dua6uvEz8KddOrm6bULCZf+EqsdcLyO4d4YIij5Gz/AFhJzjOPcVvfC/wLf+Er64Oqafod/dPLPIfEAlY6hOHfcFkUxcehxJjgcUAenUUUUAfOPxk8If2FrP8AaNjFt028bOFHEcnUr7A9R+I7U34R2AL3+ouPugQRn3PLf+y17x4m0S18RaJc6bej93KPlYdUYfdYe4NeceFtAk8P6b/Zkkkck4md5HjztY5wO3oBXl4un7PVbM9ihi/aUeSW6/I6m0UeWrt/vH6Zq1AUKF84UHrVENtgwvVztH06U66k8q2SNTyTURquKMdWy27eYp2nOOtZ88LOjOOgOKs22VtmY9WqK4lEVoB3Zs1ft3bUuNRx2OY1dXUYxjNdTplktrpcSL8kiqGYjqWI5zXPlPtmrwRnlFbJHsOT/KutIPlqv8TnP4VwZhV50ofP/IcpuWpHZSwrukmYF8YweDVK6mLM7KcAYAPrzV6+slhdX2hlIG4dwfWoruCKS3Hkt25FePUjKPuyXwjg43v3ImVksg4kwTyQKntx5cJCgc9SetUopIiVhkbbjoD3rQlRFTKtnjNTObk3KKsgty2i9x1uPmJqveMBexKf7pNW4WVk+T8RVaNDPeyEn7vyitVFKlyrqLrcL8rKkar04zVuRohaqi4LVn3AP2yOND0yWp05MYHHLEAfWs5VJpNNasfKtCawB86Zu2QP0qxekm3dR1KkfpSWqCOPb36k+9V7mYyuUj6KcMf6V3peyw3qTa8hlvIVswh4OOaS2jUJI5PJqK+Yx24RPvswA+nepY4zsXceo5rhjJqLb66FOJNDOqwOC2CfWqtmfMuncfdGFBq5NBF9nDA5PpVfTeFbj+I01FqSjISas2aqcKBSg1GrGnbq96lbQyaG3LYiYis+0ygY4yTk5q7cHMbAdcVQtrgLGePm6EGvMzD+KaR20IZJN1yVPU4I+tPuJn8rHOelV5ARdQt/eJJrSuYgbbcDyRXJKN4pltpMLdRHEB6ClJyjZ9KiibdAp9qeATGTXbF8uHdibEcE4hYpKAPQnoaivJgsbSIoYDnFTTeW0J3KS9RXMSizJXqRyK4qWrinqgbsmxbRBcNE78ZXOO1Tqqw3RB5XFUtLmL6fC46laW5mWMM0jYOOcHoKhO75YrVMqatJpheyRicN2XJ/wFVra3k1KfcxxEp69h7D1PvUdqVv5mRAQijLH0Hp9a1rWJwu2L5Yx8uf8KUE1PVXNW/ZK3UaECP5MXCdyOwrReMIqtGPkxjAqLyVjGByD1JrmNIu/EGo+J3luI5NL8PWbPEkMiqZb58kb267IxjK4OT16cV20KaV1LQ5JyvqJ4Y8TXev6xcvY2sY8MxAxLdygh7mUHBMY/55jBGT1PToa4j4p+Djp7trGkx/6FI376OMcRN/eA7Kf0Ner3t5bQttjJc+iDgfjVCXUpHheIW8bRsCrCQZBGOQRXrYR16U9I+6XCnJ6o+b1Jc4Ne+/Bbwp/ZWnyatex7by6UCIMOUj9fbcefpisTTvC2labqAvEs0lZTuVJmJRDnIIGefxzXouka5G6ATQyIM43ryua9r2sWTiIVOWyR01FRQzRzLmJ1YexqWmeY1YKKKKACiiigAooooAKKKKAOI+Nd5dad8KfE15p9zNa3cNmzRzwSGN4zkcqwOQa4aP4qXGh3Or2txb3upXFvJo9lbRTXMaxNLdW5fJYRb0X5SWLtJk9MdK9nv7G11GzmtNQtoLq1mXbJDOgdHHoyngj61h674N0nVdOvrVLa2sWvfKFzNBZW7tKsfCK4ljdGAHA3KcDpigDgj8Y51sdQ8zR7FNVtNXutJWw+3TytctAiM7Q+VbMzcv0KAAckjoM7/hfEk+nLe2HhpJIl0E67MJtQMZVRcGBo1xE245XIJwCPSu78OfDDwromiHTG0u21SFrt75n1K3ilJmcAFgNgVeFUYVQABwK2o/CHhqOEwx+H9HSI25tCgsogDAWLmLG37m75tvTPOM0Aecal8bV0u3106hoEi3Nh9hMCQXJlWYXSFoyzeWChAGCAr88DdU0Xxa1iS90fTm8GXFrqepXl1axJe3EttE4hjDiVGktw7I4OOUUgjkV6Q3hzRHW7V9G05lvIkhuQbWM+fGgwqPx8yqOADkAdKgsPCHhvTZIH07w/pFo0EjSxGCyiQxuyhWZcKMEgAEjkjigDyrw18UNe8WeNPAz6Ta29routafcT3FlPcAsGjlKOwfyiSV2kqAQG77ete0319aWEayX1zDbRs20PM4QE8nGSevBrNXwp4eWDT4V0LShFpzmSzQWceLZt27dGMfId3OVxzzWle2NpfxiO+tobiNW3BJkDgHkZwR15NAFT/hI9D/AOgzpv8A4FR/40f8JHof/QZ03/wKj/xo/wCEc0T/AKA2m/8AgLH/AIVFcaHoFtC0s2k6YqKMkm1j/wAKASvoNu/E2jx20jQ6tpzuFO0C6j5P51yUeo2Ayx1GxMjnkm6j4H/fVGo2uk6g2yDRtNhhDZ4tk3N+nH0qGLwzo7f8wuxP/buv+FcdaEask30PRpYecI66Nlk6lpxkX/iY2O0cD/So/wD4qmTalYSzD/iY2IQdD9qj/wDiqcnhXR++l2GP+vdf8Kr3Ph7RoskabYqB3+zr/hWTw0TRU5N6P8y+2q6cI9q6lYYHH/H1H/8AFVmajqVpIyiO+sioHGLqP/4qoP7M0ojEekWT+/2ZAP5Ulj4a0eS433lhYogOdv2dfm9unSspxUdWmJ0qkCpJptzqkQm0LXLW11e3k82CMTLIkoAO5JVUklCDj1B57V3Hh2W7vdPtbrVbMWF4yfvLbzBIEYHBww6jv+NJp+k6XDKJrKysoGAwHhhVSB6ZArN8ZeHV1+O1lsbqXT9WsSWs72LJMZONysucMhwAVPWuGc4zleSsvx/4YyfMdCSZp938I4FV723jXDL8r+3T8qq2GpxWbafp2sXlkuuT2/mGGMkCQqAHKAnOMnvzj6Gri5nn3H7g6Vy1opxtLVsqL10MS8sJLgnaAJhzjoD7g+tVrGeWO4MFwcKOPm4IPoa6a9QGWNV4Yc5HUVlXlr5smZB844Djv7GuKrTVJOO5106qmrTLdsobLB9rCq6MYZpAxxk7gajiV4ThPvenJpJ5C0Tgghjx0rBSVlFE8uoW7mW5eU8g8j6dqnnYyyxqTyG3YFLawh4gAQu0fTikj8uI89zyTya2m/eV9EQtdS0XKxsw7AmobFVWAu3JxuP161K5RoWAYcjiqMcjJEybTnBAPbFbVqqbilsgSuiMyme+4GVRefY1pAr5Iz1rL0oAq7HqT1rVaJRBkkZ7VErr3V0Q57lSecKu1fvN0FS2a7VqG3VXuJGxkDgGrEZ5OOlZ09JJg9iwGxTTJURJpOa9uFeEVuTyj5GPlsfY1FZokq7mAJxT+SCD0NQRkwNtOcHofavNxM1OfNuh+hFdbTcIg++vzAe2aleUmPaCcngD0qjLMv8AaUe44yvH5mtW3VJchmwMcVg46RS6/wCYPTfyGwKFhUGnMxPA6UlxiFfvZAFRJdK0agD5veiU5WceweZNMuxVxz6/Sorh43h2pzmmSzEL1yf0qpHO0kpUDOOh7VKV7yWiBXem5WMktnE4iGUJJx3H0rGRb/VrvyI12KPmJbOEHqx7n2rrYIRIT5uAB61ZtrEvGxVgkYPAUcn3NdFOtUldU47msKkKT5pK8ls/+AVLG1isrRbS2y7E5dz1Y+taEU0Fvbos8scW5xGpkYDcxOAB6k9MVmarrOmeH1tzqNwIWuJVhhUKXeVyQAFUAk9ew4rPuvCou/FY1vVbl76K3IaxsmXEVs2MM5GfnfJOGI4HT1rSjHlftJnNUm5vzEXSdY1HxWb3WLz7NpNjIfsNlaSsPOOP9bM3GepAToO+e+rczGdykJPlg4z/AHv/AK1P1rUESyKx5MzEKQvJA7ms/TLyIYVjtb3r18JSUnzy+RrRpNR52adrp6uQZKkvbSKJMipVlBQFTx7Vm6pcM2EXJYnAA65r0nZIceaUtyvBai8uCDkQp94jqT6CtsW6+WqqoVQMKB0//VUdhbCGJYs/MMlj79z/AEo1SbyrUqn+sl+VQOy9zSSsrkTm5ySRlXLvcTtHbnCLwWH8R9vapIbq+tiClzLkdmJIxU1lAIo/c9ammVSpzSs1qbPlfu2ujV0XVxefupwFnA4x0Ye1bVcAD5MyyRthlYEH3rt7Odbm1jmTo4zj0raEr6M87FUVTfNHZliiiitDkCiiigAooooAKKKKACiiigAooooAKKKCQBk0AVNSvorC3Ms2TzhVXqx9BXMXOty3J+a3OzqFD/8A1qg1K7/tHUGYH9ynyoP61PFCoUcVhKTk9D1KVCNOKc1qPgu7eQ4liKH1dQQfxqybWCRdyAAHoUOKhCoQRgVEAY3PkPtY9hyD9aRTj/K7EzQSIcRyBh6Nx+tZ88LPLsmTB6gHpWlBPubZMNrngHsankQMm1hle3pn29DRa4Kbg9TOgsVxz+VPl09WQ44NTMTAc8snTJ6g+hqRrgBM9sUJIbnLdGD+9tZjtJB6cVs2N0JlAbhx+tZF/cjcdq7mPQCqqfbGIZG8odRjk1yV6Eaq8zolT9pG7NHxV4dsfE1kltqCODG2+CeJtksD9mRv4T/PvUOoeI7LwnNpllrRvBBNEI11OVQYjIMALIw+6zdckAVettSdABcRbiOrLx+lOuBbavbyW14kU1vIpV4JVBDDuCD1rzXTnR1qK/6HHOjJFhX3nzc7i/3ccjFSywqLRhJ1PII659q5vXX1vQvsc+gadbX+k20flz6fH+7nCjG0xH7pwoxsOM9jW/ZXP9oW9vdPFLbrLGJFgmXZIgIHDL2IzjHY1zKk1Hmet/61J5tRu24iRWwjY6EdagETXLFi+M9q0XYu3+yOlQC3MspER2nGSeoz9K5qlG7UY6otStqZsivCxO7cvQgn+VJFNG9ziYFUA4z60+6gdZh5xDqp5C5/OkltS6hofnGM4rkUHGVmjZNNbklxcRINkDgs3QVLawqYyZGyw/WsdlAba6YYdCOCPwqVWlUYWT5fQ1fLeV0r+QpLlVmWorZLMOEbcCc49KldZXUc7F7+tVlcMeTlsZqaSbcuOQe1KcpOTbWoeZLFGRGSPlUfnU8MZZSVYYHXNUGnO3aWTb+VMVZOfLnAB7daIy5XqmK1+pceZUfax5PSpVUsMgVTt4AGZnk3v3J6AVILoxZXBZQOCOafO18Qeg6ScJIEPBNTT+UIN27L1SjQzuZpRtQDABpbSNJZHxllzSUpbWvcHYrTQI0sM56p8p9xmrIY7cxMCvfPajUmRUMaDgqR+lYZeUNtAy5PAHJP4VpTpxmnGpK1tupfLOaTgrmy7A5aaQFR2HSoheCUhI03Y6EDAFVrfT5ZiGu2Mak8AnJ/LtWvAlvbHag3noM8kmh8q0iDio/E7vy2K/lZGX/z+FWIFSLJWPLnjJ4FWIIC7lpBjHIX+polXOR3ojSklzMzc1sOW3EQDH5i3JNYOt+LrfRL+DSrW2l1PWbogxWNuQGC5AMjseEUepqLWdW166v00Xw5p4SQKrz6neKfs8SE9EXIMj8HgYA7mtwWUCXUk4giW7kVVeZUAdwudoJ6kDJ4J4ruUVR5ai2f9amN3K6ZWl8M6cviSTXXjeXUTGIkklcsIVxgiNScJnvjrUkl28xMcZwnQkdT9Km1C6dbYQtwzcZ9u9QWqAAYr0sLQjU/ev5I2pQtHmZNBpokXOKr3OmoGwV5roLZwqVWuyGbNerypImNablboc4fOsjlWLx9we1TaSDc6g07jKxLuHpu7Cnaw4jjPvVrRoRDp6cfPKdx9cnoPy5qEtTecrQv3NCMAxgd3OCfb1rJ80Xt48o+4p2p9PWrGtXItrQiM/PL+7XHYdz/AEqjp+EQD86bfQzpR0czS4AqCdht5p5cYzVO5fIoZcVdlS4cAgZrqfCk26zkjP8AA2R9DXFXDDeK6vweTumHYqD+popv3gxkP3LOnooorpPECiiigAooooAKKKKACiiigAooooAKo61KYNLuXBw2wgH3PAq9WN4qfZpLf7TAf1qZOyZpRjzVIrzOX0+PitbGFxWVZuQoq6bjC81zo9iom2Mupig2r941NaLtj9WPU1kCbzr9h/Cn8617N1zg007hONkTtGXXkfjSQ3DRnZOcejnofY/41bUcVXuow4IIqmjnTUtGT9VJx25B5GP6is+8hMa5X/Vn/wAdPoaktZTAyxSH5Cflb09j7VbkXqcZU/Kyn+VLcFeDMm3gjLZIyavRwpkDAxVO5R7SQMuWhPAPcH0PvVqGQOoZTSRtJtq6ZfexQx5wOlZl1Ygcrww6YrQS5YLiqt5dLGhZ6qVrGVPnTsQ2Fy2/yJ256KT39jVHxV4ZsfESQNcyXNteW2TbXdpKY5YScZKkdc4HByDVWbz7ybch2IOm3qfxrQimuoVHmfOo6g9fzrzK2Flzc1HQ0qUL6lC+vtQ8NaBaNcw3/iGdH2Ty2sCCXbyd/lgjOPlGF574rV8Oa7pusaP9v0u486IuUbcpRkcYyrKQCCM9CKtWVzFJufPzgcg9RVHXdOj1yymtJpbm3ikwQ9tKYpFIIIYMOhyB/WvOv7P4l739dDncXez2LtupdyzjO49D6U2a2AlPkMYz3A6Vk6DYavoNhffbtTl1xI03WiSRLHPwCdjPkKxPyjJA96j8MeLbDXdQewMN7YaqiGWSyvbcxShMgFh2ZeRyCaj2F42WvmHPZ3NOSzlCl5fLcD8/5VC1tEyZ8zaR2IrTvnwAoohjDY3AEe9c0qEefliaKpJK5kJCucKwz9MVK1k7IWyNo6nGau3iox2AYx0xximNDIqYWXj3FYui4tq9y/avcy/samUKZDuPQAAValsDHFuLnnoOD/SrMdkPvuzs56EcY/CnfZi64aR9voBQqMraobrN9TMjs5wCyMGGeQcg1Iu9OGGDV3yJVJWNxtH97rSfY5GG5357ACk6M30D2ie5WZJWj3YOz9KbZrMM+X1NX/ssxj2b/l9MUyO1dOFkI9eKfsZpqwudWKfkgyHz2yfTpVqFYlXbbwfN3Kjk/jViO2RG3feY9z/SpRhbkZOBitaeHcd3uTKpfREEduSS0wGR0HpSRgJMpCgZPWqOn+J9G1LW7jS9O1CK7vIYzJIIMuiDIGC4G0HnpnPtWNplj4oudXS91u+tbK0hZjHptkvmCQYIBklYAk85woAreVD2flYzUrmjqHjLSLXxDDpEEsl9qUjhJILNDMYASBukI4QDqcnOOgNVNd8KT63rZm1fVbiTR4yrQabb5hUsAMtK4O5+RkDIAro7OytIY5ns7aGB5pDNKY0CmRz1Zjjk+5qwXUxEudu3qTXS5X+D+v8AIhJ9SujeW+9eB3FR3N7EWzGCx7ntVS4ladsL8qdh3P1qe1tC46cV14bAe7+8+46VCMfemZepCW5dXVthUYA7dar2d7LBKEmGOwzXSyWIC81QubCN16fMOh969CNNQVo7G0KsWuUuQTFlBB4pZpdqkk1j20slpL5U3KnoaluJmnlWGLl24HsPU1pfQj2epGkb6hfAFcwowLeh9BW8AcgqASThcdM9zUFpAIYAicADLN/M/wCe1R6pcNBbbU4mm+VB3VfWmlZXMpydSSijJ1OT7bekwZMcQ2KR0Pqahime2fEykA96v2kAghA/iPWor8K8LKRz2NRbqdUWl7q2I2ug33TxUc0vy9axbS4IneJuo6Vakcnip5jb2dmDfPJmuy8ILgTn0AH865C3XLCu48LR7bSV/V8fkK0pfEcuPlak0blFFFdJ4YUUUUAFFFFABRRRQAUUUUAFFFFABWN4sMY0WUysFwy7c9zkcVs1yvjFjM8dseUA3Eep5AqKjtE3w0eaqjDgbCjFSythSTWZGJ7RtrAvH2I5IFW5JN0RI9K5rntuOpBprB5blvV8CtOJ9pHrWNpDASToTzu3Y9q1FNCegqi1NeC64wae8gIzmsoNTLu5McBIP0q+YwVK70LM04dtg59atWV0d5im5J4U/wB4en1rM02IsgZuWPJq9LCWX0I6GhPqOcY/CaDIGVlYbkYYx6j/ABrLnRrKQFctA33T/Q+9WrO6yfKn+8Oh6bv/AK9W3VWUqwDKex6N/gae5gm6bs9inDMJAPWm3FuJsbulMlh+yHeuWiz17r7GpopkkHBpepqu8SextkztAq7LYjYaqQvsbIq0bv5ME1atYwqc/NdGPc2mx90Z2sOhFTWU4fKyYEg6gdx60y9u448s7BRWQb5mukeFCUB5J4yO9ceKoRqx03OhQlOOp0JzI3sO1T4Ea7j94DrVGG/g64f/AL5okuo5mwX2j3BFeQqNSC5uV3MHTle1jmtO8JyWOuLeaVrOpQWRkLzWE8n2iKTOSdpfLIcnOQfwq1qvii80XVJIr/w7qT6ZkLFf2QFwDwMl41+dBkkcA+v06WJk8seWQV9RzTZGLMAOg61MZ8utTV/1/WpDV9EcvrHiJ4L2S20+3866U4LSAhV+g71nyXfiK74N1Hbqe0aAEfjXS6lpgurgXlsB9oVdrLwPMH19azy4ikKzoYmHO1wR+VbUow5bxRSMRdP1WQFn1e8yOuJCP61X1m/utA0e41LUdeuILO3Qs7O5PsAOeSTwB3NdHNcwWtjNPPLHHDGhZ3dgAoA5JPYYr5A+M/xFuPGmpC2sC8fh+0ciEYI85/8Ano3v6A9B7k12UKTqu3QzqSUEfRHgHxXc+N9D/tHTtVuYwHMcsLMA8bDpnHqMHNdA+k38zZl1S8fIz/rD/jXyJ8IvG8/gfxOl2+5tKuCIb2MAkFOzAf3l5I9Rkd6+1Le7t54ILiGaN4JYw8bqQQykAgg9xg5qq9L2UtNhUpKa8zDbSLkRFhqF5nPeQn+tMlbXrBN8OpyMqjpJh+PxFb6M0qmO3R5Wz0UcfiasR6OZXVr98jtEnT8TXNKaSvI1aRm6dqXiW90S5ktrWxe+DItu9wWjifnDFsAnAHPHXpVrTtI1X7JeJ4q1KHVReJse3jthFBEhBDIoyWYEHGWOa6FlSJFVQEUDAA4AHtSzSx+VuZ0CgckkcVyyk5RairE21uRabp1jptjHb6ZaW9pbJ92KFAij3wB1p87xx/M5A9u9Z7X+QVtzlT3pkcDyvlySTXZTwcqq5qmlzaNG3xaEhvirHyVz9azdTmupyGB27eijgGuhh08bc4qCe1C9q7qeFhTXuo0hOCem5k6ZciULuHzDgj3rpLORAOa5S8iNrdLKvCseQK2LWXco569K2i7DrQUldGrPKDnHSqMjAZpJZQi5Y1THm3jYj+WMcM56AVTdzOEOVale8RruYRQrubrnoB7k1fsLJbcYQ75G+8/r7ew/nU8FuiKIokyD94nq3ufb2qWV0jRhuCxj78n9BSS6inUb91bDmdI43ZziGPlj/ePpWQhN1O11MMZ4Vf7oqGe6N/OFX5YIz8q/1PvVgnaAB0ovcuFPkWu452qjdtxU8kmFrOnl3Pj3qWzeEdTHkTZqh/2hmrmMtVe7I/tQZIGEyafNfW0AwG8xvReazWh16u1i4HEKbm7dB6mvRtNt/sljFCeWVfmPqe9eNyvcXkw3AomeB6CvZ7J/Ms4JD1ZFP6Ct6GrZ5eaJxjHzLFFFFdB5AUUUUAFFFFABRRRQAUUUUAFFFFABXJ6yQ+rSL6AA/kK6yuR14mLVnbHDAH9P/rVnU2OvB/G/Qhe1DDIqvNanYRitCJgyCnEA1lY7+do42cNZXYk2/L0YD0rWidZEDocg1Y1W0SZOnPrXPgT6dIdnzxnkqf6VD91nUmqi8zeBFZ2rOf3SA9WAog1S2kGHbY/cNVTVJlaSB0cMiuCSPrSbVghBqWp0OlH5cVqcdDWNYSBG+taLzDbkda0i9DlqRbkV7xAxwOD61LZ35TEVzyp43H+v+NVbicYLHrTYAXXc/foKV9dC3BSjZm64G0n7ykYPfI9D/jWTc2xtwZrXLRg/MndR6+4pYLqS1YA5aL8yBWijRSgSwMAT6dP/AK1VuYWlTfkULa8V15NF5eJFEWz24qS80yOcl0zBKepUcH6j/CsS8tLiEfvxlB/EOQfxqW2jWnyTe4RRveybpOnUCtm2s0AAIyapaayfLjqK2EYZBoiupVSTWiJ4rEFeAKjubFVGSKmW6K8dqju7ktGT6VbtY5YupzGZKotsukm31HamW2rJLlTG/H8YHBqtHby385aXiEHAHr7mtuPS1WMFRwBXNVw0K26OibhFWnuQR3sWMAOMeoqT7XDINjkMPRxxSyWWwZxWRqjmIqkS5djge3vWDwFOK0bREYQqOyNC702wvo2iuLOF4mGCu3AP1Hevnz9rmC20/wAN+HbS1Xy1kupHCAkjCqBx6ffr3a1tZWiVTI7AepNfM/7XUxTX/D9gT80VrJPj03sF/wDadVhsLOFRSlK6McRTjCD1Or/ZR8PWdz4F1i9v4PN+03ph2seGVEU8jvy7da92t9M0vTrdY7ezt4YoxhFA4UegHb8K8u+BennSvhJo0hJWS4WS5btnc52/+O7a7yyaW6CtK5c9s84qa+GnUqt82jNKOH9xO5rvfhUVYUzjp2FQmS5m5ztHYLxVq0swxHFasFsicYrang6cel/Ucpwp6JHNPbyNyxJPqary2xCkNyDXY3MEfl5A5FZE0auCCK6HBIqniOZHM2zm0uPLb7p5U+ntXU6eyugasHU7cAZAwR0q7pswES5Papjo7GtX3436nRmYBeKpzsG61Wa5QDlqqy3w3bYVMjeijJrRyOaFJp3ItSKeWVPJqtaXD4VI1LMeAAMmrC6fcXUgN03lKf4ByxH9K1LW2jgXFsgHHJzkn6n+lRZs2lUjFW3K8Fi0jB7skntGp/me1XgoIAQBUXoegH09aSSRI1O87sdQOAPqay7nUmmO2Hkjv2H0Hf8AGq0RglOoy9c3cNtH8xIBPAB+Zz/hWNczzXzDI2Rj7qjoKFg3NulJZjyc1YUgLgDAqW2zohTUNepnoPssw5+RquPMCvWs/VpdkeR2NV0uT5QPcipvY6FDm1Lk8wPeqYYZLscKOSajLFuTVS+mLKLeL77/AHj6CpbNYw6FIg397I5yFJ4+laUNlHEu7AAHJJp9lbJbQl2IVVBZmbgAdSSapXVwl9dLbQvwrBjgghht3KxHcZGMH1pWKcr6LYvWU8E9y8Sn94hIKkYJweSPavUNLOdNtv8Armv8q81060itnbylwWxknkkAYAz6DGK9J0n/AJBtt/uCt6O55WZfCi5RRRXQeSFFFFABRRRQAUUUUAFFFFABRRRQAVx/jS48i9tmC5XYQ5Hbnj+tdhXI+KE8y+2kZyo4rOp8J14K3tdSlaXKMgKsCDV1XGMk1hCyEZyhKA9h0q3GSBgnOKxTPTlBPVF+VlZazLmNWByKnMhA6ZqtPM+35Y80OwQi0zMntInP3eazr22SCPjG49B3rSnF05+QBQe/eoRp8mDJISzdyayaOyLtuyfSLkywAE/OnB9a1xMCnWuWSOaB3ng5CnDKOpFadvN9pjDRnnuO4qk+hnOmm7okvpT5yKDwTk1pwyAge1YN4SksbNwMgE1oq+wgUJ6ilHRGorA9ec0xlaBt8DbSeo7H61XSTvmorq5ITaOrcCquZ8t2bFnqUch2yMFcdmPH4HtV84YYxkH8/wD69czDbjywDyT1qzBPPacI2+Puj8jHt6U1LuYToL7JoXGnQs26I+U/cqOPxHb8Kr7pbdgso69D1B+hq3aX0NwdoJST+65/ke/0qyV3Kw2hl7gjI/EVVl0MueUfdkU0mDUshDgKOhPP0pktjyWt2x/sN0/A1XaSSE4lQofcUrmitL4TQQBMbRgD0q6l1hMVlQXCsvPFWAwPSqTIlBPcty3AZMVl+Usl20hGdqgD61bqNAQWz3NJ6jguVaF20VABwK+Kv2qtQOo/GK8t0O4WVtBbLjnqvmEfnIa+zAxHQ18QzD/hMP2h3VgZIbnXCCDyTCkn/wAQlaQZyYiO3mfXFlpS6P4T0rTQNos7SK34OeUQKee/StDS4gI1x6UurMJICB25qKxnVFG44rFvU9GKahZG7BJ5ZqY3HeseS/jUcHNEclxOMxRHb/ebgfnVKRi6XVmnLclhjPFVJLmJOrDNRpZSSf6yfI9IwT+tWYrW2hwFjVn9XO40asV4R0RkztJdMRDE7j/ZBNJb6XckDeyQr/tHn8q6DPy8sQOwGFFJH/s/ki/1pco/btKyRnx6bBFhpDJMfVztX8quRxhFwihV9EG0fnTbmeODmRgrdh95vy7VnzajI5xbRkH++/J/D0p6IlKdTU1DtjQtKyqo9eB+PrWXeatEPlti0hHc5CD8O9Vmt5JzuuJCx9zmni2QKQFxSuzWFKK1lqUzJNeS4kkyOuBwB+FXURY1wBz61nW7CK5dSehq6z55qUdDj0WxIWqKWUAcdahklxmqwYu+O1FxqJX1hv3PuxGKhtoyUUH0o1I+bdxQr0X5mpJbwL+6thvk6E9hWfU3ivd0GaldxWiKhYea5wqk8k1Va3vLeOOeJI3aSQK+/PG4hQc56ZPvQbER3E73gkfz4dqsFJJOTkDjg8r9fwrXXS5L2K3e8eWGVAm8RSkhiOTxjA5GcjnFFrkymlojO0+2nnzAtwXigjMLpJ92QbnT5jjOcAHr/jWhBZpZxbQS8h5eRurnOSfYZPQcVqxQpBEsca7VUAAD0qBoXlkwBVWM1LW7EsIy79K7+wXZZQL6IP5Vg6VppUKWHJrplGFAHQV0Uo2PKx1ZTaSFooorU4AooooAKKKKACiiigAooooAKKKKACuc8SxbZ4pgOCNpro6patAJ7NxjJHI+tTJXRtQnyVEzmgquoyKa1uO1PELx84ODUi9OlYHqX7Fb7OaX7P6jiroFBAosHOzPMCg9KhuVCoRjir8oFZ944K4FJmkG2yhp0Iea4X0AI/OsuW2eC5lkgOwq56dOvpW3o8bG6mOPl2gfrUkNg9xI64J8yQ4A9M1HLc19pyyd9izPob32jwzw/OZEDFQMEHHb1rJgVzE0UylZ4flYEYOOxxXo2nW4tLGGAHPlqBmmX1hDdqxdFEhGA+ORW7pdUedDHuLcZao873Fciq5cmdNx71sanp8lvKwZcGsS6Vk+bHKnNYPQ9SnJT1RrwS44NWOGrNiYPGrr0IqeObtmmmZyiWXhVh0pY7q4tSOS6jpzggegP+NNWXNPOGp+hLV9GaVrfwXXBO2ToR0P5d/wq0UDqVBVwe3BH5Vzc8C7S2MEd6jtL26VsRybvUPyKrm7mLw99Ys33tIScbSp/wBkkfoaiNm4OY5nUehXP9aji1NguJ4m98YYfrUo1G0zgsFPp8w/pRoZ2qRGSQ3IB2zRe2cj+lMCX2OPKb33CrizxOf3UwOe3mA/pmrCrLt53H6Ef4U7A6kluczr+oXukaFqWoyogis7eS4Y71PCKWP8q+VP2YNIn1b4lSXygMbC1knLucDc+E/PDsfwr3n9prXf7F+FV7AhK3GpypZoSBnBO5/w2qw/Gua/Y+0H7J4R1fWpo/mv7kQx5XOY4geR/wACdh/wGrStFnPUqOVSPkexHTpmXE1xEueykk/yqeHSIcAt50p9eEFaxIVc4I98AVA1zABh5Yl9QW3mosjf2s5bDILeKA/u1iUjsg3H86mBMjcY+rfMfyFUJ9ThTiFDKfVuB+VVmu7y44BKL2C8Ci6Q1SnLVmvNKicSOOOpc4/IVUm1KBBhfMkPog2iqC2hLbpGJPerCRInRRSuy1Sit9SNtVnDfubeNB6nJP51TutQunbEsrhT1C8CtBwvpWdqMYMRbHTmk7m0Iw7Fi0RZV3MPpVsBVHArPsJQIR9Knaei45J3J2YZqJ5QAeageYY61Ukl3E4PFK4KBSlkJ1I46YyauvOAuBWVbt5t7I46A4Bq/wCSWbpUI6GkrXEDmQ1qadYPKrMiFmAJAHenaZpkk8gVFye5PQCuzsbSOzhCJye57k1rCnfU4cTilTVo7nn8fhm9ndnn/dlzkgdcema1bPwzHbgEjJrtce1JtHpWioxRxyzCpLQ5g6YAOBigWDAYArpTGppPKFPkRP1uRzyaYSeau22mpGckc1qiMCnBcU1BIiWIlIiijC446VNRRVnO3cKKKKBBRRRQAUUUUAFFFFABRRRQAUUUUAFNZdykHvTqKAKU1sD2qnJZegrZppQGpcUzWNaUTCa2YdqgkgfPFdE0QPam+SvpU8husScvLBIR0qGPTXkbLCut+zp6UohUdBS9mV9ctsY1jpvlA4A561qWlokByFGfWrIQCnVaikc9StKYUUUVRiVry0iu49so57EdRXMan4em2kxASL2x1/KuwoqZQUjeliJ0tjylFfTbhobhSImPBI5Q+/tU06lDleVPIIr0i5toLlMXEMci+jrmsW58NwrE32Mle4jY5A+npWPsmtj0YY+EviVmces+OtTx3I9aW+054XZWQqR1BrPaN0PestUdy5ZK6NR5gUI61W06VBO6nr2qospBwaq3TmGUSp07j2ouUqeljq9yketRSQo/Uc1mW10SivnKnoatrMG707ox5GmSfZUIIpEtSpOyR0+hIo84LzmqdxqkNjDdXF5IEt4YzM7noqqCSfyFPQWtj5u/aj1ia+8YadoEMrzizhDsgJJ86UjjHrtCf99V9A+AfDknhnwfpOkLKUa2gAkCMQDIfmcj/gRY185/CSxm+IXxlu/EN9GfsttO2oSA8gNn9zHn2wD9ENfVzTdq0nokjjw6c5SqdyCe1ARmZyxA7mktoVZQTTruXELe4qvZ3QaEKOo4NZaHdaVjRSKNe2frUocDgVTWcEdaPNz3p3I5b7lozCmGUnpVYyCmNOBRcfIWi+OtUdSnAgb6VFLcMxwtUNQkJCx/xHr9Kls0jT1LFlMQgzVlp6z4QwAAFWkiZu1JNltIVnLcVFeSC2tSw5dvlUe9aVnYSTOAiFiewq/D4TuLq6Et9KsUS/djT5j+JqlFy2MZV6dP4mYWjWZ8oFup6/Wur0/RXfa8o8tOvPU1s2Gl21ioEKZYfxNyav1tClbc82vj3N+4Q28EdvGEiUKoqaiitjz229WFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAV7i1huVxNGG9+4rFvfDqscwMMejV0VFS4p7mtOtOn8LODudBnjJ/csQO6jIrNn0tidrKQfQivTqjkiSQfOitj1GazdFM64ZjNbo8lEcmnSlJlJtmPB67T/hVsxHaGibcp5BFej3GnWlwpWW3jYEY6YrNHhiyiZjbNLED/AAZyo/Co9i+h0xzGEviVjhiZB1zXkv7RXiP+zvDEOj2pJvtUbYQuciEEbvzO1fcZr37XNOi0jTbrUL2aKOzto2mllY4CKoJJP4V4N8M/Cl58SfGt18QNZtJV0mKXy9JgdeGCEgN9FOTx1cn+7RGDTux1cTGceWD3Og+C/hceE/CMVvIu3UrhvPvAeqsRgL9FHH1ye9d80xHWtZvDU8pDxKYph0c4APsRU8+hXEcas6I7Y+by+QD+VJxk9WXGtRglCLOfaUsMHpWeS1rc7/8Alkxw3t710T6a4OChHsQaemkPKNpiZgeOAanlbN1WgkZJUsoeM7lPIIpyiQDoa3LHwpPFMHWfyYSctG3zfl6Vsf8ACPw/89n/ACFUqcmc88ZSi7XucYVduxp8dq7HmuxXQIR/y1b8hVqDSraPkqXP+0ar2T6mcsfBLQ4+PTpjEzQwSSsB0UZ5qpbaFfyTmSe1lVj2KnAFelKoRQFAAHYU6q9ijD+0Zq9kcXDocxwBAQfU8Vq2egIuDcN/wFf8a36KpU4ownjKkvIhhhjgTbCgUewqaiitDlbvqwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorwXwB8SDp/w88RyS6iut+KLW+vnttLmvd91KiOSAqEl9iqCcAcBTigD3qivnvT/jF4mufDOo3oTwm0ySWgt5pNStYV2yKxkDxfa2w67W2hpELAHgFSKbe/GzVksdFvIZdL+w3cBeR2sVN40hmMaBLI3gcpgZ8xHkB5wBg4AOy+KnhnX/AB9rlh4ZCNp/gxQl1ql6JF33ZDfLbxqDkdMliMdD2Ab0rTrK202wt7Gwgjt7S3QRRRRjCooGAAPpXjln8V/ENz8SZdDfTNMtbKPVHsWt7u4igumhHCzoHnDvnrtWEgjo7Hiui+CHizxR4y8JL4h8TRaHBY3SlrNbHzVcbJJEk80OSB91cbSe5PoAD0uivANK+NGotZeIJtZuNMik0+zN0BpdmNRgjBnWNMzxXZDkg/dZYTznIC8s0z4067d6bOZrfR4THrUWnPqzLm0t4HQsJpFjnde2OJdvP3hQB9BUVleG706hodrdDUtP1XzAT9s05dsEvzEZQb34GMfePIP0rVoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26594=[""].join("\n");
var outline_f25_62_26594=null;
var title_f25_62_26595="Atrial flutter and AV block";
var content_f25_62_26595=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Atrial flutter and AV block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intraatrial reentry tachycardia in an 18 year-old man following Mustard operation for d-transposition of the great arteries. There is 2:1 atrioventricular conduction and low amplitude \"flutter\" waves (f waves), making the diagnosis difficult to recognize. The administration of adenosine results in the obvious appearance of f waves. The sweep speed is 50 mm/sec.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26595=[""].join("\n");
var outline_f25_62_26595=null;
var title_f25_62_26596="Dress rash 1";
var content_f25_62_26596=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Drug reaction with eosinophilia and systemic symptoms (DRESS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent morbilliform rash with follicular accentuation in a patient with DRESS.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26596=[""].join("\n");
var outline_f25_62_26596=null;
var title_f25_62_26597="Nutrition label fat PI";
var content_f25_62_26597=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nutrition label fat",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 222px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The percentage of calories from fat can be calculated by dividing the calories from fat (90 in this example) by the total calories (320 in this example).",
"    <br>",
"     90 / 320 = 0.28 = 28 percent of calories from fat.",
"     <br>",
"      It is important to pay attention to serving size; these numbers apply to 1 serving, which in this example is 1 cup.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26597=[""].join("\n");
var outline_f25_62_26597=null;
var title_f25_62_26598="Gallstone ileus";
var content_f25_62_26598=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gallstone ileus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Andrew P Keaveny, MD, FRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Nezam H Afdhal, MD, FRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Steven Bowers, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Stanley W Ashley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26598/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/62/26598/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallstone ileus is an important, though infrequent cause of mechanical bowel obstruction, affecting elderly patients who often have other significant medical conditions. It is caused by impaction of a gallstone in the ileum after being passed through a biliary-enteric fistula. The diagnosis is often delayed since symptoms may be intermittent and investigations fail to identify the cause of the obstruction. The mainstay of treatment is removal of the obstructing stone after resuscitating the patient. Gallstone ileus continues to be associated with relatively high rates of morbidity and mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallstone ileus is an unusual complication of cholelithiasis, occurring in less than 0.5 percent of patients. It is responsible for approximately 1 to 4 percent of all cases of mechanical obstruction and, in patients over age 65, accounts for 25 percent of nonstrangulated small bowel obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, gallstone ileus should always be in the differential diagnosis when assessing an elderly person with intestinal obstruction.",
"   </p>",
"   <p>",
"    The average age of patients with gallstone ileus is 70 years, with the youngest reported patient being 13 years of age. Women are 3 to 16 times more likely to be affected [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual means of gallstone entry into the bowel is through a biliary enteric fistula, which complicates 2 to 3 percent of all cases of cholelithiasis with associated episodes of cholecystitis. Sixty percent are cholecystoduodenal fistulas, but cholecystocolonic and cholecystogastric fistulas can also result in gallstone ileus [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Mirizzi syndrome refers to common hepatic duct obstruction caused by an extrinsic compression from an impacted stone in the cystic duct. An association between the Mirizzi syndrome and the presence of a cholecystoenteric fistula has been suggested because when a stone is impacted in the cystic duct it can result in narrowing of the common hepatic duct, which can lead to a cholecystenteric fistula thus providing an exit route for gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a surgical series that included 5673 cholecystectomies, 327 patients (5.7 percent) had Mirizzi syndrome and 105 (1.8 percent) had a cholecystoenteric fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/6\">",
"     6",
"    </a>",
"    ]. Of patients who had a cholecystoenteric fistula, 90 percent had Mirizzi syndrome. Thus, the presence of a coexisting Mirizzi syndrome should be considered when a cholecystoenteric fistula is encountered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44565?source=see_link\">",
"     \"Mirizzi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following sequence is probably responsible for most cases of fistula formation that lead to gallstone ileus. Pericholecystic inflammation after cholecystitis leads to the development of adhesions between the biliary and enteric systems. Pressure necrosis by the gallstone against the biliary wall then causes erosion and fistula formation. In addition, cases of gallstone ileus have occurred after endoscopic sphincterotomy. In this setting, the stone is presumed to have passed into the small bowel through the sphincterotomy and to have been large enough to cause obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/7\">",
"     7",
"    </a>",
"    ]. Gallstone ileus can also complicate Crohn's disease, when a gallstone obstructs a diseased segment of the bowel [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gallstone ileus results in obstruction if the gallstone is of large enough size. Ninety percent of obstructing stones are greater than 2 cm in diameter, with the majority measuring over 2.5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/9\">",
"     9",
"    </a>",
"    ]. Fifty to 70 percent of gallstones impact in the ileum, which is the narrowest segment of the intestine. The jejunum and stomach are the next most frequently affected sites [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Colonic obstruction tends to occur where there is preexisting pathology, such as a postdiverticulitis stricture, since the normal colonic diameter usually permits passage of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ]. Multiple gallstones may be found along the obstructed bowel.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic clinical presentation of gallstone ileus is in an elderly female with episodic subacute obstruction. The episodic obstruction or &ldquo;tumbling obstruction&rdquo; is a result of the stone tumbling through the bowel lumen. Transient gallstone impaction produces abdominal pain and vomiting, which subside as the gallstone becomes disimpacted, only to recur again as the stone lodges in the more distal bowel lumen. As a result, vague and intermittent symptoms may be present for some days prior to evaluation. The mean symptom duration before hospital admission is approximately five days [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ]. Hematemesis is an occasional complication that is due to hemorrhage at the site of the biliary enteric fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bouveret's syndrome is the term used to describe gastric outlet obstruction secondary to an impacted gallstone in the duodenum or pylorus [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The presenting symptoms of this rare entity are epigastric pain, nausea, and vomiting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44793?source=see_link\">",
"     \"Gastric outlet obstruction in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On physical examination, the patient may be febrile and often appears dehydrated. Common abdominal signs include distension and increased bowel sounds. Jaundice is uncommon, occurring in less than 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, 20 percent of patients in one series had signs consistent with acute cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many affected patients have serious concomitant medical illnesses, including coronary disease, pulmonary disease, and diabetes mellitus. In a series of 22 patients with gallstone ileus, 86 percent of patients belonged to the American Society of Anesthesiology Class of 3 or 4 (",
"    <a class=\"graphic graphic_table graphicRef78084 \" href=\"UTD.htm?9/5/9307\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of anesthesia and anesthetic choices\", section on 'Risk classification systems'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis can be suggested based upon a plain radiograph, although multidetector CT may offer better visualization of the impacted stone. While the diagnosis was made preoperatively in only about one-half of cases in various reports, combined imaging modalities established the diagnosis of gallstone ileus in 77 percent of patients in a more recent series [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. One problem is that the disorder is often not considered since about one-half of patients do not have a history of biliary disease. In addition, the biochemical abnormalities that accompany ileus, such as leukocytosis, electrolyte imbalance due to dehydration, and elevated aminotransferase levels, are nonspecific [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radiographic criteria for the diagnosis of gallstone ileus were first described in 1941. Despite the many advances in diagnostic imaging since that time, a plain abdominal film remains the single most important diagnostic test in this condition [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ]. The major radiographic findings of gallstone ileus include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Signs of partial or complete intestinal obstruction.",
"     </li>",
"     <li>",
"      Air in the biliary tree (pneumobilia). Pneumobilia implies either a patent cystic duct or a fistula involving the common bile duct and can be detected on a plain radiograph or on ultrasound. Pneumobilia is shown in the radiograph (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68491 \" href=\"UTD.htm?38/55/39807\">",
"       image 1",
"      </a>",
"      ) and discussed in more detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21992?source=see_link&amp;anchor=H20554370#H20554370\">",
"       \"Ultrasonography of the hepatobiliary tract\", section on 'Detection of pneumobilia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Direct visualization of the stone if it is calcified.",
"     </li>",
"     <li>",
"      Change in position of a previously located stone.",
"     </li>",
"     <li>",
"      Two adjacent small bowel air-fluid levels in the right upper quadrant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two of the first three findings are found in up to 50 percent of cases of gallstone ileus. Pneumobilia, for example, occurs in 30 to 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It implies either a patent cystic duct or a fistula involving the common bile duct. Pneumobilia is not a specific finding for gallstone ileus since it also occurs with an incompetent sphincter of Oddi or after biliary surgery.",
"   </p>",
"   <p>",
"    Less than 15 percent of gallstones are visible on the plain abdominal film. This is due to two factors: most stones are radiolucent; and gas or bony structures can obscure gallstones outside the biliary tree. Contrast studies may be used to identify the level of bowel obstruction as well as the presence of a biliary-enteric fistula.",
"   </p>",
"   <p>",
"    Other radiographic tests may be useful in the diagnosis of gallstone ileus:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasonography can demonstrate fistulas, impacted stones, and residual cholelithiasis and choledocholithiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/13\">",
"       13",
"      </a>",
"      ]. However, intestinal gas reflects ultrasound waves, thereby limiting gallstone visualization [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Abdominal CT scanning can document gallbladder thickening, pneumobilia, intestinal obstruction, and obstructing gallstones (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80522 \" href=\"UTD.htm?1/37/1618\">",
"       image 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/15-17\">",
"       15-17",
"      </a>",
"      ]. Multi-detector CT scanners permit better evaluation of impacted stones in the bowel even before findings of mechanical obstruction are evident [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cholescintigraphy (HIDA scan) may reveal gallbladder perforation but, like ultrasonography, is relatively insensitive, detecting only 50 percent of perforations in one series (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59241 \" href=\"UTD.htm?8/52/9024\">",
"       image 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endoscopy is also of relatively limited utility in this disorder. Gastroduodenoscopy may rarely demonstrate an impacted gallstone in the duodenum (Bouveret's syndrome). ERCP can show a fistula if the gallbladder is able to be filled at the time of the examination. As noted above, a subset of patients has coexisting Mirizzi syndrome.",
"   </p>",
"   <p>",
"    Thus, the recommended diagnostic test for all patients with subacute small bowel obstruction is erect and supine plain abdominal films (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68029 \" href=\"UTD.htm?13/26/13728\">",
"     image 4",
"    </a>",
"    ). In the absence of more sensitive and specific tests, there should be a strong index of suspicion for the presence of gallstone ileus whenever evaluating an elderly patient with bowel obstruction. An abdominal CT scan using a helical single-detector or multi-detector CT scan can be useful in the further assessment of suspected gallstone ileus. However, the diagnosis is frequently made at laparotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt diagnosis and relief of intestinal obstruction after adequate fluid repletion are essential in the treatment of gallstone ileus. The main controversy in managing this condition concerns the role of biliary surgery. Enterolithotomy with stone removal addresses the obstruction. A small bowel resection may be required, depending upon the viability of intestine at the time of surgery. The surgery may be performed in one or two stages:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20554754\">",
"    <span class=\"h2\">",
"     One stage procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;A one-stage procedure includes treating the obstruction, along with cholecystectomy, and fistula division, with or without common bile duct (CBD) exploration.",
"   </p>",
"   <p>",
"    The one-stage procedure reduces the incidence of recurrent gallstone ileus. Recurrent episodes of gallstone ileus occur in up to 17 percent of patients treated with enterolithotomy alone. The one-stage procedure also prevents persistent fistulas, which can cause weight loss and malabsorption. In addition, this approach prevents cholecystitis, cholangitis, and gallbladder carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An increased rate of gallbladder cancer is associated with Mirizzi syndrome, most likely as a result of long-standing gallstone disease and chronic gallbladder inflammation with associated continuous mechanical gallbladder mucosal damage [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/19\">",
"     19",
"    </a>",
"    ]. In a retrospective study of 1759 cases of cholecystectomies, there were 18 cases of Mirizzi syndrome and 5 of these (28 percent) had gallbladder cancer, which is significantly higher than the incidence of unsuspected malignancy in long-standing gallstone disease (2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, a one-stage procedure is performed for patients who have a low operative risk and in whom findings in the right upper quadrant permit biliary tract inspection and cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/3,21,22\">",
"     3,21,22",
"    </a>",
"    ]. An elective laparoscopic cholecystectomy can be considered after enterolithotomy in individuals with symptoms or residual cholelithiasis if nonbiliary disease does not pose an unacceptable risk for further surgery.",
"   </p>",
"   <p>",
"    For those patients who are identified as high risk, with poor American Society of Anesthesiologists status, or shock at presentation, or for patients who have significant inflammation or dense adhesions at time of surgery, enterolithotomy alone should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of anesthesia and anesthetic choices\", section on 'Risk classification systems'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of patients with gallstone ileus are elderly with other serious medical conditions and the more extensive dissection and longer time under anesthesia required for the one-stage procedure may further compromise an already critically ill elderly patient. Overall mortality rates for gallstone ileus are between 4.5 and 25 percent, which is 5 to 10 times higher than with all other nonmalignant causes of mechanical small bowel obstructions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High risk patients can be managed expectantly after enterolithotomy alone because of the low rates of recurrent gallstone ileus and cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1,24\">",
"     1,24",
"    </a>",
"    ]. Biliary-enteric fistulas may close or shrink spontaneously, especially if the cystic duct is patent or there are no residual stones. In a review of 1001 reported cases, the overall recurrence rate for gallstone ileus was 4.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ]. Fifty-seven percent of recurrences occurred within six months of the original surgery. In addition, cholecystectomy does not protect all patients from recurrent gallstone ileus for two reasons: CBD stones can migrate distally and produce intestinal obstruction; and overlooked stones already within the bowel can lead to repeated obstruction. Symptomatic biliary tract disease developed in 15 percent of patients whose gallbladders were not removed [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20554761\">",
"    <span class=\"h2\">",
"     Two stage procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;A two-stage procedure consists of treating the obstruction with enterolithotomy alone. This approach is preferred for patients who are poor surgical risks. These high risk patients can be managed expectantly unless recurrent gallstone ileus or cholecystitis necessitates a definitive biliary procedure as the second stage [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1,2,9\">",
"     1,2,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At laparotomy, a longitudinal enterotomy is made along the antimesenteric border proximal to the point of impaction [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/4\">",
"     4",
"    </a>",
"    ]. The stone is milked proximally and removed. Careful transverse closure of the enterotomy is required to avoid residual bowel stenosis. Manipulation of stones through the cecum has been associated with mucosal injury and undetected serosal rupture and therefore should not be performed routinely [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"     2",
"    </a>",
"    ]. Bowel resection may be required where there is perforation, significant ischemia, or a gallstone which cannot be dislodged.",
"   </p>",
"   <p>",
"    The entire bowel should be carefully inspected for more gallstones, which occur in 3 to 16 percent of cases. These can be removed by milking the gut, thereby moving smaller stones towards bigger ones. Faceted or cylindrical gallstones are considered to increase the likelihood of multiple stones being present [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"     1",
"    </a>",
"    ]. Perioperative prophylactic antibiotics are recommended since the most common cause of postoperative morbidity is wound infection [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a laparoscopic approach is used, it is preferable to mobilize and identify the obstructed loop of the bowel and perform the stone extraction after eviscerating the loop of the bowel through a limited incision (hence laparoscopy guided surgery). This minimizes the spillage of enteral contents freely in the abdomen, as would likely result from laparoscopic enterotomy of obstructed bowel.",
"   </p>",
"   <p>",
"    Laparoscopic guided enterolithotomy has been performed in selected cases [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/3,25,26\">",
"     3,25,26",
"    </a>",
"    ]. However, this approach can be technically challenging because of the difficulty of examining a dilated small bowel and identifying the gallstone through the laparoscope. This technique is best confined to extremely experienced surgeons in highly selected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/3,26\">",
"     3,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nonsurgical therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsurgical treatments for gallstone ileus would be desirable in those high-risk patients too sick for conventional treatment. Cases of successful extracorporeal and electrohydraulic lithotripsy of obstructing stones in the jejunum, stomach, and colon have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/14,27-29\">",
"     14,27-29",
"    </a>",
"    ]. However, abdominal gas containing bowel loops may prevent visualization of the obstruction by ultrasonography, thereby precluding extracorporeal lithotripsy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endoscopic removal of gallstones from the colon and duodenum has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26598/abstract/30\">",
"     30",
"    </a>",
"    ]. However, surgery is still the main recommended therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gallstone ileus is an important, though infrequent cause of mechanical bowel obstruction, affecting elderly patients who often have other significant medical conditions. It is caused by impaction of a gallstone in the ileum after being passed through a biliary-enteric fistula. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic clinical presentation of gallstone ileus is episodic subacute obstruction in an elderly female. Transient gallstone impaction produces abdominal pain and vomiting, which subside as the gallstone becomes disimpacted, only to recur again as the progressively larger stone lodges in the more distal bowel lumen. As a result, vague and intermittent symptoms may be present for some days prior to evaluation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis can be suggested based upon a plain radiograph, although multidetector CT may offer better visualization of the impacted stone. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt diagnosis and relief of intestinal obstruction after adequate fluid repletion are essential in the treatment of gallstone ileus. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A one-stage procedure is performed for patients who have a low operative risk and in whom findings in the right upper quadrant permit biliary tract inspection and cholecystectomy. &nbsp;(See",
"      <a class=\"local\" href=\"#H20554754\">",
"       'One stage procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A two-stage procedure is performed for high risk patients, with poor American Society of Anesthesiologists status, or shock at presentation, or for patients who have significant inflammation or dense adhesions at time of surgery. Enterolithotomy alone should be performed as the first stage. A definitive biliary procedure is performed as the second stage. High risk patients can also be managed expectantly after enterolithotomy alone because of the low rates of recurrent gallstone ileus and cholecystitis. (See",
"      <a class=\"local\" href=\"#H20554761\">",
"       'Two stage procedure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/1\">",
"      Reisner RM, Cohen JR. Gallstone ileus: a review of 1001 reported cases. Am Surg 1994; 60:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/2\">",
"      Clavien PA, Richon J, Burgan S, Rohner A. Gallstone ileus. Br J Surg 1990; 77:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/3\">",
"      Ayantunde AA, Agrawal A. Gallstone ileus: diagnosis and management. World J Surg 2007; 31:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/4\">",
"      van Hillo M, van der Vliet JA, Wiggers T, et al. Gallstone obstruction of the intestine: an analysis of ten patients and a review of the literature. Surgery 1987; 101:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/5\">",
"      Mirizzi PL. Syndrome del conducto hepatico. J Int Chir 1948; 8:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/6\">",
"      Beltran MA, Csendes A, Cruces KS. The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World J Surg 2008; 32:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/7\">",
"      Despland M, Clavien PA, Mentha G, Rohner A. Gallstone ileus and bowel perforation after endoscopic sphincterotomy. Am J Gastroenterol 1992; 87:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/8\">",
"      Basili G, Lorenzetti L, Celona G, et al. Gallstone ileus in patient with Crohn's disease: report of a clinical observation. Surg Endosc 2006; 20:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/9\">",
"      Deitz DM, Standage BA, Pinson CW, et al. Improving the outcome in gallstone ileus. Am J Surg 1986; 151:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/10\">",
"      Ferreira LE, Topazian MD, Baron TH. Bouveret's syndrome: diagnosis and endoscopic treatment. Clin Gastroenterol Hepatol 2008; 6:e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/11\">",
"      Kishi K, Yamada K, Sugiyama T. Gastric outlet obstruction caused by a large gallstone in the duodenum (Bouveret's syndrome). Clin Gastroenterol Hepatol 2008; 6:e11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/12\">",
"      Moss JF, Bloom AD, Mesleh GF, et al. Gallstone ileus. Am Surg 1987; 53:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/13\">",
"      Lasson A, Lor&eacute;n I, Nilsson A, et al. Ultrasonography in gallstone ileus: a diagnostic challenge. Eur J Surg 1995; 161:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/14\">",
"      Sackmann M, Holl J, Haerlin M, et al. Gallstone ileus successfully treated by shock-wave lithotripsy. Dig Dis Sci 1991; 36:1794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/15\">",
"      Seal EC, Creagh MF, Finch PJ. Gallstone ileus: a new role for abdominal computed tomography. Postgrad Med J 1995; 71:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/16\">",
"      Lassandro F, Gagliardi N, Scuderi M, et al. Gallstone ileus analysis of radiological findings in 27 patients. Eur J Radiol 2004; 50:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/17\">",
"      Lassandro F, Romano S, Ragozzino A, et al. Role of helical CT in diagnosis of gallstone ileus and related conditions. AJR Am J Roentgenol 2005; 185:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/18\">",
"      Swayne LC, Filippone A. Gallbladder perforation: correlation of cholescintigraphic and sonographic findings with the Niemeier classification. J Nucl Med 1990; 31:1915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/19\">",
"      Chiam QL, Lau K. Coexistent gallbladder carcinoma in Mirizzi syndrome. Australas Radiol 2003; 47:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/20\">",
"      Redaelli CA, B&uuml;chler MW, Schilling MK, et al. High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery 1997; 121:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/21\">",
"      Rodr&iacute;guez-Sanju&aacute;n JC, Casado F, Fern&aacute;ndez MJ, et al. Cholecystectomy and fistula closure versus enterolithotomy alone in gallstone ileus. Br J Surg 1997; 84:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/22\">",
"      Lobo DN, Jobling JC, Balfour TW. Gallstone ileus: diagnostic pitfalls and therapeutic successes. J Clin Gastroenterol 2000; 30:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/23\">",
"      Tan YM, Wong WK, Ooi LL. A comparison of two surgical strategies for the emergency treatment of gallstone ileus. Singapore Med J 2004; 45:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/24\">",
"      Doko M, Zovak M, Kopljar M, et al. Comparison of surgical treatments of gallstone ileus: preliminary report. World J Surg 2003; 27:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/25\">",
"      Montgomery A. Laparoscope-guided enterolithotomy for gallstone ileus. Surg Laparosc Endosc 1993; 3:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/26\">",
"      Behrens C, Amson B. Laparoscopic management of multiple gallstone ileus. Surg Laparosc Endosc Percutan Tech 2010; 20:e64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/27\">",
"      Fujita N, Noda Y, Kobayashi G, et al. Gallstone ileus treated by electrohydraulic lithotripsy. Gastrointest Endosc 1992; 38:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/28\">",
"      Bourke MJ, Schneider DM, Haber GB. Electrohydraulic lithotripsy of a gallstone causing gallstone ileus. Gastrointest Endosc 1997; 45:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/29\">",
"      Meyenberger C, Michel C, Metzger U, Koelz HR. Gallstone ileus treated by extracorporeal shockwave lithotripsy. Gastrointest Endosc 1996; 43:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26598/abstract/30\">",
"      Oakland DJ, Denn PG. Endoscopic diagnosis of gallstone ileus of the duodenum. Dig Dis Sci 1986; 31:98.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3683 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26598=[""].join("\n");
var outline_f25_62_26598=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20554754\">",
"      One stage procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20554761\">",
"      Two stage procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nonsurgical therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/3683\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3683|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/55/39807\" title=\"diagnostic image 1\">",
"      Pneumobilia due to gallstone ileus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/37/1618\" title=\"diagnostic image 2\">",
"      Gallstone ileus on computed tomography of the abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/52/9024\" title=\"diagnostic image 3\">",
"      Normal HIDA scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/26/13728\" title=\"diagnostic image 4\">",
"      Small bowel obstruction on plain abdominal radiograph",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3683|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/5/9307\" title=\"table 1\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44793?source=related_link\">",
"      Gastric outlet obstruction in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44565?source=related_link\">",
"      Mirizzi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21992?source=related_link\">",
"      Ultrasonography of the hepatobiliary tract",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_62_26599="Serous cystadenoma Light III";
var content_f25_62_26599=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Pancreatic serous cystadenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of biopsy obtained with an EUS-guided trucut needle showing a pancreatic serous cystadenoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Levy, MD and Maurits J Wiersema, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26599=[""].join("\n");
var outline_f25_62_26599=null;
var title_f25_62_26600="Emergency Rx severe asthma";
var content_f25_62_26600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Management of asthma exacerbations: emergency department and hospital-based care",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 790px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     : forced expiratory volume in 1 second; ICS: inhaled corticosteroid; MDI: metered dose inhaler; PCO",
"     <sub>",
"      2",
"     </sub>",
"     : partial pressure carbon dioxide; PEF: peak expiratory flow; SABA: short-acting beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist; SaO",
"     <sub>",
"      2",
"     </sub>",
"     : oxygen saturation.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26600=[""].join("\n");
var outline_f25_62_26600=null;
var title_f25_62_26601="Omeprazole: Drug information";
var content_f25_62_26601=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Omeprazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/61/32725?source=see_link\">",
"    see \"Omeprazole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"    see \"Omeprazole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F16572479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Bone Fracture Risk with Proton Pump Inhibitors: Health Canada Issues Alert",
"     </span>",
"     <span class=\"collapsible-date\">",
"      April 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Health Canada has informed healthcare professionals that proton pump inhibitors (PPIs) may increase the risk of bone fractures. The risk of fracture was observed to be higher in patients receiving multiple daily doses for &ge;1 year; age, gender, and concomitant health conditions may also be a factor. Patients with risk factors for osteoporosis should be closely monitored and should receive a PPI at the lowest effective dose and for the shortest duration of therapy appropriate for the condition.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, refer to file://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/26523a-eng.php.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      First&reg;-Omeprazole;",
"     </li>",
"     <li>",
"      PriLOSEC OTC&reg; [OTC];",
"     </li>",
"     <li>",
"      PriLOSEC&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F203558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Omeprazole&reg;;",
"     </li>",
"     <li>",
"      Losec&reg;;",
"     </li>",
"     <li>",
"      Mylan-Omeprazole;",
"     </li>",
"     <li>",
"      PMS-Omeprazole;",
"     </li>",
"     <li>",
"      PMS-Omeprazole DR;",
"     </li>",
"     <li>",
"      ratio-Omeprazole;",
"     </li>",
"     <li>",
"      Sandoz-Omeprazole",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F203607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Proton Pump Inhibitor;",
"     </li>",
"     <li>",
"      Substituted Benzimidazole",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F203562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Active duodenal ulcer:",
"     </b>",
"     Oral: 20 mg once daily for 4-8 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gastric ulcers:",
"     </b>",
"     Oral: 40 mg once daily for 4-8 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Symptomatic GERD (without esophageal lesions):",
"     </b>",
"     Oral: 20 mg once daily for up to 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Erosive esophagitis:",
"     </b>",
"     Oral: 20 mg once daily for 4-8 weeks; maintenance of healing: 20 mg once daily for up to 12 months total therapy (including treatment period of 4-8 weeks)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"     </b>",
"     <b>",
"      eradication:",
"     </b>",
"     Oral: Dose varies with regimen:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer labeling: 40 mg once daily administered with clarithromycin 500 mg 3 times daily for 14 days",
"     <b>",
"      or",
"     </b>",
"     20 mg twice daily administered with amoxicillin 1000  mg",
"     <i>",
"      and",
"     </i>",
"     clarithromycin 500 mg twice daily for 10 days.",
"     <b>",
"      Note:",
"     </b>",
"     Presence of ulcer at time of therapy initiation may necessitate an additional 14-18 days of omeprazole 20 mg daily (monotherapy) after completion of combination therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     American College of Gastroenterology guidelines (Chey, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Nonpenicillin allergy: 20 mg twice daily administered with amoxicillin 1000  mg",
"     <i>",
"      and",
"     </i>",
"     clarithromycin 500 mg twice daily for 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Penicillin allergy: 20 mg twice daily administered with clarithromycin 500 mg",
"     <i>",
"      and",
"     </i>",
"     metronidazole 500 mg twice daily for 10-14 days",
"     <b>",
"      or",
"     </b>",
"     20 mg once or twice daily administered with bismuth subsalicylate 525 mg",
"     <i>",
"      and",
"     </i>",
"     metronidazole 250 mg",
"     <i>",
"      plus",
"     </i>",
"     tetracycline 500 mg 4 times daily for 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pathological hypersecretory conditions:",
"     </b>",
"     Oral: Initial: 60 mg once daily; doses up to 120 mg 3 times daily have been administered; administer daily doses &gt;80 mg in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      NSAID-induced ulcer treatment (unlabeled use):",
"     </b>",
"     Oral: 20 mg once daily for 4-8 weeks; Maintenance: 20 mg once daily for up to 6 months  (Hawkey, 1998)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      NSAID-induced ulcer prophylaxis (unlabeled use):",
"     </b>",
"     Oral: 20 mg once daily for up to 6 months (Cullen, 1998)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Stress-ulcer prophylaxis (ICU patients; unlabeled use):",
"     </b>",
"     Oral: 40 mg once daily; periodically evaluate patient for continued need (Levy, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Frequent heartburn (OTC labeling):",
"     </b>",
"     Oral: 20 mg once daily for 14 days; treatment may be repeated after 4 months if needed",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F203584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"      see \"Omeprazole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      GERD or other acid-related disorders:",
"     </b>",
"     Oral: Children 1-16 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 kg to &lt;10 kg: 5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 kg to &lt;20 kg: 10 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &ge;20 kg: 20 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F203563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F203564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment is necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F203565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.  However, based on increased bioavailability, a dosage reduction should be considered, especially for maintenance of healing of erosive esophagitis.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F203531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, delayed release, oral: 10 mg, 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PriLOSEC&reg;: 10 mg, 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules for suspension, delayed release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PriLOSEC&reg;: 2.5 mg/packet (30s); 10 mg/packet (30s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral [compounding kit]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     First&reg;-Omeprazole: 2 mg/mL (90 mL, 150 mL, 300 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, delayed release, oral: 20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PriLOSEC OTC&reg;: 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F203517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes granules for suspension",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F15241703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Prilosec&reg; capsules, granules for oral suspension:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM322359.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM322359.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F203535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Best if administered before breakfast.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Capsule: Should be swallowed whole; do not chew or crush. Delayed release capsule may be opened and contents added to 1 tablespoon of applesauce (use immediately after adding to applesauce); mixture should not be chewed or warmed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral suspension: Following reconstitution, the suspension should be left to thicken for 2-3 minutes and administered within 30 minutes. If any material remains after administration, add more water, stir, and administer immediately.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tablet: Should be swallowed whole; do not crush or chew.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Nasogastric/orogastric (NG/OG) tube administration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral suspension (using packets): After removing a catheter-tip syringe plunger, add 5 mL of water to the syringe and the contents of a 2.5 mg packet (or 15 mL of water for the 10 mg packet). Immediately shake syringe and leave to thicken for 2-3 minutes; shake syringe again and within 30 minutes administer via NG or gastric tube (French size 6 or larger). Refill syringe with an equal amount of water, shake, and flush remaining contents through NG or gastric tube",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral suspension (using capsules): The manufacturer of Prilosec&reg; does not give recommendations for extemporaneous preparation of omeprazole capsules for NG/OG administration. Consider using the packets for oral suspension. If packets are unavailable, methods of preparation of capsules for NG/OG administration have been described (Balaban, 1997; Phillips, 1996). An extemporaneously prepared suspension with extended stability may also be used (DiGiacinto, 2000; Quercia, 1997; Sharma, 1999).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F203534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Short-term (4-8 weeks) treatment of active duodenal ulcer disease or active benign gastric ulcer; treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD); short-term (4-8 weeks) treatment of endoscopically-diagnosed erosive esophagitis; maintenance healing of erosive esophagitis; long-term treatment of pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome); as part of a multidrug regimen for",
"     <i>",
"      H. pylori",
"     </i>",
"     eradication to reduce the risk of duodenal ulcer recurrence",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     OTC labeling: Short-term treatment of frequent, uncomplicated heartburn occurring &ge;2 days/week",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F203603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Healing NSAID-induced ulcers; prevention of NSAID-induced ulcer; stress-ulcer prophylaxis in the critically-ill",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F203615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Omeprazole may be confused with aripiprazole, fomepizole",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       PriLOSEC&reg; may be confused with Plendil&reg;, Prevacid&reg;, predniSONE, prilocaine, Prinivil&reg;, Proventil&reg;, PROzac&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Losec [multiple international markets] may be confused with Lasix brand name for furosemide [U.S., Canada, and multiple international markets]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Medral [Mexico] may be confused with Medrol brand name for methylprednisolone [U.S., Canada, and multiple international markets]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Norpramin: Brand name for omeprazole [Spain], but also the brand name for desipramine [U.S., Canada] and enalapril/hydrochlorothiazide [Portugal]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F203605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (7%), dizziness (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (5%), diarrhea (4%), nausea (4%), vomiting (3%), flatulence (3%), acid regurgitation (2%), constipation (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (1%), weakness (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory infection (2%), cough (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &le;1% (Limited to important or life-threatening; adverse event occurrence may vary based on formulation): Abdominal swelling, abnormal dreams, aggression, agitation, agranulocytosis, alkaline phosphatase increased, allergic reactions, alopecia, ALT increased, anaphylaxis, anemia, angina, angioedema, anorexia, anxiety, apathy, AST increased, atrophic gastritis, benign gastric polyps, bilirubin increased, blurred vision, bradycardia, bronchospasm, chest pain, cholestatic hepatitis,",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD), confusion, creatinine increased, depression, double vision, dry skin, epistaxis, erythema multiforme, esophageal candidiasis, fatigue, fecal discoloration, fever, fracture, gastroduodenal carcinoids, GGT increased, glycosuria, gynecomastia, hallucinations, hematuria, hemolytic anemia, hepatic encephalopathy, hepatic failure, hepatic necrosis, hepatitis, hepatocellular hepatitis, hyperhidrosis, hypersensitivity, hypertension, hypoglycemia, hypomagnesemia, hyponatremia, insomnia, interstitial nephritis, irritable colon, jaundice, joint pain, leg pain, leukocytosis, leukopenia, liver disease (hepatocellular, cholestatic, mixed), malaise, microscopic colitis, microscopic pyuria, mucosal atrophy (tongue), muscle cramps, muscle weakness, myalgia, nervousness, neutropenia, ocular irritation, optic atrophy, optic neuritis, optic neuropathy (anterior ischemic), osteoporosis-related fracture, pain, palpitation, pancreatitis, pancytopenia, paresthesia, peripheral edema, petechiae, pharyngeal pain, photosensitivity, pneumonia, proteinuria, pruritus, psychiatric disturbance, purpura, skin inflammation, sleep disturbance, somnolence, Stevens-Johnson syndrome, stomatitis, tachycardia, taste perversion, testicular pain, thrombocytopenia, tinnitus, toxic epidermal necrolysis, tremor, urinary frequency, urinary tract infection, urticaria, vertigo, weight gain, xerophthalmia, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F203539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to omeprazole, other substituted benzimidazole proton pump inhibitors, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F203521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Atrophic gastritis: Long-term omeprazole therapy has caused atrophic gastritis (identified by biopsy).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Carcinoma: In long-term (2-year) studies in rats, omeprazole produced a dose-related increase in gastric carcinoid tumors. While available endoscopic evaluations and histologic examinations of biopsy specimens from human stomachs have not detected a risk from short-term exposure to omeprazole, further human data on the effect of sustained hypochlorhydria and hypergastrinemia are needed to rule out the possibility of an increased risk for the development of tumors in humans receiving long-term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD): Use of proton pump inhibitors (PPIs) may increase risk of CDAD, especially in hospitalized patients; consider CDAD diagnosis in patients with persistent diarrhea that does not improve. Use the lowest dose and shortest duration of PPI therapy appropriate for the condition being treated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fractures: Increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist may occur with proton pump inhibitor (PPI) therapy. Patients on high-dose (multiple daily doses) or long-term (&ge;1 year) therapy should be monitored.  Use the lowest effective dose for the shortest duration of time, use vitamin D and calcium supplementation, and follow appropriate guidelines to reduce risk of fractures in patients at risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypomagnesemia: Reported rarely, usually with prolonged PPI use of &gt;3 months (most cases &gt;1 year of therapy). May be symptomatic or asymptomatic; severe cases may cause tetany, seizures, and cardiac arrhythmias. Consider obtaining serum magnesium concentrations prior to beginning long-term therapy, especially if taking concomitant digoxin, diuretics, or other drugs known to cause hypomagnesemia; and periodically thereafter.  Hypomagnesemia may be corrected by magnesium supplementation, although discontinuation of omeprazole may be necessary; magnesium levels typically return to normal within 1 week of stopping.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastric malignancy: Relief of symptoms does not preclude the presence of a gastric malignancy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal infection (eg,",
"     <i>",
"      Salmonella, Campylobacter",
"     </i>",
"     ): Use of proton pump inhibitors may increase risk of these infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Bioavailability may be increased in patients with hepatic dysfunction; consider dosage reductions, especially for maintenance healing of erosive esophagitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Clopidogrel: Proton pump inhibitors (PPIs) may diminish the therapeutic effect of clopidogrel, thought to be due to reduced formation of the active metabolite of clopidogrel. The manufacturer of clopidogrel recommends either avoidance of both omeprazole (even when scheduled 12 hours apart) and esomeprazole or use of a PPI with comparatively less effect on the active metabolite of clopidogrel (eg, pantoprazole). In contrast to these warnings, others have recommended the continued use of PPIs, regardless of the degree of inhibition, in patients with a history of GI bleeding or multiple risk factors for GI bleeding who are also receiving clopidogrel since no evidence has established clinically meaningful differences in outcome; however, a clinically-significant interaction cannot be excluded in those who are poor metabolizers of clopidogrel  (Abraham, 2010; Levine, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; High potential for other interactions: Concomitant use of omeprazole with some drugs may require cautious use, may not be recommended, or may require dosage adjustments.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asian ethnicity: Bioavailability may be increased in patients of Asian descent; consider dosage reductions, especially for maintenance healing of erosive esophagitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Bioavailability may be increased in the elderly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use:",
"     <i>",
"      Helicobacter pylori",
"     </i>",
"     eradication: Short-term combination therapy (&le;7 days) has been associated with a higher incidence of treatment failure. The American College of Gastroenterology recommends 10-14 days of therapy (triple or quadruple) for eradication of",
"     <i>",
"      H. pylori",
"     </i>",
"     (Chey, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Laboratory test interference: Serum chromogranin A (CgA) levels increase secondary to drug-induced decreases in gastric acid; May cause false positive results in diagnostic investigations for neuroendocrine tumors.  Stop omeprazole treatment temporarily before CgA test; If CgA level high repeat to confirm.  Use same commercial lab for testing to prevent variable results.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): When used for self-medication (OTC), do not use for &gt;14 days; treatment should not be repeated more often than every 4 months.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F203601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2A6 (minor), CYP2C19 (major), CYP2C9 (minor), CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (moderate), CYP2C9 (moderate), CYP2D6 (weak), CYP3A4 (weak);",
"     <b>",
"      Induces",
"     </b>",
"     CYP1A2 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F203526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Proton Pump Inhibitors may increase the serum concentration of Amphetamines. Specifically, data indicate that Proton Pump Inhibitors may increase the rate at which Amphetamines are absorbed.  Total exposure to Amphetamines is not significantly changed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Proton Pump Inhibitors may decrease the serum concentration of Atazanavir.  Management: Avoid concurrent PPI in HIV treatment-experienced patients.  For treatment-naive patients, atazanavir/ritonavir dose should be given approximately 12 hours after the PPI, and the PPI should not exceed the equivalent of 20 mg omeprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Proton Pump Inhibitors may increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Proton Pump Inhibitors may diminish the therapeutic effect of Bisphosphonate Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Proton Pump Inhibitors may decrease the serum concentration of Bosutinib.  Management: Consider alternatives to proton pump inhibitors, such as antacids or H2 receptor antagonists.  Administer alternative agents more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Proton Pump Inhibitors may decrease the serum concentration of Cefditoren.  Management: If possible, avoid use of cefditoren with proton pump inhibitors (PPIs). Consider alternative methods to minimize/control acid reflux (eg, diet modification) or alternative antimicrobial therapy if use of PPIs can not be avoided.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cilostazol: Omeprazole may enhance the adverse/toxic effect of Cilostazol. Omeprazole may increase the serum concentration of Cilostazol. Omeprazole may increase the serum concentration of  OPC-13015, an active metabolite of Cilostazol.  Management: Monitor for increased effects of cilostazol when coadministered with omeprazole. Consider a 50% dose reduction of cilostazol (eg, 100 mg twice daily to 50 mg twice daily) with concomitant use of these agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Citalopram: CYP2C19 Inhibitors (Moderate) may increase the serum concentration of Citalopram.  Management: Limit citalopram dose to a maximum of 20 mg/day if used with a moderate CYP2C19 inhibitor.  Patients using this combination should be monitored closely for evidence of citalopram toxicity (e.g., serotonin syndrome, QT prolongation, etc.).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: Omeprazole may decrease serum concentrations of the active metabolite(s) of Clopidogrel.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Omeprazole may decrease the serum concentration of CloZAPine. Omeprazole may increase the serum concentration of CloZAPine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Omeprazole may increase the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Substrates: CYP2C19 Inhibitors (Moderate) may decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inhibitors (Moderate) may decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Proton Pump Inhibitors may decrease serum concentrations of the active metabolite(s) of Dabigatran Etexilate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Proton Pump Inhibitors may decrease the serum concentration of Dasatinib.  Management: Antacids (taken 2 hours before or after dasatinib administration) can be used in place of the proton pump inhibitor if some acid-reducing therapy is needed.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Proton Pump Inhibitors may decrease the serum concentration of Delavirdine.  Management: Chronic therapy with proton pump inhibitors (PPIs) should be avoided in patients treated with delavirdine.  The clinical significance of short-term PPI therapy with delavirdine is uncertain, but such therapy should be undertaken with caution.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Proton Pump Inhibitors may increase the absorption of Dexmethylphenidate. Specifically, proton pump inhibitors may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Proton Pump Inhibitors may decrease the serum concentration of Erlotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Escitalopram: Omeprazole may increase the serum concentration of Escitalopram.  Management: Monitor for increased escitalopram toxicity with concomitant use of omeprazole. Escitalopram dosing recommendations may differ between international labelings in regards to concomitant use of omeprazole. Consult appropriate labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Proton Pump Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Proton Pump Inhibitors may increase the serum concentration of Fosphenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gefitinib: Proton Pump Inhibitors may decrease the serum concentration of Gefitinib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indinavir: Proton Pump Inhibitors may decrease the serum concentration of Indinavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Proton Pump Inhibitors may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Proton Pump Inhibitors may decrease the serum concentration of Itraconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Proton Pump Inhibitors may decrease the serum concentration of Ketoconazole (Systemic). Ketoconazole (Systemic) may increase the serum concentration of Proton Pump Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Proton Pump Inhibitors may diminish the therapeutic effect of Mesalamine. Proton pump inhibitor-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Consider avoiding concurrent administration of high-dose proton pump inhibitors (PPIs) with sustained-release mesalamine products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Proton Pump Inhibitors may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Proton Pump Inhibitors may increase the absorption of Methylphenidate. Specifically, proton pump inhibitors may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Proton Pump Inhibitors may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, the absorption of iron may be decreased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Proton Pump Inhibitors may decrease the serum concentration of Mycophenolate. Specifically, concentrations of the active mycophenolic acid may be reduced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nelfinavir: Proton Pump Inhibitors may decrease serum concentrations of the active metabolite(s) of Nelfinavir. Proton Pump Inhibitors may decrease the serum concentration of Nelfinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Proton Pump Inhibitors may decrease the serum concentration of Nilotinib.  Management: Avoid this combination when possible since separation of doses is not likely to be an adequate method of minimizing the interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Proton Pump Inhibitors may increase the serum concentration of Phenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Proton Pump Inhibitors may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Posaconazole: Proton Pump Inhibitors may decrease the serum concentration of Posaconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raltegravir: Proton Pump Inhibitors may increase the serum concentration of Raltegravir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May decrease the serum concentration of Omeprazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Proton Pump Inhibitors may decrease the serum concentration of Rilpivirine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Risedronate: Proton Pump Inhibitors may diminish the therapeutic effect of Risedronate. Proton Pump Inhibitors may increase the serum concentration of Risedronate. This applies specifically to use of delayed-release risedronate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saquinavir: Proton Pump Inhibitors may increase the serum concentration of Saquinavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of Omeprazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Proton Pump Inhibitors may increase the serum concentration of Tacrolimus (Systemic).  Management: Tacrolimus dose adjustment may be required. Rabeprazole, pantoprazole, or selected H2-receptor antagonists (i.e., ranitidine or famotidine) may be less likely to interact. Genetic testing may predict patients at highest risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May decrease the serum concentration of Proton Pump Inhibitors. These data are derived from studies with Ritonavir-boosted Tipranavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Proton Pump Inhibitors may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Omeprazole may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Proton Pump Inhibitors may increase the serum concentration of Voriconazole. Voriconazole may increase the serum concentration of Proton Pump Inhibitors.  Management: In patients receiving omeprazole 40 mg/day or greater, reduce omeprazole dose by half when initiating voriconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F203553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may cause gastric mucosal irritation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Food delays absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Avoid use of St John&rsquo;s wort (may decrease efficacy of omeprazole).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F203528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F203542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in some animal reproduction studies. Based on data collected by the Teratogen Information System (TERIS), it was concluded that therapeutic doses used during pregnancy would be unlikely to pose a substantial teratogenic risk (quantity/quality of data: fair). Because the possibility of harm still exists, the manufacturer recommends use during pregnancy only if the potential benefit to the mother outweighs the possible risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F203568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10903169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following administration of omeprazole 20 mg, peak concentrations detected in the breast milk were &lt;7% of the maternal serum concentration.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F203543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Should be taken on an empty stomach; best if taken before breakfast.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F203541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, delayed release",
"     </b>",
"     (Omeprazole Magnesium Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20.6 (20 Base) mg (28): $19.11",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, delayed release",
"     </b>",
"     (Omeprazole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $111.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $390.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $739.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, delayed release",
"     </b>",
"     (PriLOSEC Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $205.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $229.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $1129.51",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (PriLOSEC Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (30): $205.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $205.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (First-Omeprazole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg/mL (150 mL): $53.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (Omeprazole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (14): $9.99",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (PriLOSEC OTC Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (28): $21.34",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13459510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Susceptibility testing is recommended in patients who fail",
"     <i>",
"      H. pylori",
"     </i>",
"     -eradication regimen.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F203544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aleprozil (MX);",
"     </li>",
"     <li>",
"      Antra (IT);",
"     </li>",
"     <li>",
"      Azoran (MX);",
"     </li>",
"     <li>",
"      Crismel (HU);",
"     </li>",
"     <li>",
"      Desec (TH);",
"     </li>",
"     <li>",
"      Domer (MX);",
"     </li>",
"     <li>",
"      Duogas (TH);",
"     </li>",
"     <li>",
"      Epirazole (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Gasec (BB, BM, BS, BZ, GY, HK, JM, MY, SR, TT);",
"     </li>",
"     <li>",
"      Gasec Gastrocaps (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Gastec (AR);",
"     </li>",
"     <li>",
"      Gastop (PE);",
"     </li>",
"     <li>",
"      Gastracid (DE);",
"     </li>",
"     <li>",
"      Gastrofer (ID);",
"     </li>",
"     <li>",
"      Hyposec (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Inhibitron (MX);",
"     </li>",
"     <li>",
"      Inhipump (ID);",
"     </li>",
"     <li>",
"      Lensor (LU);",
"     </li>",
"     <li>",
"      Logastric (BE);",
"     </li>",
"     <li>",
"      Lokev (ID);",
"     </li>",
"     <li>",
"      Lomac (IN);",
"     </li>",
"     <li>",
"      Losec (AE, AR, AT, BB, BE, BF, BH, BJ, BM, BR, BS, BZ, CI, CL, CN, CY, CZ, DK, EE, EG, ES, ET, FI, GB, GH, GM, GN, GR, GY, HK, HU, IE, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, NO, NZ, OM, PH, PK, PL, PT, PY, QA, RU, SA, SC, SD, SE, SL, SN, SR, SY, TH, TN, TR, TW, TZ, UG, UY, VE, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Losec MUPS (CO, MY, PH);",
"     </li>",
"     <li>",
"      Luodan (CL);",
"     </li>",
"     <li>",
"      Madiprazole (TH);",
"     </li>",
"     <li>",
"      Medoprazole (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, MY, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Mepha Gasec (CR, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Mepracid (PH);",
"     </li>",
"     <li>",
"      Meprazol (AU);",
"     </li>",
"     <li>",
"      Miracid (TH);",
"     </li>",
"     <li>",
"      Mopral (FR, MX);",
"     </li>",
"     <li>",
"      Nocid (TH);",
"     </li>",
"     <li>",
"      Novek (CL);",
"     </li>",
"     <li>",
"      Ocid (IN, SG);",
"     </li>",
"     <li>",
"      Ogal (CO, PE);",
"     </li>",
"     <li>",
"      Olexin (MX);",
"     </li>",
"     <li>",
"      Olit (SG);",
"     </li>",
"     <li>",
"      Omed (BF, BJ, CH, CI, ET, GH, GM, GN, ID, IN, KE, KP, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Omedar (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Omelon (MY, TW);",
"     </li>",
"     <li>",
"      OMEP (DE);",
"     </li>",
"     <li>",
"      Omepra (IL);",
"     </li>",
"     <li>",
"      Omepradex (IL);",
"     </li>",
"     <li>",
"      Omepradex-Z (IL);",
"     </li>",
"     <li>",
"      Omepral (AU, JP);",
"     </li>",
"     <li>",
"      Omeprazon (JP);",
"     </li>",
"     <li>",
"      Omepril (EC);",
"     </li>",
"     <li>",
"      Omeq (KP);",
"     </li>",
"     <li>",
"      Omesec (MY, SG);",
"     </li>",
"     <li>",
"      Omex (CO);",
"     </li>",
"     <li>",
"      Omezol (AE, BH, CY, EG, IN, IQ, IR, JO, KW, LB, LY, NZ, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Omezole (MY, SG, TW);",
"     </li>",
"     <li>",
"      Omezzol (EC);",
"     </li>",
"     <li>",
"      Omisec (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Omizac (IN);",
"     </li>",
"     <li>",
"      Omizec (HK);",
"     </li>",
"     <li>",
"      OMP (KP);",
"     </li>",
"     <li>",
"      Omprazole (KP);",
"     </li>",
"     <li>",
"      OMZ (ID);",
"     </li>",
"     <li>",
"      Onic (ID);",
"     </li>",
"     <li>",
"      Opal (PE);",
"     </li>",
"     <li>",
"      Oprax (PE);",
"     </li>",
"     <li>",
"      Ortanol (HR);",
"     </li>",
"     <li>",
"      Parizac (ES);",
"     </li>",
"     <li>",
"      Penrazole (SG);",
"     </li>",
"     <li>",
"      Peptizole (TH);",
"     </li>",
"     <li>",
"      Prazidec (MX);",
"     </li>",
"     <li>",
"      Prazole (TH);",
"     </li>",
"     <li>",
"      Probitor (AU, BG, MY);",
"     </li>",
"     <li>",
"      Proceptin (SG);",
"     </li>",
"     <li>",
"      Promezol (ID);",
"     </li>",
"     <li>",
"      Protonix (PH);",
"     </li>",
"     <li>",
"      Pumpitor (ID, SG);",
"     </li>",
"     <li>",
"      Pumpitor DI (ID);",
"     </li>",
"     <li>",
"      Qrazol (KP);",
"     </li>",
"     <li>",
"      Ramezol (KP);",
"     </li>",
"     <li>",
"      Risek (MY, PH);",
"     </li>",
"     <li>",
"      Siozole (IN);",
"     </li>",
"     <li>",
"      Stomacer (ID);",
"     </li>",
"     <li>",
"      Stomec (TH);",
"     </li>",
"     <li>",
"      Suifac (MX);",
"     </li>",
"     <li>",
"      Ulcozol (BR, PE);",
"     </li>",
"     <li>",
"      Ulcuprazol (DO);",
"     </li>",
"     <li>",
"      Ulnor (DE);",
"     </li>",
"     <li>",
"      Ulsen (MX);",
"     </li>",
"     <li>",
"      Ultop (HR);",
"     </li>",
"     <li>",
"      Ulzec (ZA);",
"     </li>",
"     <li>",
"      Ulzol (ID);",
"     </li>",
"     <li>",
"      Viprazo (PH);",
"     </li>",
"     <li>",
"      Vulcasid (MX);",
"     </li>",
"     <li>",
"      Wonmp (KP);",
"     </li>",
"     <li>",
"      Xoprin (PE);",
"     </li>",
"     <li>",
"      Zatrol (CN);",
"     </li>",
"     <li>",
"      Zefxon (TH);",
"     </li>",
"     <li>",
"      Zenpro (MY, SG);",
"     </li>",
"     <li>",
"      Zimor (MY, SG)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F203520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Proton pump inhibitor; suppresses gastric basal and stimulated acid secretion by inhibiting the parietal cell H+/K+ ATP pump",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F203538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Antisecretory: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: Within 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Up to 72 hours; 50% of maximum effect at 24 hours; after stopping treatment, secretory activity gradually returns over 3-5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP2C19 primarily and (to a lesser extent) via 3A4 to hydroxy, desmethyl, and sulfone metabolites (all inactive); saturable first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: ~30% to 40%; Hepatic dysfunction: ~100%; Asians: AUC increased up to fourfold compared to Caucasians",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 0.5-1 hour; hepatic impairment: ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: 0.5-3.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~77% as metabolites, very small amount as unchanged drug); feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abraham NS, Hlatky MA, Antman EM, et al, &ldquo;ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(24):2619-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/21060077/pubmed\" id=\"21060077\" target=\"_blank\">",
"        21060077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Andersson T, &ldquo;Omeprazole Drug Interaction Studies,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1991, 21(3):195-212.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/1764870/pubmed\" id=\"1764870\" target=\"_blank\">",
"        1764870",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Andersson T, Hasan-Alin M, Hasselgren G, et al, &ldquo;Drug Interactions Studies With Esomeprazole, the (S)-Isomer of Omeprazole,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 2001, 40(7):523-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/11510629/pubmed\" id=\"11510629\" target=\"_blank\">",
"        11510629",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Balaban DH, Duckworth CW, and Peura DA, \"Nasogastric Omeprazole: Effects on Gastric pH in Critically Ill Patients,\"",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 1997, 92(1):79-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/8995942/pubmed\" id=\"8995942\" target=\"_blank\">",
"        8995942",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Balian JD, Sukhova N, Harris JW, et al, &ldquo;The Hydroxylation of Omeprazole Correlates With S-Mephenytoin Metabolism: A Population Study,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1995, 57(6):662-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/7781266/pubmed\" id=\"7781266\" target=\"_blank\">",
"        7781266",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bell AD, Roussin A, Cartier R, et al, &ldquo;The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2011, 27(Suppl A):1-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/21640290/pubmed\" id=\"21640290\" target=\"_blank\">",
"        21640290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berardi RR and Dunn-Kucharski VA, &ldquo;Omeprazole: Defining Its Role in Gastroesophageal Reflux Disease,&rdquo;",
"      <i>",
"       Hosp Formul",
"      </i>",
"      , 1995, 30:216-25.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Beutler M, Hartmann K, Kuhn M, et al, &ldquo;Arthralgias on Omeprazole,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 1994, 309(6969):1620.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blume H, Donath F, Warnke A, et al, &ldquo;Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 2006, 29(9): 769-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/16944963/pubmed\" id=\"16944963\" target=\"_blank\">",
"        16944963",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Broussard CN and Richter JE, &ldquo;Treating Gastro-oesophageal Reflux Disease During Pregnancy and Lactation: What Are the Safest Therapy Options?&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1998, 19(4):325-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/9804446/pubmed\" id=\"9804446\" target=\"_blank\">",
"        9804446",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carvajal A and Martin Arias LH, &ldquo;Gynecomastia and Sexual Disorders After the Administration of Omeprazole,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 1995, 90(6):1028-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chey WD, Wong BC, et al, &ldquo;American College of Gastroenterology Guideline on the Management of",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"      Infection,&rdquo;",
"      <i>",
"       Am J Gastroent",
"      </i>",
"      , 2007, 102(8):1808-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/17608775/pubmed\" id=\"17608775\" target=\"_blank\">",
"        17608775",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cockayne SE, Glet RJ, Gawkrodger DJ, et al, &ldquo;Severe Erythrodermic Reactions to the Proton Pump Inhibitors Omeprazole and Lansoprazole,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 1999, 141(1):173-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10417548/pubmed\" id=\"10417548\" target=\"_blank\">",
"        10417548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cullen D, Bardhan KD, Eisner M, et al, &ldquo;Primary Gastroduodenal Prophylaxis With Omeprazole for NSAID Users,&rdquo;",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 1998, 12(2):135-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/9692687/pubmed\" id=\"9692687\" target=\"_blank\">",
"        9692687",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Jager CP, Wever PC, Gemen EF, et al, &ldquo;Proton Pump Inhibitor Therapy Predisposes to Community-Acquired",
"      <i>",
"       Streptococcus pneumoniae",
"      </i>",
"      Pneumonia,&rdquo;",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 2012, 36(10):941-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/23034135/pubmed\" id=\"23034135\" target=\"_blank\">",
"        23034135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Carlet JM, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008,&rdquo; [published correction appears in",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(4):1394-6],",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(1):296-327.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/18158437/pubmed\" id=\"18158437\" target=\"_blank\">",
"        18158437",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Rhodes A, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2013, 41(2):580-637.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/23353941/pubmed\" id=\"23353941\" target=\"_blank\">",
"        23353941",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DiGiacinto JL, Olsen KM, Bergman KL, et al, &ldquo;Stability of Suspension Formulations of Lansoprazole and Omeprazole Stored in Amber-Colored Plastic Oral Syringes,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(5):600-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10852086/pubmed\" id=\"10852086\" target=\"_blank\">",
"        10852086",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Epelde Gonzalo FD, Boada Montagut L, and Tomas Vecina S, &ldquo;Exfoliative Dermatitis Related to Omeprazole,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1995, 29(1):82-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/7711353/pubmed\" id=\"7711353\" target=\"_blank\">",
"        7711353",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gunasekaran TS and Hassall EG, &ldquo;Efficacy and Safety of Omeprazole for Severe Gastroesophageal Reflux in Children,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1993, 123(1):148-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/8320610/pubmed\" id=\"8320610\" target=\"_blank\">",
"        8320610",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hawkey CJ, Karrasch JA, Szczepa&ntilde;ski L, et al, &ldquo;Omeprazole Compared With Misoprostol for Ulcers Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(11):727-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/9494149/pubmed\" id=\"9494149\" target=\"_blank\">",
"        9494149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kahrilas PJ, Shaheen NJ, Vaezi MF, et al, &ldquo;American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2008, 135(4):1383-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/18789939/pubmed\" id=\"18789939\" target=\"_blank\">",
"        18789939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kane DL, &ldquo;Administration of Omeprazole (Prilosec&reg;) in the Atypical Patient,&rdquo;",
"      <i>",
"       Int J Pharm Compounding",
"      </i>",
"      , 1997, 1(1):13.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kato S, Ebina K, Fujii K, et al, &ldquo;Effect of Omeprazole in the Treatment of Refractory Acid-Related Diseases in Childhood: Endoscopic Healing and Twenty-Four Hour Intragastric Acidity,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1996, 128(3):415-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/8774516/pubmed\" id=\"8774516\" target=\"_blank\">",
"        8774516",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kraus A and Flores-Suarez LF, &ldquo;Acute Gout Associated With Omeprazole,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1995, 345(8947):461-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/7853986/pubmed\" id=\"7853986\" target=\"_blank\">",
"        7853986",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lanza FL, Chan FK, and Quigley EM, &ldquo;Guidelines for Prevention of NSAID-Related Ulcer Complications,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2009, 140(3):728-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/19240698/pubmed\" id=\"19240698\" target=\"_blank\">",
"        19240698",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Larner AJ and Lendrum R, &ldquo;Oesophageal Candidiasis After Omeprazole Therapy,&rdquo;",
"      <i>",
"       Gut",
"      </i>",
"      , 1992, 33(6):860-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/1624174/pubmed\" id=\"1624174\" target=\"_blank\">",
"        1624174",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lau JY, Sung JJ, Lee KK, et al, &ldquo;Effect of Intravenous Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2000, 343(5):310-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10922420/pubmed\" id=\"10922420\" target=\"_blank\">",
"        10922420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine GN, Bates ER, Blankenship JC, et al, &ldquo;2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):e574-651.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/22064601/pubmed\" id=\"22064601\" target=\"_blank\">",
"        22064601",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levy MJ, Seelig CB, Robinson NJ, et al, &ldquo;Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis,&rdquo;",
"      <i>",
"       Dig Dis Sci",
"      </i>",
"      , 1997, 42(6):1255-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/9201091/pubmed\" id=\"9201091\" target=\"_blank\">",
"        9201091",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lindquist M and Edwards IR, &ldquo;Endocrine Adverse Effects of Omeprazole,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 1992, 305(6851):451-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/1392958/pubmed\" id=\"1392958\" target=\"_blank\">",
"        1392958",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Natsch S, Vinks MH, Voogt AK, et al, &ldquo;Anaphylactic Reactions to Proton-Pump Inhibitors,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(4):474-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10772433/pubmed\" id=\"10772433\" target=\"_blank\">",
"        10772433",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ottervanger JP, Stricker BH, Kappelle JW, et al, &ldquo;Omeprazole-Associated Agranulocytosis,&rdquo;",
"      <i>",
"       Eur J Haematol",
"      </i>",
"      , 1995, 54(4):279-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/7789474/pubmed\" id=\"7789474\" target=\"_blank\">",
"        7789474",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Paoluzi P, Iacopini F, Crispino P, et al, &ldquo;2-Week Triple Therapy for",
"      <i>",
"       Helicobacter pylori",
"      </i>",
"      Infection is Better Than 1-Week in Clinical Practice: A Large Prospective Single-Center Randomized Study,&rdquo;",
"      <i>",
"       Helicobacter",
"      </i>",
"      , 2006, 11(6):562-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/17083378/pubmed\" id=\"17083378\" target=\"_blank\">",
"        17083378",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips JO, Metzler MH, Palmieri MT, et al, \"A Prospective Study of Simplified Omeprazole Suspension for the Prophylaxis of Stress-Related Mucosal Damage,\"",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1996, 24(11):1793-800",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/8917027/pubmed\" id=\"8917027\" target=\"_blank\">",
"        8917027",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Quercia R, Fan C, Liu X, et al, &ldquo;Stability of Omeprazole in an Extemporaneously Prepared Oral Liquid,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1997, 54(16):1833-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/9269520/pubmed\" id=\"9269520\" target=\"_blank\">",
"        9269520",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sharma V, &ldquo;Comparison of 24-hour Intragastric pH Using Four Liquid Formulations of Lansoprazole and Omeprazole,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1999, 56(23 Suppl 4):18-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10597120/pubmed\" id=\"10597120\" target=\"_blank\">",
"        10597120",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Soll AH, Weinstein WM, Kurata J, et al, &ldquo;Nonsteroidal Anti-inflammatory Drugs and Peptic Ulcer Disease,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1991, 114(4):307-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/1987878/pubmed\" id=\"1987878\" target=\"_blank\">",
"        1987878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Talley NJ and Vakil N, &ldquo;Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the Management of Dyspepsia,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2005, 100(10):2324-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/16181387/pubmed\" id=\"16181387\" target=\"_blank\">",
"        16181387",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wolfe MM and Sachs G, &ldquo;Acid Suppression: Optimizing Therapy for Gastroduodenal Ulcer Healing, Gastroesophageal Reflux Disease, and Stress-Related Erosive Syndrome,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 2000, 118(2 Suppl 1):9-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/10868896/pubmed\" id=\"10868896\" target=\"_blank\">",
"        10868896",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Woods DJ and McClintock AD, &ldquo;Omeprazole Administration,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1993, 27(5):651.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/62/26601/abstract-text/8347919/pubmed\" id=\"8347919\" target=\"_blank\">",
"        8347919",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9718 Version 51.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-8C00B56BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26601=[""].join("\n");
var outline_f25_62_26601=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16572479\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203557\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203558\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203607\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203562\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203584\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203563\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203564\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203565\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203531\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203517\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15241703\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203535\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203534\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203603\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203615\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203605\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203539\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203521\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203601\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203526\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203553\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203528\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203542\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203568\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10903169\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203543\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203541\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13459510\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203544\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203520\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203538\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9718\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9718|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/61/32725?source=related_link\">",
"      Omeprazole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=related_link\">",
"      Omeprazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_62_26602="Overview of transvaginal placement of reconstructive materials (surgical mesh or biografts) for treatment of pelvic organ prolapse or stress urinary incontinence";
var content_f25_62_26602=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of transvaginal placement of reconstructive materials (surgical mesh or biografts) for treatment of pelvic organ prolapse or stress urinary incontinence",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Emanuel C Trabuco, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26602/contributors\">",
"     John B Gebhart, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/62/26602/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/62/26602/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are common, often comorbid, disorders in women, and can greatly impact quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/1\">",
"     1",
"    </a>",
"    ]. Population based studies report an 11 to 19 percent lifetime risk in women undergoing surgery for prolapse or incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Recurrence of symptoms is common following POP or SUI. Six to 29 percent of women who undergo pelvic floor repair will require additional surgery for recurrent prolapse or stress incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The success observed with the use of surgical mesh in general surgery, combined with the high failure rates for traditional colporrhaphy, have led gynecologic reconstructive surgeons to implement surgical approaches that utilize reconstructive materials [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/5\">",
"     5",
"    </a>",
"    ]. According to medical device manufacturer estimates, approximately 33 percent of POP repair procedures and 80 percent of anti-incontinence procedures utilize reconstructive materials [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/6\">",
"     6",
"    </a>",
"    ]. However, concerns have been raised about the safety of transvaginal placement of these materials. Data from randomized trials show mesh erosion rates ranging from 3.2 to 17.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/7-10\">",
"     7-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of transvaginal placement of reconstructive materials for surgical treatment of POP or SUI in women is presented here. Related topics are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Classification of reconstructive materials. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=see_link\">",
"       \"Reconstructive materials used in surgery: Classification and host response\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Transabdominal use of reconstructive materials for pelvic reconstructive surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link\">",
"       \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Specific surgical procedures. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link\">",
"       \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link\">",
"       \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nonsurgical treatment approaches. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link\">",
"       \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32842?source=see_link\">",
"       \"Treatment of urinary incontinence\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314126\">",
"    <span class=\"h1\">",
"     TYPES OF PROCEDURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pelvic reconstructive surgery, reconstructive materials may be used for surgical treatment of either pelvic organ prolapse (POP) or stress urinary incontinence (SUI). Alternatively, these conditions may be treated nonsurgically or with a procedure that does not use reconstructive materials (referred to as non-graft, non-mesh, traditional, suture-only, or native tissue procedures).",
"   </p>",
"   <p>",
"    Nonsurgical treatments for POP and SUI are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H13817294#H13817294\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Management options'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32842?source=see_link\">",
"     \"Treatment of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314134\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314143\">",
"    <span class=\"h3\">",
"     Pelvic organ prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP may involve the anterior or posterior vaginal walls or the vaginal apex (vaginal vault or cervix) or any combination of these. Reconstructive materials may be used for repair of prolapse at any of these sites. Use of these materials is applied differently depending upon anatomic site. In addition, grafts may be placed transvaginally or transabdominally, depending upon the procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=see_link&amp;anchor=H2327248#H2327248\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'General approach to choice of procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For anterior or posterior vaginal wall prolapse, a graft is typically placed deep to the vaginal epithelium in the vesicovaginal or rectovaginal space. A graft can augment a suture plication repair (eg, mesh overlay) or it can directly bridge a fascial gap. Additionally, the graft can be secured to fascial structures (eg, pubocervical fascia or the arcus tendineus fascia pelvis) or placed tension-free with or without the use of commercially available kits. These procedures may be performed with any type of reconstructive material (synthetic nonabsorbable or absorbable, biograft); polypropylene is the most commonly used material.",
"   </p>",
"   <p>",
"    Most anterior or posterior vaginal wall repair procedures are performed transvaginally. There are few exceptions to this, including (eg, transabdominal paravaginal repair), which are typically performed only when other transabdominal procedures are required (eg, hysterectomy or sacral colpopexy). &nbsp;",
"   </p>",
"   <p>",
"    Sacral colpopexy, the transabdominal approach to repair of prolapse of the vaginal apex, uses reconstructive materials to attach the apex to the anterior longitudinal ligament of the sacrum. Typically, nonabsorbable macroporous polypropylene mesh is used for this approach.",
"   </p>",
"   <p>",
"    Transvaginal suture-only apical prolapse repair procedures are usually performed with sutures placed in the sacrospinous or uterosacral ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/11\">",
"     11",
"    </a>",
"    ]. However, some POP repair kits (eg, Elevate&reg;, Uphold&reg;) utilize devices to secure mesh arms through the sacrospinous ligaments for apical prolapse repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transvaginal mesh kits have been introduced for surgical treatment of POP. These kits apply mesh to one or more anatomic sites. (See",
"    <a class=\"local\" href=\"#H314234\">",
"     'Transvaginal mesh kits'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314181\">",
"    <span class=\"h3\">",
"     Stress urinary incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midurethral slings, using macroporous polypropylene mesh, are the most common procedures for treatment of SUI [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/12\">",
"     12",
"    </a>",
"    ]. A sling made of microporous material (ObTape) for midurethral slings was associated with high complication rates and was removed from the market [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link&amp;anchor=H6#H6\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Types of procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bladder neck slings are less commonly used. These slings are typically made of autologous rectus fascia. Attempts at using allografts or xenografts for autologous bladder neck slings resulted in diminished efficacy compared to autologous materials and are therefore discouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Suture-only transvaginal procedures for SUI (transvaginal needle suspensions) have largely been replaced by sling procedures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314234\">",
"    <span class=\"h2\">",
"     Transvaginal mesh kits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Commercial kits for transvaginal placement of reconstructive materials (usually referred to as mesh kits; some are also referred to as trocar-guided mesh kits) involve interposition of pre-cut synthetic or biologic graft material (a few kits use porcine graft) between the vaginal epithelium and underlying fascia. The graft is suspended in a tension-free manner with polypropylene mesh arms that are passed through a supportive connective tissue structure (eg, arcus tendineus fascia, obturator membrane, iliococcygeus fascia, or sacrospinous ligaments). Transvaginal mesh kits are available in different versions that treat one or multiple anatomic sites within the same procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/15-19\">",
"     15-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mesh kits commonly use macroporous polypropylene mesh. Use of materials with microporous structures (eg, ObTape) was associated with high complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=see_link&amp;anchor=H14#H14\">",
"     \"Reconstructive materials used in surgery: Classification and host response\", section on 'Pore size and weave'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    First generation mesh kits (eg, Apogee&trade;) use trocars for insertion of the mesh arms. Newer kit procedures involve placing mesh arms or suture into the sacrospinous ligament with various delivery devices, with the goal of improving support of the vaginal apex and decreasing the total amount of mesh material (",
"    <a class=\"graphic graphic_figure graphicRef85544 \" href=\"UTD.htm?42/8/43141\">",
"     figure 1",
"    </a>",
"    ). There are no data that these changes in device design have improved outcomes or lowered complications compared to first generation of kits.",
"   </p>",
"   <p>",
"    There have been concerns regarding complications associated with mesh kits; complications rates are discussed below (see",
"    <a class=\"local\" href=\"#H32\">",
"     'Complications'",
"    </a>",
"    below). In addition, following use of a mesh kit, if complications occur, removal of mesh after mesh kit repair can be surgically challenging, morbid, and result in only partial improvement in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314664\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314673\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a pelvic reconstructive procedure using reconstructive materials is considered, a detailed preoperative informed consent process is of paramount importance to establish appropriate patient expectations. A patient should be counseled regarding the specific procedure about the uncertainties of improved efficacy with graft use and risk of complications. In addition, the patient should be informed that mesh placement is permanent. Alternative approaches to treatment should be reviewed. This discussion should be documented on the procedure consent form and in the medical record.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H314709\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend antibiotic prophylaxis for surgical site infection for all procedures for treatment of POP or SUI with or without surgical mesh. Infectious complications of such procedures include infections associated with the surgical mesh (eg, abscess, cellulitis) and urinary tract infections, particularly for procedures that involve periurethral dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/23-28\">",
"     23-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since antibiotic prophylaxis has typically been used for procedures using reconstructive materials, there are few data regarding the infection rate if antibiotics are not administered. The only randomized trial to address this found no significant differences in rates of bacteriuria or wound infection in women treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    compared with placebo at the time of midurethral sling placement, but the study was underpowered to detect these differences [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/29\">",
"     29",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The utility of antibiotic prophylaxis in pelvic reconstructive procedures that use mesh is based upon indirect data from other procedures involving mesh. The use of surgical mesh may increase the risk of surgical site infection, although not all experts advise the use of antibiotic prophylaxis for all procedures involving reconstructive material [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/30\">",
"     30",
"    </a>",
"    ]. Mesh use in inguinal or femoral hernia repair is the most similar clinical use. A meta-analysis of six randomized trials in which reconstructive material was used for inguinal hernia repair demonstrated that infection rates were significantly lower when antimicrobial prophylaxis was administered (1.4 versus 2.9 percent; OR 0.48, 95% CI 0.27-0.85) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=see_link\">",
"     \"Control measures to prevent surgical site infection following gastrointestinal procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For transvaginal placement of reconstructive materials, the risk of infection is likely higher than with inguinal or femoral hernia repair, since midurethral sling placement involves a vaginal incision. A vaginal incision is classified as a clean-contaminated procedure, which is associated with a 2.4 to 7.7 percent rate of surgical site infection, and antibiotic prophylaxis is typically used for this risk of infection. The use of mesh would likely further increase the risk of infection, providing additional support for the role of antibiotic prophylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=see_link\">",
"     \"Epidemiology and pathogenesis of and risk factors for surgical site infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Our recommendation is in concert with professional society guidelines. American College of Obstetricians and Gynecologists (ACOG) guidelines advise antibiotic prophylaxis for surgical site infection for urogynecologic procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/32\">",
"     32",
"    </a>",
"    ]. American Urological Association (AUA) guidelines also advise use of antibiotic prophylaxis for all patients undergoing open or laparoscopic procedures involving an implanted prosthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of reconstructive materials does not affect the need for antibiotic prophylaxis of bacterial endocarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link&amp;anchor=H22969468#H22969468\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Guidelines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H775454\">",
"    <span class=\"h1\">",
"     ISSUES REGARDING TRANSVAGINAL GRAFTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous transvaginal approaches to pelvic floor repair in women, using synthetic, autologous, allograft, or xenograft materials. In general, there is a paucity of data to confirm an advantage for graft augmentation compared with suture-only repairs and of one graft material over another [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. Safety concerns have been raised regarding the use of these materials in surgical treatment of pelvic organ prolapse (POP) or stress urinary incontinence (SUI) in women [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, there is limited information regarding sexual, urinary, and bowel function following graft augmentation. Surgical decision-making regarding the use of reconstructive materials must be based upon the procedure and patient characteristics and use of existing data to determine the approach that will offer the greatest benefit with the least potential harm.",
"   </p>",
"   <p>",
"    The types and properties of reconstructive materials are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=see_link\">",
"     \"Reconstructive materials used in surgery: Classification and host response\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H313019\">",
"    <span class=\"h2\">",
"     Safety concerns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns have been raised regarding the safety of transvaginal placement of reconstructive materials. In addition, data regarding the efficacy of the use of these materials is variable. This uncertainty makes it difficult to assess whether these procedures improve efficacy, and if so, if these improvements outweigh the risk of complications. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For POP repair, transvaginal mesh placement has primarily been associated with improved short-term outcomes for isolated repair of anterior vaginal wall prolapse. This was demonstrated in three randomized trials that excluded women with prolapse of other anatomic compartments (vaginal apex, posterior vaginal wall) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/8,35,36\">",
"     8,35,36",
"    </a>",
"    ]. However, the clinical relevance of this is limited, because most women have prolapse of multiple compartments [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/37\">",
"     37",
"    </a>",
"    ]. The prevailing view is that a common pathogenesis underlies support defects at different sites of the vaginal wall, replacing a previous focus on isolated anatomic compartments.",
"   </p>",
"   <p>",
"    Slings made of reconstructive materials are placed transvaginally for treatment of SUI. In particular, midurethral sling procedures, which utilize polypropylene mesh and are the treatment of choice for SUI, have been proven to be effective and have low complication rates. Thus, these procedures are not the focus of this discussion. (See",
"    <a class=\"local\" href=\"#H314181\">",
"     'Stress urinary incontinence'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The most common complication of transvaginal mesh placement is mesh erosion, which is usually treated successfully with mesh excision. The most important issue of concern regarding transvaginal mesh is the development of severe pelvic pain or dyspareunia in a subset of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of mesh erosion varies by type of procedure and anatomic site of prolapse; the overall reported rate ranges widely from 0 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. Many patients with mesh erosion are asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/8,36\">",
"     8,36",
"    </a>",
"    ]. Treatment of simple mesh erosion requires a surgical procedure to excise the mesh, but these procedures are generally successful and associated with little morbidity. Complex mesh erosion is more complicated and associated with potential greater morbidity. (See",
"    <a class=\"local\" href=\"#H34\">",
"     'Graft erosion or extrusion'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Women who develop severe pelvic pain or dyspareunia are also treated surgically, but in contrast to mesh erosion, multiple procedures are often required and pain may persist following treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Unfortunately, definitive surgical removal of the mesh body and segmental removal of the mesh arms have not resulted in universal resolution of symptoms for a proportion of women [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H178271\">",
"     'Pelvic pain or dyspareunia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The pathophysiology of mesh-related complications is not known, but several etiologies have been postulated, including: inappropriate vaginal dissection (eg, too superficial), excessive graft tension, placement of a foreign body via a contaminated vaginal field, or poor wound healing (eg, due to vaginal atrophy, smoking, or use of immunosuppressive medications). Based upon available data and our clinical experience, the development of severe pain appears to be associated with scarring of the mesh arms [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Improvements in surgical training and understanding of pelvic anatomy may help avoid some complications. In addition, surgeons who perform mesh procedures should be trained in evaluating and treating mesh-related complications. A large number of kits have been introduced for transvaginal placement of reconstructive materials. However, the introduction of these kits has not been consistently accompanied by additional surgical training. As an example, some surgeons may not have been trained that the dissection for anterior mesh placement should be in a deeper surgical plane than the plane used for traditional colporrhaphy. A dissection that is too superficial may result in mesh erosion. Similarly, inexperienced surgeons may place excessive tension on the vaginal mesh. Often, increased tension is placed in an attempt to replicate the appearance of a complete repair with traditional suture. In suture-only repairs, following plication of the pubocervical connective tissue and trimming of the excess vaginal epithelium, the vaginal topography will be restored so that there is no apparent relaxation of the anterior compartment. Conversely, following correct placement of transvaginal mesh, there will still be persistent relaxation of the anterior vaginal wall to allow for mesh contraction during the postoperative period. &nbsp;",
"   </p>",
"   <p>",
"    In our practice, we do not perform transvaginal mesh placement of women with chronic pelvic pain or dyspareunia, or in immunosuppressed patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20571124\">",
"    <span class=\"h2\">",
"     FDA warning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Safety concerns have been raised about the use of grafts for reconstructive pelvic surgery, particularly for transvaginal placement for correction of prolapse. These concerns have led to warnings from the US Food and Drug Administration (FDA), which are detailed in the following section. Complications of transvaginal placement of reconstructive materials are discussed below. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The FDA has issued several documents regarding the use of reconstructive materials for female pelvic floor surgery. The conclusions to-date have been that transvaginal placement of these materials are of uncertain efficacy and are associated with safety risks. In contrast, use of synthetic mesh for abdominal sacral colpopexy or for full-length retropubic or transobturator midurethral slings was considered safe and effective; further evaluation of single incision slings has been advised [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/7,41,42\">",
"     7,41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In January, 2012, the FDA announced that it was considering implementation of the recommendations of the Advisory Committee from September, 2011 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/43\">",
"     43",
"    </a>",
"    ]. In September, 2011, an Advisory Committee (panel of experts) convened by the FDA concluded that transvaginal mesh placement for POP repair is of uncertain safety and efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/42\">",
"     42",
"    </a>",
"    ]. The panel introduced more stringent requirements for premarket evaluation of materials intended for this use and advised that studies of devices that involve transvaginal mesh must include a suture-only control arm (downgrading the evaluation process from a class II to class III).",
"   </p>",
"   <p>",
"    In July, 2011, the FDA issued a safety communication regarding serious adverse events associated with transvaginal placement of surgical mesh for treatment of POP [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/7\">",
"     7",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The FDA statement applied to use specifically for repair of POP; the FDA noted that they are still reviewing the safety of use of surgical mesh for treatment of SUI. The statement was an update to a public health notification regarding transvaginal placement of mesh that was issued in October, 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/41\">",
"     41",
"    </a>",
"    ]. Of note, reconstructive materials are placed transvaginally for most procedures for POP or SUI, with few exceptions (eg, abdominal sacral colpopexy). (See",
"    <a class=\"local\" href=\"#H775454\">",
"     'Issues regarding transvaginal grafts'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The updated FDA warning was based upon 2874 complications involving use of mesh for procedures for treatment of POP or SUI [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/7\">",
"     7",
"    </a>",
"    ]. The complications were reported voluntarily to a United States national database from 2008 to 2010. The most common complications were mesh erosion, pain (including dyspareunia), infection, urinary problems, bleeding, and organ perforation; three deaths were associated with mesh placement for POP repair (two bowel perforations, one hemorrhage).",
"   </p>",
"   <p>",
"    The FDA warning was also based upon a review of the literature that showed that serious adverse events associated with urogynecologic use of mesh were not rare and that transvaginally placed mesh does not conclusively improve clinical outcomes over traditional suture-only repairs [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some experts have questioned the data presented by the FDA [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/44\">",
"     44",
"    </a>",
"    ]. A response to the FDA warning that was supported by over 600 members of the Pelvic Surgeons Network highlighted the paucity of evidence-based surgical approaches to pelvic reconstruction surgery in general and that both suture-only and abdominal approaches to mesh use have associated complications. The conclusion was that the pelvic surgeon must be acutely aware of the risk and benefits of each surgical procedure and have the required knowledge and surgical skills to execute the appropriate technique chosen.",
"   </p>",
"   <p>",
"    FDA recommendations for clinicians include the following recommendations initially published in 2008:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obtain specialized training for each mesh placement technique, and be aware of its risks.",
"     </li>",
"     <li>",
"      Be vigilant for potential adverse events from the mesh, especially erosion and infection.",
"     </li>",
"     <li>",
"      Watch for complications associated with the tools used in transvaginal placement, especially bowel, bladder, and blood vessel perforations.",
"     </li>",
"     <li>",
"      Inform patients that implantation of surgical mesh is permanent, and that some complications associated with the implanted mesh may require additional surgery that may or may not correct the complication.",
"     </li>",
"     <li>",
"      Inform patients about the potential for serious complications and their effect on quality of life, including pain during sexual intercourse, scarring, and narrowing of the vaginal wall (in POP repair).",
"     </li>",
"     <li>",
"      Provide patients with a written copy of the patient labeling from the surgical mesh manufacturer, if available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In 2011, the agency added the following recommendations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recognize that in most cases, POP can be treated successfully without mesh, thus avoiding the risk of mesh-related complications.",
"     </li>",
"     <li>",
"      Choose mesh surgery only after weighing the risks and benefits of surgery with mesh versus all surgical and non-surgical alternatives.",
"     </li>",
"     <li>",
"      Consider these factors before placing surgical mesh:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Surgical mesh is a permanent implant that may make future surgical repair more challenging.",
"     </li>",
"     <li>",
"      A mesh procedure may put the patient at risk for requiring additional surgery or for the development of new complications.",
"     </li>",
"     <li>",
"      Removal of mesh due to mesh complications may involve multiple surgeries and significantly impair the patient&rsquo;s quality of life. Complete removal of mesh may not be possible and may not result in complete resolution of complications, including pain.",
"     </li>",
"     <li>",
"      Mesh placed abdominally for POP repair may result in lower rates of mesh complications compared to transvaginal POP surgery with mesh.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inform the patient about the benefits and risks of non-surgical options, suture-only surgery, surgical mesh placed abdominally and the likely success of these alternatives compared to transvaginal surgery with mesh.",
"     </li>",
"     <li>",
"      Notify the patient if mesh will be used in her POP surgery and provide the patient with information about the specific product used.",
"     </li>",
"     <li>",
"      Ensure that the patient understands the postoperative risks and complications of mesh surgery, as well as limited long-term outcomes data.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In June, 2012, Ethicon announced that it was removing four transvaginal mesh devices from the market (TVT Secur&trade;, Prosima&trade;, Prolift&reg;, and Prolift+M&trade;).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H420043\">",
"    <span class=\"h2\">",
"     Professional society guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) issued a statement in December, 2011 regarding vaginal placement of surgical mesh for POP repair [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/45\">",
"     45",
"    </a>",
"    ]. They advised that:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgeons placing vaginal mesh should undergo training specific to each device and have experience with reconstructive surgical procedures and a thorough understanding of pelvic anatomy.",
"     </li>",
"     <li>",
"      Use of reconstructive materials by surgeons experienced with the specific procedure is a reasonable option for women with factors that increase the risk of prolapse recurrence (eg, recurrent prolapse, medical comorbidities that preclude more invasive and lengthier open and endoscopic procedures). Such use should be individualized and surgeons should counsel patients about the lack of efficacy and safety data, and about alternative treatments.",
"     </li>",
"     <li>",
"      Patients should provide their informed consent after reviewing the risks and benefits of the procedure, as well as discussing alternative repairs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, the Society of Gynecologic Surgeons (SGS) issued a statement in July, 2011, advising the following [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/46\">",
"     46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SGS is in agreement with the interpretations and recommendations made in the FDA Safety Communication. The general consensus is that this reservation should not apply to midurethral sling procedures or sacral colpopexies utilizing the same mesh materials, but further longer-term evaluations of all of these procedures is important.",
"     </li>",
"     <li>",
"      For now, thoughtful, discriminant use of transvaginal mesh to augment vaginal defects should be performed by trained surgeons with experience in complex reconstructive surgery, and only on patients who are perceived to have an unacceptable risk of clinical failure when other procedures are performed.",
"     </li>",
"     <li>",
"      We should all follow outcomes when we employ new procedures, and should feel comfortable about benefit verses risk before employing them. It is important that patients are informed of the risks and benefits of any surgical procedure, as well as the specific potential adverse events associated with transvaginal mesh use, including outcomes that may still be unclear and require further investigation. Alternative treatments should be explained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The International Urogynecologic Association (IUGA) convened a Grafts Roundtable regarding transvaginal graft use in 2010, and advised [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/47-51\">",
"     47-51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individual patient characteristics have to be included in the risk-benefit ratio when counseling patients regarding transvaginal mesh repair.",
"     </li>",
"     <li>",
"      Informed consent for vaginal reconstructive surgery with mesh should include verbal and written review with the patient of expected benefits, therapeutic alternatives, and potential risks.",
"     </li>",
"     <li>",
"      Manufacturers should provide detailed product description, data on biologic properties, cadaveric studies, and well-designed prospective clinical trials to support the claimed benefits of the new product.",
"     </li>",
"     <li>",
"      A process of added surgeon qualification for transvaginal mesh placement is desirable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20571989\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term efficacy of the use of reconstructive materials compared with suture-only procedures is not well established. Evolving data are limited and mixed, but there is some suggestion that mesh may provide improved anatomic support, particularly in the anterior compartment. Outcomes vary by the indication, anatomic site, procedure, and type of material used. Use of grafts for specific anatomic sites of prolapse and for SUI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=see_link\">",
"     \"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44424?source=see_link\">",
"     \"Surgical management of posterior vaginal defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of reconstructive materials introduces some types of complications (eg, graft erosion). For other adverse events, use of reconstructive materials may increase frequency or severity (eg, infection). This section will review the incidence of complications associated with transvaginal placement of reconstructive materials. In current clinical practice, pelvic organ prolapse (POP) repair may be performed with or without graft augmentation, and comparative data will be presented where available. In contrast, stress urinary incontinence (SUI) is treated surgically primarily with slings made of reconstructive materials, and so comparative data for suture-only procedures will not be included.",
"   </p>",
"   <p>",
"    The United States Food and Drug Administration (FDA) national database received 3979 reports of complications associated with use of reconstructive materials for surgical treatment of POP or SUI from 2005 to 2007, as noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/6\">",
"     6",
"    </a>",
"    ]. The limitation of these data is that these were voluntary reports and it is uncertain how many complications were not reported. In addition, the number or procedures performed without a complication is unknown. To give some sense of the denominator, according to manufacturer data, approximately 300,000 procedures for repair of POP or SUI using mesh are performed annually [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20571124\">",
"     'FDA warning'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p>",
"    The International Urogynecological Association (IUGA) and the International Continence Society (ICS) have published a system of terminology and classification of complications related to reconstructive materials that may be useful to surgeons in reporting complications (",
"    <a class=\"graphic graphic_table graphicRef74128 \" href=\"UTD.htm?1/27/1469\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Avoidance of complications is the primary goal. It is essential for a surgeon to be familiar with the anatomy of the planned graft site and the physiology and biomechanical properties of the graft.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Graft erosion or extrusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erosion, or exposure, is defined as visible exposure of a reconstructive material [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/53\">",
"     53",
"    </a>",
"    ]. Eroded material may be noted in the vagina and may come into contact with the urethra, bladder, or bowel. This may occur with any reconstructive material (ie, synthetic, biograft) and following any pelvic reconstructive procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Erosion is a potential complication for all types of procedures using nonabsorbable mesh. &nbsp;",
"   </p>",
"   <p>",
"    Overall, for POP repair with reconstructive materials, a systematic review that included 110 comparative and noncomparative studies reported a graft erosion rate of 10.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For anterior wall repair, the rate of graft erosion ranged from 3.2 to 17.2 percent in randomized trials, based upon 2 meta-analyses that each included 10 or more randomized trials, as well as observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Erosion appears to be of particular concern for anterior or posterior vaginal wall repair with nonabsorbable synthetic mesh. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=see_link&amp;anchor=H1936017#H1936017\">",
"     \"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse\", section on 'Use of reconstructive materials'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For apical prolapse repair, the erosion rate in a meta-analysis of 105 studies (4 were randomized trials) was 0.5 for transvaginal procedures and 2.2 percent for sacral colpopexy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/38\">",
"     38",
"    </a>",
"    ]. For sacral colpopexy, erosion rates vary considerably depending upon the type of material (0.5 percent for macroporous polypropylene to 5.5 percent for polytetrafluoroethylene) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/59\">",
"     59",
"    </a>",
"    ]. Use of Gore-Tex, concomitant hysterectomy and smoking increases the risk of erosion by over four-fold following sacral colpopexy. When counseling patients prior to an abdominal repair, it is imperative to emphasize the need to discontinue smoking. If an abdominal hysterectomy is performed, the cuff should be closed in two layers and surgeons should preferably use macroporous polypropylene mesh to minimize the risk of erosion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H3584659#H3584659\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of a transvaginal mesh kit was associated with a 5.8 percent rate of mesh erosion in the systematic review, described above, that included 16 comparative studies and more than 35 noncomparative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For women who are treated for SUI with a midurethral sling, which are made almost exclusively of synthetic mesh, the reported rate of vaginal mesh erosion is 0.4 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=see_link&amp;anchor=H3907598#H3907598\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Vaginal mesh erosion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6017123\">",
"    <span class=\"h3\">",
"     Management of erosion",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most materials, small areas of mesh erosion are usually managed by local excision of the mesh followed by mobilization and closure of the surrounding epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/20,60\">",
"     20,60",
"    </a>",
"    ]. Large areas of erosion often require excision of large sections of mesh. A large resection leaves gaps in the vaginal epithelium that may need to be bridged with a biologic graft, as direct approximation would overly tighten the vagina and lead to further dyspareunia. We use porcine mesh (Surgisis&reg;) or an autologous split-thickness skin graft. Pre- and postoperative use of topical estrogen may aid the healing response, but commonly does not resolve exposure once they have occurred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=see_link&amp;anchor=H325436#H325436\">",
"     \"Treatment of vaginal atrophy\", section on 'Vaginal estrogen preparations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5693853\">",
"    <span class=\"h2\">",
"     Graft contraction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraction of reconstructive materials following POP repair was first described in the 2000s and has not been fully characterized [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/40,61-65\">",
"     40,61-65",
"    </a>",
"    ]. This phenomenon involves the formation of tight vaginal bands and scarring within the vaginal fornices (along the course of the mesh arms) and is associated with vaginal pain and dyspareunia. Data are insufficient to determine the incidence of this type of complication. Interestingly, some sonographic studies have found no graft contraction or have attributed apparent shrinkage to mesh folding [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In a small case series (n = 17), for example, women who underwent POP repair with a transvaginal polypropylene mesh kit and developed postoperative vaginal pain and dyspareunia were found to have focal tenderness along contracted vaginal bands on pelvic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/40\">",
"     40",
"    </a>",
"    ]. Excision of the palpable band or all of the accessible mesh resulted in partial resolution of symptoms for most, but not all patients: 15 of 17 (88 percent) had substantial improvement in pain and 9 of 14 (68 percent) had substantial improvement in dyspareunia.",
"   </p>",
"   <p>",
"    There are two hypotheses for the mechanism of mesh contraction, placement of excessive tension on the mesh arms during insertion or postoperative mesh shrinkage. In our opinion, excessive tension at insertion seems like a more plausible explanation. Transabdominal mesh use, which in theory should incur similar shrinkage as polypropylene mesh placed vaginally, has not been associated with vaginal bands, dyspareunia or abnormal pelvic examination findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178271\">",
"    <span class=\"h2\">",
"     Pelvic pain or dyspareunia",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP is not typically associated with dyspareunia, but some women develop sexual pain following surgical treatment, especially following posterior compartment repair. The etiology of these symptoms is often not clear, but scarring, graft erosion, or graft contraction are likely contributing factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link&amp;anchor=H24639741#H24639741\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Effects on sexual function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transvaginal placement of reconstructive materials for POP repair was associated with postoperative dyspareunia in 9.1 percent of women in a systematic review that included 77 comparative and noncomparative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/56\">",
"     56",
"    </a>",
"    ]. In a systematic review of 16 comparative studies and more than 35 noncomparative studies, mesh kit procedures were associated with a 3 to 13 percent rate of dyspareunia or sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some women experience persistent pelvic pain or dyspareunia. As an example, a randomized trial that compared repair of anterior POP with a polypropylene mesh kit to traditional colporrhaphy and found that 5 out of 206 patients developed severe pain at two months and 1 out of 206 patients had severe pain at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/35\">",
"     35",
"    </a>",
"    ]. Further study is needed to determine the incidence of persistent pain following transvaginal mesh procedures.",
"   </p>",
"   <p>",
"    Although many experts have raised particular concern for the development of dyspareunia when reconstructive materials are used, such symptoms of dyspareunia have also been reported in women who have undergone suture-only repairs. A meta-analysis of four randomized trials found no significant difference in de novo dyspareunia in women who underwent suture-only compared with mesh POP repair (RR 1.15; 95% CI 0.65-2.04). This finding, however, lacks adequate statistical power and further study is needed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Prevention of postoperative vaginal pain",
"      </strong>",
"      &ndash; To prevent postoperative vaginal pain when using nonabsorbable synthetic mesh (polypropylene) for vaginal prolapse repair, in our experience, it is critical to avoid placing too much tension on the graft. As the graft becomes incorporated during the healing response, ingrowth of host connective tissue may lead to mesh shrinkage and cause contraction. This may place the repair under further tension, often resulting in pain. Pain may also arise if the graft is placed too superficially or too close to nerves. Proper placement of the mesh is along the sacrospinous ligament sutures or devices should be placed at least 3 cm medial to the ischial spine to avoid direct injury to the pudendal neurovascular bundle or, more commonly, chronic irritation due to inflammation, scarring or both. In our experience, surgical removal of the mesh does not always completely treat this pain.",
"     </li>",
"     <li>",
"      <strong>",
"       Evaluation and treatment of postoperative vaginal pain",
"      </strong>",
"      &ndash; A thorough pelvic examination should be performed to try to identify other potential causes of dyspareunia (eg, atrophy, vulvodynia, myofascial pelvic floor pain). The examiner should check for mesh erosion, palpate for a tight band along the site of mesh placement, and assess whether palpation of a tight band reproduces the pain.",
"      <br/>",
"      <br/>",
"      Various treatments have been attempted. Injection of a combination of a steroid and a local anesthetic may be useful (eg, a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/60/34758?source=see_link\">",
"       bupivacaine",
"      </a>",
"      ). However, often all or a portion of the graft requires removal. This can be technically difficult and may not resolve all pain issues. The most limited surgical approach is to mobilize the vaginal epithelium until the offending mesh arm can be identified and transected. Alternatively, complete removal of the mesh body and the accessible segments of the arm may be performed. Surgical removal of mesh alleviates the pain of most, but not all, of these women [",
"      <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment should be given promptly upon presentation of severe pelvic pain to avoid further scarring of the graft. As an example, in our practice, we had a patient who presented with voiding dysfunction and vaginal pain immediately after a mesh kit procedure. Computed tomography scan and physical examination revealed no postoperative secondary causes for these symptoms (eg, pelvic hematoma, visceral injury, or infection). Excision of all of the graft material (body and arms) resulted in complete resolution of voiding dysfunction and pain. Complete mesh excision was technically feasible because the patient presented early during the postoperative period (two weeks after mesh placement). &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Surgical treatment of SUI is less likely to be associated with dyspareunia than POP repair. There have been reports of dyspareunia following midurethral sling placement, and some data suggest that adverse effect is more common when a transobturator rather than a retropubic approach is used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16055?source=see_link&amp;anchor=H2822326#H2822326\">",
"     \"Stress urinary incontinence in women: Choosing a type of midurethral sling\", section on 'Transobturator versus retropubic midurethral slings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H312308\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transvaginal mesh placement is rarely associated with serious infectious complications. Urinary tract and vaginal wound infections, the most common types of infection following these procedures, are usually easily treated.",
"   </p>",
"   <p>",
"    For POP repair, it appears that higher rates of infections are associated with biografts than synthetic mesh (urinary tract infection: 8 to 26 versus 0 to 19 percent; vaginal wound infection 0 to 18 versus 1 to 3 percent), based upon data from a systemic review of 16 comparative studies (6 were randomized trials) and more than 35 noncomparative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. No comparative data were included regarding the rate of infection in suture-only repairs.",
"   </p>",
"   <p>",
"    Urinary tract infections are common following midurethral sling procedures (approximately 30 percent). Vaginal wound infections following these procedures occur infrequently and have not been reported in the literature. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=see_link&amp;anchor=H4701170#H4701170\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Urinary tract infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abscess formation (pelvic, retropubic, or other sites) occurs in some women following transvaginal placement of reconstructive materials [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. For transvaginal mesh placement for POP repair, case series of 20 to 90 patients have reported abscess formation in 1.6 to 4.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. There have been case reports of abscess formation following midurethral sling procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=see_link&amp;anchor=H373089#H373089\">",
"     \"Stress urinary incontinence in women: Transobturator midurethral slings\", section on 'Other complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H280554\">",
"    <span class=\"h2\">",
"     Urinary tract function",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP repair with reconstructive materials was associated with the following rates of voiding dysfunction in the systematic review of 16 comparative studies, and more than 35 noncomparative studies described above found [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonabsorbable synthetic mesh &ndash; 0 to 12 percent; trocar-placed grafts had a 7 to 12 percent incidence",
"     </li>",
"     <li>",
"      Biografts &ndash; 1 to 28 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the same review, rates of overactive bladder symptoms and urge urinary incontinence were [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Synthetic mesh &ndash; 18 percent",
"     </li>",
"     <li>",
"      Biografts &ndash; 28 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Voiding dysfunction is one of the most common complications of midurethral sling procedures, occurring in 20 to 47 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=see_link&amp;anchor=H4701484#H4701484\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Voiding dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H279441\">",
"    <span class=\"h2\">",
"     Defecatory dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior vaginal wall prolapse repair with reconstructive materials is associated with defecatory dysfunction in some women, but there are few data regarding this issue. Use of nonabsorbable synthetic mesh was associated with these symptoms in 1 to 10 percent of women in two small observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276875\">",
"    <span class=\"h2\">",
"     Fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;For POP, the systematic review of 16 comparative studies and more than 35 noncomparative studies described above reported a 1 percent incidence of genital tract fistula (fistulas between the genital tract and urinary or gastrointestinal tract) or visceral erosion in women who underwent POP repair with reconstructive materials [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. No comparative data were included regarding the rate of fistula in suture-only repairs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of reconstructive materials is associated with the formation of granulation tissue or granulomas in 3 to 39 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. This appears to occur most commonly when biografts are used.",
"   </p>",
"   <p>",
"    Use of reconstructive materials for POP repair was associated with visceral injury (eg, bladder, rectal, vaginal perforation) in 1 to 4 percent and bleeding in 0 to 3 percent of women in a systematic review of 16 comparative studies and more than 35 noncomparative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"     34",
"    </a>",
"    ]. Data comparing these rates to suture-only procedures were not reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical treatment of women for pelvic organ prolapse (POP) or stress urinary incontinence (SUI) is increasingly performed using reconstructive materials (surgical mesh, biografts). Reconstructive materials may be used for repair of POP at any anatomic site (anterior vaginal wall, posterior vaginal wall, vaginal apex). Use of these materials is applied differently depending upon anatomic site. In addition, grafts may be placed transvaginally or transabdominally, depending upon the procedure. (See",
"      <a class=\"local\" href=\"#H314126\">",
"       'Types of procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Macroporous polypropylene mesh is the most common type of synthetic mesh used for pelvic floor repair procedures. Use of materials with microporous structure should be avoided, as it is associated with increased complications rates. (See",
"      <a class=\"local\" href=\"#H314181\">",
"       'Stress urinary incontinence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend antibiotic prophylaxis for surgical site infection for surgical procedures for treatment of POP or SUI that utilize surgical mesh (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H314709\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transvaginal placement is the major focus of safety concern regarding use of reconstructive materials. The unique aspects of the configuration of the mesh and trocar passage, tensioning and characteristics of the vaginal operative field, contribute to the risk of graft-related complications (eg, mesh erosion). (See",
"      <a class=\"local\" href=\"#H775454\">",
"       'Issues regarding transvaginal grafts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Safety concerns have been raised regarding the transvaginal use of reconstructive materials for treatment of POP. The most common complication of transvaginal mesh placement is mesh erosion, which is usually treated successfully with mesh excision. A small proportion of women develop severe pelvic pain or dyspareunia. (See",
"      <a class=\"local\" href=\"#H313019\">",
"       'Safety concerns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women considering pelvic floor surgery with reconstructive materials should be counseled regarding the uncertainties of improved efficacy with graft use and risk of complications. In addition, the patient should be informed that mesh placement is permanent. Alternative approaches to treatment should be reviewed. (See",
"      <a class=\"local\" href=\"#H314673\">",
"       'Informed consent'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/1\">",
"      Helstr&ouml;m L, Nilsson B. Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus. Acta Obstet Gynecol Scand 2005; 84:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/2\">",
"      Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997; 89:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/3\">",
"      Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010; 116:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/4\">",
"      Blandon RE, Bharucha AE, Melton LJ 3rd, et al. Incidence of pelvic floor repair after hysterectomy: A population-based cohort study. Am J Obstet Gynecol 2007; 197:664.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/5\">",
"      Rogo-Gupta L, Rodriguez LV, Litwin MS, et al. Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol 2012; 120:1105.",
"     </a>",
"    </li>",
"    <li>",
"     Urogynecologic Surgical Mesh: Update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. Safety Communication, Food and Drug Administration, Silver Spring, MD, 2011.",
"    </li>",
"    <li>",
"     FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse file://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm (Accessed on August 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/8\">",
"      Hiltunen R, Nieminen K, Takala T, et al. Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol 2007; 110:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/9\">",
"      Withagen MI, Milani AL, den Boon J, et al. Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial. Obstet Gynecol 2011; 117:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/10\">",
"      Iglesia CB, Sokol AI, Sokol ER, et al. Vaginal mesh for prolapse: a randomized controlled trial. Obstet Gynecol 2010; 116:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/11\">",
"      Feiner B, Jelovsek JE, Maher C. Efficacy and safety of transvaginal mesh kits in the treatment of prolapse of the vaginal apex: a systematic review. BJOG 2009; 116:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/12\">",
"      Jonsson Funk M, Levin PJ, Wu JM. Trends in the surgical management of stress urinary incontinence. Obstet Gynecol 2012; 119:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/13\">",
"      Occhino JA, Casiano ER, Trabuco EC, Klingele CJ. A three-incision approach to treat persistent vaginal exposure and sinus tract formation related to ObTape mesh insertion. Int Urogynecol J 2012; 23:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/14\">",
"      Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev 2011; :CD001754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/15\">",
"      Elm&eacute;r C, Altman D, Engh ME, et al. Trocar-guided transvaginal mesh repair of pelvic organ prolapse. Obstet Gynecol 2009; 113:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/16\">",
"      Simon M, Debodinance P. Vaginal prolapse repair using the Prolift kit: a registry of 100 successive cases. Eur J Obstet Gynecol Reprod Biol 2011; 158:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/17\">",
"      Lo TS. One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series. J Minim Invasive Gynecol 2010; 17:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/18\">",
"      Pacqu&eacute;e S, Palit G, Jacquemyn Y. Complications and patient satisfaction after transobturator anterior and/or posterior tension-free vaginal polypropylene mesh for pelvic organ prolapse. Acta Obstet Gynecol Scand 2008; 87:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/19\">",
"      Khandwala S, Jayachandran C. Transvaginal mesh surgery for pelvic organ prolapse--Prolift+M: a prospective clinical trial. Int Urogynecol J 2011; 22:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/20\">",
"      Ridgeway B, Walters MD, Paraiso MF, et al. Early experience with mesh excision for adverse outcomes after transvaginal mesh placement using prolapse kits. Am J Obstet Gynecol 2008; 199:703.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/21\">",
"      Tijdink MM, Vierhout ME, Heesakkers JP, Withagen MI. Surgical management of mesh-related complications after prior pelvic floor reconstructive surgery with mesh. Int Urogynecol J 2011; 22:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/22\">",
"      Hurtado EA, Appell RA. Management of complications arising from transvaginal mesh kit procedures: a tertiary referral center's experience. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/23\">",
"      Madjar S, Frischer Z, Nieder AM, Waltzer WC. Bladder wall abscess following midurethral sling procedure. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/24\">",
"      Lee SY, Kim JY, Park SJ, et al. Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence. Korean J Urol 2010; 51:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/25\">",
"      DeSouza R, Shapiro A, Westney OL. Adductor brevis myositis following transobturator tape procedure: a case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/26\">",
"      Connolly TP. Necrotizing surgical site infection after tension-free vaginal tape. Obstet Gynecol 2004; 104:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/27\">",
"      Sivanesan K, Abdel-Fattah M, Tierney J. Perineal cellulitis and persistent vaginal erosion after transobturator tape (Obtape)--case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/28\">",
"      Karsenty G, Boman J, Elzayat E, et al. Severe soft tissue infection of the thigh after vaginal erosion of transobturator tape for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/29\">",
"      Harmanli O, Boyer RL, Metz S, et al. Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures and review of the literature. Int Urogynecol J 2011; 22:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/30\">",
"      Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/31\">",
"      Sanabria A, Dom&iacute;nguez LC, Valdivieso E, G&oacute;mez G. Prophylactic antibiotics for mesh inguinal hernioplasty: a meta-analysis. Ann Surg 2007; 245:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/32\">",
"      ACOG Committee on Practice Bulletins--Gynecology. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2009; 113:1180.",
"     </a>",
"    </li>",
"    <li>",
"     American Urologic Association: Urologic surgery antimicrobial prophylaxis file://www.auanet.org/content/media/antimicroprop08.pdf (Accessed on August 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/34\">",
"      Sung VW, Rogers RG, Schaffer JI, et al. Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol 2008; 112:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/35\">",
"      Altman D, V&auml;yrynen T, Engh ME, et al. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 2011; 364:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/36\">",
"      Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 2008; 111:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/37\">",
"      Rooney K, Kenton K, Mueller ER, et al. Advanced anterior vaginal wall prolapse is highly correlated with apical prolapse. Am J Obstet Gynecol 2006; 195:1837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/38\">",
"      Diwadkar GB, Barber MD, Feiner B, et al. Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstet Gynecol 2009; 113:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/39\">",
"      Blandon RE, Gebhart JB, Trabuco EC, Klingele CJ. Complications from vaginally placed mesh in pelvic reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/40\">",
"      Feiner B, Maher C. Vaginal mesh contraction: definition, clinical presentation, and management. Obstet Gynecol 2010; 115:325.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm (Accessed on August 10, 2011).",
"    </li>",
"    <li>",
"     United States Food and Drug Administration Obstetrics &amp; Gynecology Devices Panel report, September, 2011. file://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM271769.pdf (Accessed on September 26, 2011).",
"    </li>",
"    <li>",
"     file://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm (Accessed on January 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/44\">",
"      Murphy M, Holzberg A, van Raalte H, et al. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: \"UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse\". Int Urogynecol J 2012; 23:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/45\">",
"      Committee on Gynecologic Practice. Committee Opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol 2011; 118:1459.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.sgsonline.org/sgsinc/sgsmeetings/pdf/SGS_Statement.pdf (Accessed on April 17, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/47\">",
"      Davila GW. Optimizing safety and appropriateness of graft use in pelvic reconstructive surgery: introduction to the 2nd IUGA Grafts Roundtable. Int Urogynecol J 2012; 23 Suppl 1:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/48\">",
"      Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J 2012; 23 Suppl 1:S7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/49\">",
"      Slack M, Ostergard D, Cervigni M, Deprest J. A standardized description of graft-containing meshes and recommended steps before the introduction of medical devices for prolapse surgery. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J 2012; 23 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/50\">",
"      Winters JC, Jacquetin B, Castro R. Credentialing for transvaginal mesh placement--a case for \"added qualification\" in competency. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J 2012; 23 Suppl 1:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/51\">",
"      Miller D, Milani AL, Sutherland SE, et al. Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J 2012; 23 Suppl 1:S33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/52\">",
"      Haylen BT, Freeman RM, Swift SE, et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) &amp; grafts in female pelvic floor surgery. Int Urogynecol J 2011; 22:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/53\">",
"      Bako A, Dhar R. Review of synthetic mesh-related complications in pelvic floor reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/54\">",
"      Sivaslioglu AA, Unlubilgin E, Dolen I. A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/55\">",
"      Trabuco EC, Klingele CJ, Gebhart JB. Xenograft use in reconstructive pelvic surgery: a review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/56\">",
"      Abed H, Rahn DD, Lowenstein L, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J 2011; 22:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/57\">",
"      Jia X, Glazener C, Mowatt G, et al. Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. BJOG 2008; 115:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/58\">",
"      Foon R, Toozs-Hobson P, Latthe PM. Adjuvant materials in anterior vaginal wall prolapse surgery: a systematic review of effectiveness and complications. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/59\">",
"      Nygaard IE, McCreery R, Brubaker L, et al. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol 2004; 104:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/60\">",
"      Margulies RU, Lewicky-Gaupp C, Fenner DE, et al. Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol 2008; 199:678.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/61\">",
"      Gauruder-Burmester A, Koutouzidou P, Rohne J, et al. Follow-up after polypropylene mesh repair of anterior and posterior compartments in patients with recurrent prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/62\">",
"      Hinoul P, Ombelet WU, Burger MP, Roovers JP. A prospective study to evaluate the anatomic and functional outcome of a transobturator mesh kit (prolift anterior) for symptomatic cystocele repair. J Minim Invasive Gynecol 2008; 15:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/63\">",
"      Letouzey V, Deffieux X, Levailolant J, et al. Ultrasound evaluation of polypropylene mesh contraction at long term after vaginal surgery for cystocele repair (abstract). Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:S205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/64\">",
"      Moore RD, Miklos JR. Vaginal repair of cystocele with anterior wall mesh via transobturator route: efficacy and complications with up to 3-year followup. Adv Urol 2009; :743831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/65\">",
"      Velemir L, Amblard J, Fatton B, et al. Transvaginal mesh repair of anterior and posterior vaginal wall prolapse: a clinical and ultrasonographic study. Ultrasound Obstet Gynecol 2010; 35:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/66\">",
"      Dietz HP, Erdmann M, Shek KL. Mesh contraction: myth or reality? Am J Obstet Gynecol 2011; 204:173.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/67\">",
"      Svab&iacute;k K, Martan A, Masata J, et al. Ultrasound appearances after mesh implantation--evidence of mesh contraction or folding? Int Urogynecol J 2011; 22:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/68\">",
"      Chien HW, Kumakura E, Koyama M. Iliosacral bacterial arthritis and retroperitoneal abscess after tension-free vaginal mesh reconstruction. Int Urogynecol J 2010; 21:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/69\">",
"      Lo TS, Ashok K. Recurrent mesh erosion and retropubic abscess following anterior intravaginal slingplasty. J Obstet Gynaecol Res 2011; 37:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/70\">",
"      Chen HW, Guess MK, Connell KA, Bercik RS. Ischiorectal abscess and ischiorectal-vaginal fistula as delayed complications of posterior intravaginal slingplasty: a case report. J Reprod Med 2009; 54:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/71\">",
"      Milani R, Salvatore S, Soligo M, et al. Functional and anatomical outcome of anterior and posterior vaginal prolapse repair with prolene mesh. BJOG 2005; 112:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/72\">",
"      Ng CC, Chong CY. The effectiveness of transvaginal anterior colporrhaphy reinforced with polypropylene mesh in the treatment of severe cystoceles. Ann Acad Med Singapore 2006; 35:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/73\">",
"      Luck AM, Steele AC, Leong FC, McLennan MT. Short-term efficacy and complications of posterior intravaginal slingplasty. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/74\">",
"      Karateke A, Akdemir Y, Kucukbas M, et al. Recurrent ischiorectal abscess secondary to transobturator tape erosion: an unusual chronic complication. Eur J Obstet Gynecol Reprod Biol 2011; 158:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/75\">",
"      Araco F, Gravante G, DE Vita D, et al. Obturator abscess with spread to the thigh after three years from a transobturator procedure. Aust N Z J Obstet Gynaecol 2009; 49:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/76\">",
"      Ogle CA, Shepherd JP, Sutkin G. Posterior rectus abdominis sheath abscess after tension-free vaginal tape. Int Urogynecol J 2012; 23:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/77\">",
"      Dwyer PL, O'Reilly BA. Transvaginal repair of anterior and posterior compartment prolapse with Atrium polypropylene mesh. BJOG 2004; 111:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/62/26602/abstract/78\">",
"      Fatton B, Amblard J, Debodinance P, et al. Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)--a case series multicentric study. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:743.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8077 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-211.167.112.17-380DEE3FB3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26602=[""].join("\n");
var outline_f25_62_26602=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H38\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H314126\">",
"      TYPES OF PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H314134\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H314143\">",
"      - Pelvic organ prolapse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H314181\">",
"      - Stress urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H314234\">",
"      Transvaginal mesh kits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H314664\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H314673\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H314709\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H775454\">",
"      ISSUES REGARDING TRANSVAGINAL GRAFTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H313019\">",
"      Safety concerns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20571124\">",
"      FDA warning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H420043\">",
"      Professional society guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20571989\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Graft erosion or extrusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6017123\">",
"      - Management of erosion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5693853\">",
"      Graft contraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H178271\">",
"      Pelvic pain or dyspareunia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H312308\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H280554\">",
"      Urinary tract function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H279441\">",
"      Defecatory dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H276875\">",
"      Fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/8077\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8077|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/8/43141\" title=\"figure 1\">",
"      Transvaginal mesh kits second generation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8077|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/27/1469\" title=\"table 1\">",
"      Urogynecologic reconstructive materials terminology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=related_link\">",
"      Control measures to prevent surgical site infection following gastrointestinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=related_link\">",
"      Epidemiology and pathogenesis of and risk factors for surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9337?source=related_link\">",
"      Pelvic organ prolapse in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/33/11799?source=related_link\">",
"      Reconstructive materials used in surgery: Classification and host response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16055?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a type of midurethral sling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33562?source=related_link\">",
"      Stress urinary incontinence in women: Retropubic midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=related_link\">",
"      Stress urinary incontinence in women: Transobturator midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44424?source=related_link\">",
"      Surgical management of posterior vaginal defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32842?source=related_link\">",
"      Treatment of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_62_26603="Tx AF after pneumonectomy";
var content_f25_62_26603=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested guidelines for the treatment of atrial fibrillation after pneumonectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Anticoagulation with heparin*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug for rate control",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrical cardioversion if hemodynamically unstable or no reversion to sinus rhythm in 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If no recurrence, discontinue rate control drug in 4 to 8 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If recurrence, start antiarrhythmic drug",
"        <sup>",
"         &Delta;",
"        </sup>",
"        or electrical cardioversion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If no recurrence, discontinue antiarrhythmic agent in 4 to 8 weeks and rate control drug in 12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If second recurrence, anticoagulate with warfarin. If no response in 6 to 12 weeks, attempt electrical cardioversion",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * If no contraindication to anticoagulation.",
"     <br>",
"      &bull; Beta-adrenergic blockers are the first choice unless contraindicated. If so, diltiazem is recommended. Digoxin may be used in patients with left ventricular dysfunction.",
"      <br>",
"       &Delta; Includes procainamide, quinidine, disopyramide, flecainide, propafenone, amiodarone, sotalol, and ibutilide. Amiodarone should be used with caution due to reports of ARDS developing after pneumonectomy.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Ommen SR, Odell JA, Stanton MS, N Engl J Med 1997; 336:1429.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26603=[""].join("\n");
var outline_f25_62_26603=null;
var title_f25_62_26604="Evidence for maternal outcomes from TOLAC versus ERCD";
var content_f25_62_26604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of strength of evidence and findings for maternal outcomes from TOLAC compared with ERCD",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Maternal outcome",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number of studies/subjects",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Grade of evidence",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Direction of effect",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Magnitude of effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        TOL",
"       </td>",
"       <td class=\"subtitle2\">",
"        ERCD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maternal death",
"       </td>",
"       <td>",
"        12/402,883",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Significantly reduced by TOL",
"       </td>",
"       <td>",
"        0.004 percent",
"       </td>",
"       <td>",
"        0.013 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uterine rupture",
"       </td>",
"       <td>",
"        8/63,4999",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Significantly increased by TOL",
"       </td>",
"       <td>",
"        0.47 percent",
"       </td>",
"       <td>",
"        0.026 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hysterectomy",
"       </td>",
"       <td>",
"        8/402,059",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        No significant change",
"       </td>",
"       <td>",
"        0.17 percent",
"       </td>",
"       <td>",
"        0.28 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemorrhage",
"       </td>",
"       <td>",
"        6/47,754",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td colspan=\"3\">",
"        Insufficient data to evaluate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transfusion",
"       </td>",
"       <td>",
"        9/401,307",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        No significant difference",
"       </td>",
"       <td>",
"        0.9 percent",
"       </td>",
"       <td>",
"        1.2 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"       <td>",
"        22/354,060",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        No significant difference",
"       </td>",
"       <td>",
"        4.6 percent",
"       </td>",
"       <td>",
"        3.2 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Surgical injury",
"       </td>",
"       <td>",
"        4/53,282",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td colspan=\"3\">",
"        Insufficient data to evaluate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TOL: trial of labor; ERCD: elective repeat cesarean delivery; TOLAC: trial of labor after cesarean.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Guise JM, Denman MA, Emeis C, et al. Vaginal birth after cesarean. New insights on Maternal and neonatal outcomes. Obstet Gynecol 2010; 115:1267. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26604=[""].join("\n");
var outline_f25_62_26604=null;
var title_f25_62_26605="Magnetic imaging colonoscopy";
var content_f25_62_26605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/52473/magcolon_conv.mp4?title=Magnetic+imaging+colonoscopy\" style=\"width:168px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Magnetic imaging colonoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intubation from the splenic flexure to the cecal pole through an amazingly long and mobile proximal and sigmoid colon, with an unusual spiral or gamma loop in the transverse colon. See how the sigmoid colon is pushed up toward the diaphragm due to its remarkable elasticity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher B Williams BM, FRCP, FRCS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26605=[""].join("\n");
var outline_f25_62_26605=null;
var title_f25_62_26606="Trials ESA in patients treated with RT or chemotherapy";
var content_f25_62_26606=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F83619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F83619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Controlled trials of an erythropoiesis stimulating agent (ESA) in patients treated with radiation therapy or chemotherapy that were included in the Glaspy 2010 meta-analysis",
"    <sup>",
"     [1]",
"    </sup>",
"    addressing the survival impact of ESAs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study publication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Study number or alias",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tumor type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients analyzed*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Odds ratio (95 percent CI) for disease progression*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Radiotherapy only setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Henke et al, 2003",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        ENHANCE",
"       </td>",
"       <td>",
"        Head and neck",
"       </td>",
"       <td>",
"        351",
"       </td>",
"       <td>",
"        1.56 (1.01 - 2.39)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Overgaard et al, 2007",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        SE-2002-9001 (DAHANCA-10)",
"       </td>",
"       <td>",
"        Head and neck",
"       </td>",
"       <td>",
"        513",
"       </td>",
"       <td>",
"        1.77 (1.25 - 2.52)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Machtay et al, 2007",
"       </td>",
"       <td>",
"        RTOG-99-03",
"        <br/>",
"        PR99-03-046",
"       </td>",
"       <td>",
"        Head and neck",
"       </td>",
"       <td>",
"        148",
"       </td>",
"       <td>",
"        1.05 (0.55 - 2.00)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Identified as unpublished in Glaspy et al, 2010",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-GBR-7",
"       </td>",
"       <td>",
"        Head and neck",
"       </td>",
"       <td>",
"        300",
"       </td>",
"       <td>",
"        1.02 (0.65 - 1.62)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Chemotherapy setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Osterborg et al, 1996",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        MF4250",
"       </td>",
"       <td>",
"        Hematological",
"       </td>",
"       <td>",
"        144",
"       </td>",
"       <td>",
"        1.20 (0.60 - 2.40)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Littlewood et al, 2001",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-INT-10",
"       </td>",
"       <td>",
"        Solid/non-myeloid malignancy",
"       </td>",
"       <td>",
"        375",
"       </td>",
"       <td>",
"        0.64 (0.40 - 1.02)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pronzato et al, 2002",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-INT-47",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        223",
"       </td>",
"       <td>",
"        1.02 (0.46 - 2.26)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vansteenkiste et al, 2002",
"       </td>",
"       <td>",
"        AMG 980297",
"       </td>",
"       <td>",
"        SCLC and NSCLC",
"       </td>",
"       <td>",
"        314",
"       </td>",
"       <td>",
"        0.58 (0.30 - 1.11)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hedenus et al, 2003",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        AMG 20000161",
"       </td>",
"       <td>",
"        Hematological",
"       </td>",
"       <td>",
"        344",
"       </td>",
"       <td>",
"        1.08 (0.66 - 1.76)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Milroy et al, 2003",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-INT-49",
"       </td>",
"       <td>",
"        NSCLC",
"       </td>",
"       <td>",
"        424",
"       </td>",
"       <td>",
"        0.90 (0.57 - 1.41)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blohmer et al, 2004",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        AGO/NOGGO",
"        <br/>",
"        EPO-GER-8",
"       </td>",
"       <td>",
"        Cervical",
"       </td>",
"       <td>",
"        250",
"       </td>",
"       <td>",
"        0.61 (0.33 - 1.13)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vadhan-Raj et al, 2004",
"        <sup>",
"         &loz;&sect;",
"        </sup>",
"       </td>",
"       <td>",
"        PR00-03-006",
"       </td>",
"       <td>",
"        Gastric and rectal",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        1.01 (0.35 - 2.94)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chang et al, 2005",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-CAN-17",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        354",
"       </td>",
"       <td>",
"        0.82 (0.39 - 1.72)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Grote et al, 2005",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        N93-004",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"       <td>",
"        224",
"       </td>",
"       <td>",
"        0.85 (0.50 - 1.44)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Leyland-Jones et al, 2005",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-INT-76 (BEST)",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        939",
"       </td>",
"       <td>",
"        0.84 (0.64 - 1.08)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Osterborg et al, 2005",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        MF4467",
"       </td>",
"       <td>",
"        Hematological",
"       </td>",
"       <td>",
"        343",
"       </td>",
"       <td>",
"        0.74 (0.44 - 1.25)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Witzig et al, 2005",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        PR98-27-008",
"       </td>",
"       <td>",
"        Mixed",
"       </td>",
"       <td>",
"        344",
"       </td>",
"       <td>",
"        1.20 (0.75 - 1.91)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wilkinson et al, 2006e",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-INT-45",
"       </td>",
"       <td>",
"        Ovarian",
"       </td>",
"       <td>",
"        181",
"       </td>",
"       <td>",
"        7.47 (0.95 - 58.54)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Engert et al, 2007",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        GHSG",
"        <br/>",
"        HD15EPO",
"       </td>",
"       <td>",
"        Hodgkin's lymphoma",
"       </td>",
"       <td>",
"        688",
"       </td>",
"       <td>",
"        0.86 (0.33 - 2.24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Moebus et al, 2007",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        EPO-GER-7",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        643",
"       </td>",
"       <td>",
"        1.05 (0.75 - 1.48)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aapro et al, 2008",
"       </td>",
"       <td>",
"        BRAVE",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        463",
"       </td>",
"       <td>",
"        1.07 (0.82 - 1.40)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pirker et al, 2008",
"       </td>",
"       <td>",
"        AMG 20010145",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"       <td>",
"        596",
"       </td>",
"       <td>",
"        0.87 (0.52 - 1.46)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Strauss et al, 2008",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        MARCH",
"       </td>",
"       <td>",
"        Cervical",
"       </td>",
"       <td>",
"        74",
"       </td>",
"       <td>",
"        0.87 (0.32 - 2.33)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thomas et al, 2008",
"        <sup>",
"         &bull;&sect;",
"        </sup>",
"       </td>",
"       <td>",
"        GOG-191",
"       </td>",
"       <td>",
"        Cervical",
"       </td>",
"       <td>",
"        109",
"       </td>",
"       <td>",
"        1.02 (0.48 - 2.15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Untch et al, 2008",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        PREPARE",
"       </td>",
"       <td>",
"        Breast",
"       </td>",
"       <td>",
"        733",
"       </td>",
"       <td>",
"        1.36 (0.97 - 1.91)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ESA: erythropoiesis-stimulating agent; BEST: Breast Cancer Erythropoietin Survival Trial; CI: confidence interval; DAHANCA-10: The Danish Head and Neck Cancer-10; ENHANCE: Erythropoietin in Head and Neck Cancer; Epo: erythropoietin; NSCLC: non-small cell lung cancer; PREPARE: The Preoperative Epirubicin Paclitaxel Aranesp; RTOG: The Radiation Therapy Oncology Group; SCLC: small cell lung cancer.",
"     <br/>",
"     * Data are from the Glaspy et al (2010) study-level meta-analysis of controlled ESA trials in the oncology setting that reported survival data (these data are not from the ESA-product labels). Odds ratios were calculated using a random effects model. References listed refer to those used for the Glaspy et al (2010) meta-analysis.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     ESA oncology studies of concern described in the ESA-product labeling.",
"     <br/>",
"     &Delta; As the Glaspy et al (2010) meta-analysis, updated publications have been made available for these studies.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Studies in which disease progression was evaluated only as part of tumour assessment.",
"     <br/>",
"     &sect; Patients received chemotherapy and radiotherapy.",
"    </div>",
"    <div class=\"reference\">",
"     Reference:",
"     <ol>",
"      <li>",
"       Glaspy J, et al. Br J Cancer 2010; 102:301.",
"      </li>",
"     </ol>",
"     <p>",
"      &nbsp;Reprinted by permission from: Macmillan Publishers Ltd on behalf of Cancer Research UK: Aapro M, Jelkmann W, Constantinescu SN, Leyland-Jones B. Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer 2012; 106:1249.",
"      <a href=\"file://www.nature.com/bjc/index.html\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"       file://www.nature.com/bjc/index.html",
"      </a>",
"      . Copyright &copy; 2012.",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26606=[""].join("\n");
var outline_f25_62_26606=null;
var title_f25_62_26607="Breisky Navratil retractors";
var content_f25_62_26607=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    Breisky-Navratil vaginal retractors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_62_26607=[""].join("\n");
var outline_f25_62_26607=null;
